<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?DTDIdentifier.IdentifierValue http://null/schema/dtds/document/fulltext/xcr/xocs-article.xsd?><?DTDIdentifier.IdentifierType schema?><?SourceDTD.DTDName xocs-article.xsd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName ftrr2jats.xsl?><?ConverterInfo.Version 1?><?origin publisher?><front><journal-meta><journal-id journal-id-type="nlm-ta">S Afr J Bot</journal-id><journal-id journal-id-type="iso-abbrev">S Afr J Bot</journal-id><journal-title-group><journal-title>South African Journal of Botany</journal-title></journal-title-group><issn pub-type="ppub">0254-6299</issn><issn pub-type="epub">0254-6299</issn><publisher><publisher-name>SAAB. Published by Elsevier B.V.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7970016</article-id><article-id pub-id-type="pii">S0254-6299(21)00086-7</article-id><article-id pub-id-type="doi">10.1016/j.sajb.2021.03.012</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Natural product remedies for COVID-19: A focus on safety</article-title></title-group><contrib-group><contrib contrib-type="author" id="au0001"><name><surname>Omokhua-Uyi</surname><given-names>Aitebiremen Gift</given-names></name></contrib><contrib contrib-type="author" id="au0002"><name><surname>Van Staden</surname><given-names>Johannes</given-names></name><xref rid="cor0001" ref-type="corresp">&#x0204e;</xref></contrib><aff id="aff0001">Research Centre for Plant Growth and Development, School of Life Sciences, University of KwaZulu-Natal Pietermaritzburg, Private Bag X01, Scottsville 3201, South Africa</aff></contrib-group><author-notes><corresp id="cor0001"><label>&#x0204e;</label>Corresponding author.</corresp></author-notes><pub-date pub-type="pmc-release"><day>18</day><month>3</month><year>2021</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.--><pub-date pub-type="ppub"><month>7</month><year>2021</year></pub-date><pub-date pub-type="epub"><day>18</day><month>3</month><year>2021</year></pub-date><volume>139</volume><fpage>386</fpage><lpage>398</lpage><history><date date-type="received"><day>26</day><month>11</month><year>2020</year></date><date date-type="rev-recd"><day>23</day><month>1</month><year>2021</year></date><date date-type="accepted"><day>3</day><month>3</month><year>2021</year></date></history><permissions><copyright-statement>&#x000a9; 2021 SAAB. Published by Elsevier B.V. All rights reserved.</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>SAAB</copyright-holder><license><license-p>Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.</license-p></license></permissions><abstract id="abs0002"><p>Infection by the novel coronavirus SARS-CoV-2 causing the coronavirus disease (COVID-19), is currently a global pandemic with more than two million deaths to date. Though a number of vaccines have recently been approved against the virus, availability remains a big challenge, and also acceptance by most people has become a big debate. This review discusses possible/proposed natural product remedies and some major conventional treatment options used to manage the infection and, safety concerns on the use of unproven or unapproved health products against COVID-19. An extensive literature review indicated that the influx of unproven and unapproved health products in the global market are on the rise, leading to various forms of self- medication. To this effect, there have been warnings by the United States Food and Drug Administration and the World Health Organisation against the use of such products. Conventional drugs such as remdesivir, chloroquine/hydroxychloroquine and dexamethasone are the major proposed drugs that are currently undergoing clinical trials for the management of this disease. Efforts are being made globally in the search for possible therapeutics which may be the best way to eradicating this disease. Some countries have approved the use of natural products in the management of COVID-19, despite little or no clinical evidence on their efficacy and safety. Natural products may hold a great potential in the fight against COVID-19 but without detailed clinical trials, their potency against the virus and their safe use cannot be established. To attain this goal, extensive research followed by clinical studies are needed. Collaborative efforts between researchers, clinicians, governments and traditional medicinal practitioners in the search and development of safe and effective therapeutics from natural products for the treatment of COVID-19 could be a potential option.</p></abstract><kwd-group id="keys0001"><title>Keywords</title><kwd>Coronavirus</kwd><kwd>COVID-19 treatment</kwd><kwd>Natural products</kwd><kwd>Safety</kwd><kwd>Self-medication</kwd><kwd>Toxicity</kwd></kwd-group></article-meta><notes><p id="m1">Edited by S Gupta</p></notes></front><body><sec id="sec0001"><label>1</label><title>Introduction</title><p id="para0007">Coronaviruses are a large group of viruses belonging to the family Coronaviridaea that cause upper-respiratory tract illnesses, ranging from common colds to more severe diseases (<xref rid="bib0129" ref-type="bibr">WHO,&#x000a0;2020a</xref>). Coronaviruses are zoonotic with many varieties common in animal species (<xref rid="bib0129" ref-type="bibr">WHO,&#x000a0;2020a</xref>). From these animal origins, they can undergo mutation, recombination and adaptation and be passed on to humans (<xref rid="bib0049" ref-type="bibr">Health24, 2020</xref>; <xref rid="bib0070" ref-type="bibr">Lau&#x000a0;et&#x000a0;al., 2020</xref>; <xref rid="bib0129" ref-type="bibr">WHO,&#x000a0;2020a</xref>). The first coronavirus was characterised and identified in humans in the mid-1960s (<xref rid="bib0062" ref-type="bibr">Kahn&#x000a0;and McIntosh,&#x000a0;2005</xref>; <xref rid="bib0007" ref-type="bibr">Andersen&#x000a0;et&#x000a0;al., 2020</xref>; <xref rid="bib0056" ref-type="bibr">Jaiswal&#x000a0;and Saxena,&#x000a0;2020</xref>). To date, seven coronaviruses have been recorded in humans and are classified as &#x003b1;-coronaviruses (NL63 and 229E) and &#x003b2;-coronaviruses (OC43 and HKU1) (<xref rid="bib0007" ref-type="bibr">Andersen&#x000a0;et&#x000a0;al., 2020</xref>; <xref rid="bib0056" ref-type="bibr">Jaiswal&#x000a0;and Saxena,&#x000a0;2020</xref>). The &#x003b2;-coronavirus SARS-CoV, which causes severe acute respiratory syndrome (SARS) was first recorded in humans in 2002 (<xref rid="bib0070" ref-type="bibr">Lau&#x000a0;et&#x000a0;al., 2020</xref>). This was followed by the &#x003b2;-MERS-CoV, known as the Middle East respiratory syndrome (MERS) coronavirus, in 2012 (<xref rid="bib0019" ref-type="bibr">CDC,&#x000a0;2020a</xref>; <xref rid="bib0104" ref-type="bibr">Schr&#x000f6;der,&#x000a0;2020</xref>). The SARS-CoV was transmitted from civet cats to humans with outbreaks traced to Chinese markets, while the MERS-CoV was believed to have been contracted by humans first in Saudi Arabi from dromedary camels who may have been infected by bats (<xref rid="bib0063" ref-type="bibr">Kan&#x000a0;et&#x000a0;al., 2005</xref>; <xref rid="bib0094" ref-type="bibr">Paden&#x000a0;et&#x000a0;al., 2018</xref>; <xref rid="bib0127" ref-type="bibr">WHO,&#x000a0;2019a</xref>, <xref rid="bib0129" ref-type="bibr">2020a</xref>).</p><p id="para0008">The recent outbreak is the <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/coronavirus/2019-ncov/index.html" id="interref0001">SARS-CoV-2, a novel coronavirus which causes the disease COVID-19</ext-link> (<xref rid="bib0070" ref-type="bibr">Lau&#x000a0;et&#x000a0;al., 2020</xref>). The first reported case was in China in December 2019. The virus was believed to have developed in bats and later in pangolins (<xref rid="bib0048" ref-type="bibr">Hassanin,&#x000a0;2020</xref>; <xref rid="bib0095" ref-type="bibr">Panyod&#x000a0;et&#x000a0;al., 2020</xref>; <xref rid="bib0142" ref-type="bibr">Zhang&#x000a0;et&#x000a0;al., 2020</xref>) and to have spread from a Chinese seafood marketplace (<xref rid="bib0107" ref-type="bibr">Shereen&#x000a0;et&#x000a0;al., 2020</xref>). However, recent studies show a virus with 99% genomic agreement to SARS-CoV-2, suggesting that the COVID-19 virus is the result of a recombination between two different viruses. Thus, the exact origin of the virus is still uncertain (<xref rid="bib0048" ref-type="bibr">Hassanin,&#x000a0;2020</xref>). The virus spreads through saliva droplets from talking and discharge from the nose and mouth of an infected person, through coughing or sneezing (<xref rid="bib0020" ref-type="bibr">CDC,&#x000a0;2020b</xref>). When these droplets are aerosolized, the virus can remain viable in the air for about 3 h, suggesting possible airborne transmission (<xref rid="bib0117" ref-type="bibr">van&#x000a0;Doremalen et&#x000a0;al., 2020</xref>). The presence of SARS-CoV-2 RNA have also been detected in stools and urine of infected patients (<xref rid="bib0114" ref-type="bibr">Sun&#x000a0;et&#x000a0;al., 2020</xref>; <xref rid="bib0120" ref-type="bibr">Wang&#x000a0;et&#x000a0;al., 2020a</xref>). With more research, other possible SARS-CoV-2 routes of transmission may be discovered. Hence, alternative forms of transmission cannot be excluded when taking safety measures.</p><p id="para0009">Most people exposed to the COVID-19 virus experience mild to moderate respiratory illness and recover without requiring special treatment (<xref rid="bib0130" ref-type="bibr">WHO,&#x000a0;2020b</xref>). However, the older population and those whose immune systems have been compromised due to medical conditions such as diabetes, obesity, chronic kidney disease, cardiovascular diseases, chronic respiratory diseases (CRDs), cancers, sickle cell disease and human immunodeficiency virus - acquired immunodeficiency syndrome (HIV-AIDS) are at higher risk (<xref rid="bib0021" ref-type="bibr">CDC,&#x000a0;2020c</xref>; <xref rid="bib0025" ref-type="bibr">Clark&#x000a0;et&#x000a0;al., 2020</xref>). People infected with COVID-19 usually start to show symptoms between 2-14 days after exposure to the virus (<xref rid="bib0022" ref-type="bibr">CDC,&#x000a0;2020d</xref>). Symptoms include cough, headache, muscle or body aches, fever or chills, fatigue, shortness of breath or difficulty with breathing, new loss of taste or smell, congestion or runny nose, sore throat, nausea or vomiting and diarrhoea (<xref rid="bib0022" ref-type="bibr">CDC,&#x000a0;2020d</xref>). Due to the novel nature of the virus, the list of possible symptoms is not exhaustive, and research is still ongoing.</p><p id="para0010">The disease progression and mortality rates of MERS and SARS cannot be compared to that of COVID-19 which has resulted in unprecedented number of deaths more than two million and placed massive pressure on the world economy (<xref rid="bib0042" ref-type="bibr">Gazeta,&#x000a0;2020</xref>). The World Health Organisation (WHO) declared the COVID-19 outbreak a global pandemic (<xref rid="bib0131" ref-type="bibr">WHO,&#x000a0;2020c</xref>). Millions of people have been placed under quarantine all over the world as a measure to curb the COVID-19 outbreak. Only recently has the economy in certain countries started to open gradually even though the infection rate is still on the increase. A global situation report by the WHO as of 7:08pm Central European Summer Time (CEST) on 15 January 2021 showed 91,816,091 confirmed cases of COVID-19, including 1,986,871 deaths (<xref rid="bib0132" ref-type="bibr">WHO,&#x000a0;2020d</xref>). This review highlights: (1) proposed/repurposed therapeutics for the management of COVID-19 virus including natural products (2) the dangers of self-medication in using products with no clinical evidence of therapeutic activity, possible mechanisms of action and safety records against COVID-19 and (3) possible ways forward that may assist in the fight against the pandemic.</p></sec><sec id="sec0002"><label>2</label><title>Methodology</title><p id="para0011">The information presented in this review was obtained from scientific literature databases such as Google Scholar, Science-Direct, PubMed, Scifinder, Web of Science and Scopus. Key words used include; Coronavirus, COVID-19, natural products, traditional, herbal preparation, toxicity, safety, World Health Organisation, Centers for Disease Control and Food and Drug Administration. More than 400 units of literature were screened and those relevant to the aim of this review were considered.</p></sec><sec id="sec0003"><label>3</label><title>Conventional drugs currently under investigation and used in the management of COVID-19</title><p id="para0012">Though a number of vaccines have recently been approved against the SARS-CoV-2 virus, availability to the public remains a big challenge, and also acceptance by most people has become a big debate. In most cases, patients are given medical care or supportive therapy with oxygen and fluids to help relieve symptoms (<xref rid="bib0012" ref-type="bibr">Auwaerter,&#x000a0;2020</xref>; <xref rid="bib0032" ref-type="bibr">Eyvazzadeh,&#x000a0;2020</xref>). Sometimes antibiotics are used to treat secondary infections (<xref rid="bib0035" ref-type="bibr">Farooq,&#x000a0;2020</xref>; <xref rid="bib0048" ref-type="bibr">Hassanin,&#x000a0;2020</xref>). However, there are many ongoing clinical trials evaluating potential treatments. Drugs of target for the treatment of COVID-19 should be able to stop the replication of the virus SARS-CoV-2 that causes COVID-19, thereby reducing its disease-causing ability. Some of the established drugs currently under trials supported by the WHO are: remdesivir, chloroquine and hydroxychloroquine, and dexamethasone (<xref rid="bib0057" ref-type="bibr">Jean&#x000a0;et&#x000a0;al., 2020</xref>; <xref rid="bib0059" ref-type="bibr">Joseph,&#x000a0;2020</xref>; <xref rid="bib0133" ref-type="bibr">WHO,&#x000a0;2020e</xref>).</p><sec id="sec0004"><label>3.1</label><title>Remdesivir</title><p id="para0013">Remdesivir is an intravenous antiviral drug which was developed during the Ebola crisis. The drug can block the replication of viruses (<xref rid="bib0057" ref-type="bibr">Jean&#x000a0;et&#x000a0;al., 2020</xref>; <xref rid="bib0119" ref-type="bibr">Wang&#x000a0;et&#x000a0;al., 2020b</xref>). In a current study, 36 (68%) COVID-19 patients out of 53 treated with remdesivir showed clinical improvement (<xref rid="bib0044" ref-type="bibr">Grein&#x000a0;et&#x000a0;al., 2020</xref>). In another study, 541 patients were treated with remdesivir while 521 received the placebo. Patients treated with remdesivir recovered faster than patients in similar conditions who received the placebo (<xref rid="bib0014" ref-type="bibr">Beigel&#x000a0;et&#x000a0;al., 2020</xref>). In a multicentre trial in ten hospitals in Hubei province, China, most patients administered remdesivir for 10 days recovered faster than those administered the placebo. However, no significant advantage was recorded. Adverse events of 66% (102 out of 155) were reported in patients administered remdesivir while 64% (50 out of 70) were reported in patients who received the placebo (<xref rid="bib0121" ref-type="bibr">Wang&#x000a0;et&#x000a0;al., 2020c</xref>). Currently, there is a randomized controlled clinical trial (Adaptive COVID-19 Treatment Trial 3 (ACTT 3)), evaluating the safety and efficacy of remdesivir plus the immunomodulator interferon &#x003b2;-1a (traded as Rebif) in COVID-19 patients. This trial is sponsored by the National Institute of Allergy and Infectious Diseases (NIAID). The drug shows antiviral and anti-inflammatory properties, and the type 1 interferon can inhibit SARS-CoV-2, SARS-CoV and MERS-CoV (<xref rid="bib0084" ref-type="bibr">Medscape,&#x000a0;2020</xref>).</p></sec><sec id="sec0005"><label>3.2</label><title>Chloroquine and hydroxychloroquine</title><p id="para0014">Chloroquine and hydroxychloroquine are currently used to treat malaria, arthritis and lupus disease. In a study conducted by <xref rid="bib0105" ref-type="bibr">Self&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref>, hospitalized patients with respiratory illness from COVID-19 that were administered hydroxychloroquine compared with placebo, did not show significant improvement clinically after 14 days. Hence authors suggested that hydroxychloroquine is not effective against COVID-19. Some other clinical trials using hydroxychloroquine in COVID-19 patients also concluded that it did not in any way prevent infections better than a placebo (<xref rid="bib0050" ref-type="bibr">Herper,&#x000a0;2020</xref>). However, some clinical trials on the drug are still being conducted (<xref rid="bib0024" ref-type="bibr">Chen&#x000a0;et&#x000a0;al., 2020</xref>). In May 2020, chloroquine, hydroxychloroquine and remdesivir received emergency use authorization (EUA) from the Food and Drug Administration (<xref rid="bib0038" ref-type="bibr">FDA,&#x000a0;2020a</xref>) to manage severe cases of COVID-19 under hospital settings. However, on June 15, 2020, the FDA revoked the emergency use authorisation of chloroquine and hydroxychloroquine in cases where clinical trials were unavailable. The main concern with these drugs was their ability to cause cardiac problems (<xref rid="bib0039" ref-type="bibr">FDA,&#x000a0;2020b</xref>).</p></sec><sec id="sec0006"><label>3.3</label><title>Dexamethasone</title><p id="para0015">Current studies show dexamethasone as one of the most promising drugs for managing COVID-19. Dexamethasone is a glucocorticosteroid used in the treatment of different inflammatory conditions related to allergic disorders, skin conditions and lupus, <ext-link ext-link-type="uri" xlink:href="https://www.drugs.com/cg/psoriasis.html" id="interref0002">psoriasis</ext-link>, <ext-link ext-link-type="uri" xlink:href="https://www.drugs.com/cg/ulcerative-colitis.html" id="interref0003">ulcerative colitis</ext-link>, arthritis and respiratory disorders (<xref rid="bib0023" ref-type="bibr">Chemocare,&#x000a0;2020</xref>, <xref rid="bib0133" ref-type="bibr">WHO,&#x000a0;2020e</xref>). Dexamethasone is also used either alone or in combination with other drugs to treat some types of cancers or to prevent/treat cancer-related conditions (<xref rid="bib0090" ref-type="bibr">NCI, 2019</xref>). A preliminary clinical trial released by the University of Oxford, United Kingdom (UK) to the WHO on June 16, 2020, showed the effective use of dexamethasone in patients with COVID-19 under critical conditions. The treatment reduced mortality in patients on ventilators by about one-third. For patients requiring only oxygen, mortality was cut by about one-fifth (<xref rid="bib0133" ref-type="bibr">WHO,&#x000a0;2020e</xref>). The study, however, indicated that the positive effect was not as clear in patients with milder symptoms of the disease. A recent recovery trial conducted on 1007 hospitalised COVID-19 patients with respiratory failure that were administered a moderate dose of dexamethasone for 10 days with supplemental oxygen or mechanical ventilation, showed a reduced mortality rate. However, the same recovery trial also indicated that there might be an increased mortality rate in patients administered dexamethasone in the absence of supplementary oxygen or mechanical ventilator (<xref rid="bib0081" ref-type="bibr">Matthay&#x000a0;and Thompson,&#x000a0;2020</xref>). Following the outcome of the above studies, it can be deduced that it might not be advisable to administer dexamethasone to patients without oxygen support or ventilator.</p><p id="para0016">Even though the adverse effects of this drug may be less severe, this may not be the case with COVID-19 patients with Strongyloidiasis comorbidity, a rare but fatal parasitic disease caused by nematodes mostly associated with <italic>Strongyloides stercoralis</italic> (<xref rid="bib0110" ref-type="bibr">Stauffer&#x000a0;et&#x000a0;al., 2020</xref>). Therefore, proper diagnosis is very important before administering corticosteroids such as dexamethasone to patients. There is a relationship between corticosteroid therapy and strongyloidiasis with a two- to three-fold increased risk of being infected by <italic>S. stercoralis</italic> (<xref rid="bib0034" ref-type="bibr">Fardet&#x000a0;et&#x000a0;al., 2006</xref>). With little knowledge available on the mechanism involved in susceptibility, it is hypothesized that this may be through its suppressive effects on some major mediators of the immune response such as eosinophils to the parasite (<xref rid="bib0034" ref-type="bibr">Fardet&#x000a0;et&#x000a0;al., 2006</xref>). Such hypothesis needs to be tested through clinical studies.</p></sec></sec><sec id="sec0007"><label>4</label><title>Natural products as possible management/treatment options for COVID-19</title><p id="para0017">The use of natural products in the treatment and management of infections and diseases has a long history in human existence. Hence, it is possible that treatment for viral infections such as COVID-19 can be discovered from natural products such as plants and microorganisms (<xref rid="bib0109" ref-type="bibr">Sohail&#x000a0;et&#x000a0;al 2011</xref>; <xref rid="bib0001" ref-type="bibr">Abdalla&#x000a0;and McGaw,&#x000a0;2018</xref>). For example, one of the proposed treatments (as explained above) for COVID-19 is chloroquine (<xref rid="bib0035" ref-type="bibr">Farooq,&#x000a0;2020</xref>). Chloroquine is an anti-malaria drug which is an analogue of quinine isolated from the plant extract of <italic>Cinchona officinalis</italic> L. belonging to the family Rubiaceae (<xref rid="bib0073" ref-type="bibr">Lowe,&#x000a0;2020</xref>). Exploration of microorganisms such as endophytes as possible treatment for COVID-19 may also be beneficial as they are sources of treatments for other human diseases (<xref rid="bib0001" ref-type="bibr">Abdalla&#x000a0;and McGaw,&#x000a0;2018</xref>).</p><sec id="sec0008"><label>4.1</label><title>Endophytes</title><p id="para0018">Endophytes are microorganisms, mainly bacteria and fungi, living in the intercellular and intracellular regions of healthy plant tissues without constituting any harm to the plant. These organisms have a symbiotic relationship with the host plant. Many plants host at least one endophytic microbe (<xref rid="bib0102" ref-type="bibr">Ryan&#x000a0;et&#x000a0;al., 2008</xref>). These endophytes act as biological defences for the host plants against plant pathogens through the release of metabolites against plant predators or lyse affected cells by either inducing cell defence mechanisms or promoting the growth of the plant (<xref rid="bib0006" ref-type="bibr">Alvin&#x000a0;et&#x000a0;al., 2014</xref>). Endophytes can release hydrolytic enzymes or active compounds which help prevent the colonization of plant by pathogens, nematodes or insects (<xref rid="bib0112" ref-type="bibr">Strobel,&#x000a0;2003</xref>; <xref rid="bib0046" ref-type="bibr">Hallmann&#x000a0;et&#x000a0;al., 2006</xref>). Endophytes produce biologically active compounds, similar to those present in the host and sometimes distinct compounds that are effective against diseases such as cancers, viral infections and other life-threatening ailments (<xref rid="bib0001" ref-type="bibr">Abdalla&#x000a0;and McGaw,&#x000a0;2018</xref>). Several compounds have been isolated from endophytes that are useful for the treatment of various diseases caused by bacteria, fungi, and viruses. <xref rid="bib0140" ref-type="bibr">Zhang&#x000a0;et&#x000a0;al.&#x000a0;(2011)</xref> evaluated the antiviral activity of isolated compounds Emerimidine A and Emerimidine B from the endophytic fungi <italic>Emericella</italic> sp. from the mangrove plant <italic>Aegiceras corniculatum</italic> (L.). These compounds exhibited moderate antiviral activity. An endophytic fungi <italic>Pleospora tarda</italic> isolated from <italic>Ephedra aphylla</italic> Forssk showed a 40.7% inhibition against herpes simplex virus (HSV) and 15.2% against Vesicular stomatitis virus (VSV) (<xref rid="bib0106" ref-type="bibr">Selim&#x000a0;et&#x000a0;al., 2018</xref>). Although not tested, authors hypothesised that two compounds; alternariol and alternariol-(9)-methyl ether isolated from the endophytic fungi may be responsible for the antiviral activity. Extracts of endophytic fungi such as <italic>Alternaria alternata, Nigrospora sphaerica</italic> and <italic>Phialophora</italic> sp. showed antiviral activity against the HSV (<xref rid="bib0077" ref-type="bibr">Manganyi&#x000a0;and Ateba 2020</xref>). Compounds from endophytic fungi <italic>Phomopsis</italic> sp. isolated from <italic>Achyranthes bidentate</italic> Blume was reported to display promising antiviral activity against HIV-1 (<xref rid="bib0139" ref-type="bibr">Yang&#x000a0;et&#x000a0;al., 2020</xref>). Following the above reported antiviral activities, it is not unlikely that effective therapeutics may be discovered from endophytes. However, this may not be known if investigations are not carried out. For example, camphotothecin and podophyllotoxin are anticancer drugs isolated from endophytes (<xref rid="bib0098" ref-type="bibr">Puri&#x000a0;et&#x000a0;al., 2005</xref>, <xref rid="bib0097" ref-type="bibr">2006</xref>).</p></sec><sec id="sec0009"><label>4.2</label><title>Medicinal plants</title><p id="para0019">A plethora of research exploring herbal formulations and plant-derived molecules as possible treatments against COVID-19 are ongoing in countries such as China, India, Switzerland, Spain, USA, Saudi Arabia, Senegal, Nigeria, South Africa, among others (<xref rid="bib0003" ref-type="bibr">Akindele&#x000a0;et&#x000a0;al., 2020</xref>; <xref rid="bib0015" ref-type="bibr">Benarba&#x000a0;and Pandiella,&#x000a0;2020</xref>; <xref rid="bib0054" ref-type="bibr">Islam&#x000a0;et&#x000a0;al., 2020</xref>; <xref rid="bib0068" ref-type="bibr">Koe,&#x000a0;2020</xref>; <xref rid="bib0072" ref-type="bibr">Li&#x000a0;et&#x000a0;al.&#x000a0;2020</xref>; <xref rid="bib0093" ref-type="bibr">Orhan&#x000a0;and Deniz,&#x000a0;2020</xref>; <xref rid="bib0111" ref-type="bibr">Stirgus,&#x000a0;2020</xref>). A natural product supplement of curcumin and artemisinin-based oral spray with the product name artemiC, developed by MCG in collaboration with a Swiss firm Micelle Technology is currently undergoing clinical trials as a possible treatment for COVID-19 (<xref rid="bib0068" ref-type="bibr">Koe,&#x000a0;2020</xref>). Another example is the collaboration between the Universities of Yale, Minnesota and Michigan in two randomized trials evaluating the efficacy of administering a dietary supplement containing resistant starch to non-hospitalized COVID-19 patients (<xref rid="bib0079" ref-type="bibr">Mansour,&#x000a0;2020</xref>). There is some scientific evidence supporting dietary therapy and herbal medicines as potential antiviral agents against COVID-19, as have been noticed with other viral diseases (<xref rid="bib0095" ref-type="bibr">Panyod&#x000a0;et&#x000a0;al., 2020</xref>).</p><p id="para0020">A recent review screened 55 research articles to identify active phytochemicals against coronavirus infection. Compounds such as quercetin, tryptanthrin, scutellarein, saikosaponin B2, myricetin, caffeic acid, psoralidin, isobavachalcone and griffithsin were reported to inhibit human coronavirus, serving as leads for further studies (<xref rid="bib0078" ref-type="bibr">Mani&#x000a0;et&#x000a0;al., 2020</xref>). The most promising small molecules capable of inhibiting coronavirus contained a conjugated fused ring structure with the majority classified as polyphenols (<xref rid="bib0078" ref-type="bibr">Mani&#x000a0;et&#x000a0;al., 2020</xref>). Theaflavin (a polyphenol) from <italic>Camellia sinensis</italic> (L.) Kuntze suppressed SARS-CoV-2 via the inhibition of RNA-dependent RNA polymerase (RdRp) activity (<xref rid="bib0074" ref-type="bibr">Lung&#x000a0;et&#x000a0;al., 2020</xref>). A detailed mechanism of action and safety profile for this phytochemical will be necessary. Plant-derived alkaloids such as emetine, homoharringtonine and cepharanthine are other small molecules which display broad-spectrum antiviral activities and are currently being targeted as potential therapeutics for COVID-19 (<xref rid="bib0122" ref-type="bibr">Wang&#x000a0;and Yang,&#x000a0;2020</xref>). Cepharanthine inhibits SARS-CoV-2 through the suppression of agiotensin-converting enzyme 2 (ACE2) activity (<xref rid="bib0033" ref-type="bibr">Fan&#x000a0;et&#x000a0;al., 2020</xref>). Other plant molecules such as 7-methoxycryptopleurine, ouabain, lycorine, silvestrol, homoharringtonine and tylophorine are also under investigation (<xref rid="bib0054" ref-type="bibr">Islam&#x000a0;et&#x000a0;al., 2020</xref>).</p><p id="para0021">The potential of plant molecules with anti-inflammatory properties in the treatment of COVID-19 are also being considered. One example is celastrol (<xref rid="bib0087" ref-type="bibr">Nabavi&#x000a0;et&#x000a0;al., 2020</xref>), a plant-derived product mainly found in the Celastraceae family (<xref rid="bib0069" ref-type="bibr">Kutney&#x000a0;et&#x000a0;al., 1981</xref>). Extracts from the plant family have been used traditionally in the treatment of oedema, fever and joint pain, and they have low toxicity (<xref rid="bib0005" ref-type="bibr">Allison&#x000a0;et&#x000a0;al., 2001</xref>). The compound celastrol has been exploited as a source of neuroprotective agent. A collaborative screening of existing drugs against neurodegenerative diseases showed celastrol as one of the active components (<xref rid="bib0143" ref-type="bibr">Zhao&#x000a0;et&#x000a0;al., 2012</xref>). The anti-inflammatory activity of this compound both in <italic>in vitro</italic> and <italic>in vivo</italic> animal models was evaluated and mechanisms of action established (<xref rid="bib0087" ref-type="bibr">Nabavi&#x000a0;et&#x000a0;al., 2020</xref>). Celastrol alleviated chronic obstructive pulmonary disease in the lungs of mice (<xref rid="bib0108" ref-type="bibr">Shi&#x000a0;et&#x000a0;al., 2018</xref>). It has an anti-inflammatory pathway through the suppression of nuclear factor kappa B (NF-&#x003ba;B) signalling (<xref rid="bib0141" ref-type="bibr">Zhang&#x000a0;et&#x000a0;al., 2019</xref>). In a study conducted on MERS-CoV and SARS-CoV infections, the inflammatory response mediated by NF-&#x003ba;B pathway was regulated by transmembrane serine protease 2 (TMPRSS2) levels within the airway in a TMPRSS2 knockout murine model (<xref rid="bib0055" ref-type="bibr">Iwata-Yoshikawa&#x000a0;et&#x000a0;al., 2019</xref>; <xref rid="bib0087" ref-type="bibr">Nabavi&#x000a0;et&#x000a0;al., 2020</xref>), suggesting that the inhibition of TMPRSS2 may exert a dual effect on COVID-19, limiting viral entry by reducing the cleavage of the spike protein in ACE2 receptor mediated viral entry (<xref rid="bib0052" ref-type="bibr">Hoffmann&#x000a0;et&#x000a0;al., 2020</xref>; <xref rid="bib0087" ref-type="bibr">Nabavi&#x000a0;et&#x000a0;al., 2020</xref>).</p><p id="para0022">There is a high demand for herbal products in the treatment of COVID-19 in some countries in Africa, Asia and in the United States of America, with approval by governments in some countries (<xref rid="bib0115" ref-type="bibr">Timoshyna&#x000a0;et&#x000a0;al., 2020</xref>). Some scientists have suggested the repurposing of available drugs in the market for the management of COVID-19, as the fastest way to curb the spread of the disease, as many diseases share overlapping molecular pathways <xref rid="bib0144" ref-type="bibr">Hodos et&#x000a0;al., (2016)</xref>; <xref rid="bib0145" ref-type="bibr">Ahmad et&#x000a0;al., (2020)</xref>. The use of herbal remedies has been widely embraced in China with 91.5% of the total number of coronavirus cases nationwide using repurposed herbal products for treatment. Based on clinical observation, more than 90% efficacy was observed (<xref rid="bib0115" ref-type="bibr">Timoshyna&#x000a0;et&#x000a0;al., 2020</xref>)<italic>.</italic> More than 125 plant species are reported to be used in the Chinese herbal formulations to treat COVID-19 patients. The most mentioned plants were <italic>Schisandra chinensis</italic> Turcz. (Baill.), <italic>Glycyrrhiza uralensis</italic> Fisch., <italic>Atractylodes macrocephala</italic> Koidz., <italic>Astragalus membranaceus</italic> fisch. ex bunge, <italic>Lonicera japonica</italic> Thunb., <italic>Scutellaria baicalensis</italic> Georgi., <italic>Panax quinquenfolius</italic> L<italic>.</italic> and <italic>Angelica sinensis</italic> (Oliv.) Diels. Twenty-eight traditional medicine guidelines that provide treatment measures for COVID-19 have been documented, of which 26 were issued by the Chinese government and two by the Korean medicine-professional associations (<xref rid="bib0008" ref-type="bibr">Ang&#x000a0;et&#x000a0;al., 2020</xref>). Following these guidelines, the most recommended herbal formulas were Shen Fu Tang with Angong Niuhuang Pill or Su He Xiang Pill for treatment of severe case of COVID-19 and a combined formula of Xiang Sha Liu Junzi Tang and Li Zhong Pill at the recovery stage (<xref rid="bib0008" ref-type="bibr">Ang&#x000a0;et&#x000a0;al., 2020</xref>). In the formulation of these herbal remedies for COVID-19, 12 common herbs include <italic>Glycyrrhiza</italic> Radix et Rhizoma, <italic>Glycyrrhiza uralensis</italic>, Armeniacae Semen Amarum, Ephedrae Herba, Gypsum Fibrosum, Scutellariae Radix, Atractylodis Rhizoma, Poria Sclerotium, Citri Reticulatae Pericarpium, Pinelliae Praeparatum Cum Zingiberis, Forsythiae Fructus, Magnoliae Officinalis Cortex and Agastachis Herba. These herbal formulae were used to treat patients with mild, moderate to severe cases and in recovery. Another Chinese herbal product, Lianhua Qingwen which has been clinically proven active against influenza virus, has also been screened against the SARS-CoVs (<xref rid="bib0075" ref-type="bibr">Lv&#x000a0;et&#x000a0;al., 2020</xref>). In a clinical trial, the herbal capsule reduced symptoms such as cough, fatigue, fever and shortness of breath in 63 COVID-19 patients (<xref rid="bib0075" ref-type="bibr">Lv&#x000a0;et&#x000a0;al., 2020</xref>). A 91.5% recovery rate was recorded in 142 COVID-19 patients after 14 days of administering Lianhua Qingwen in a multicenter open-label randomized controlled trial, and this herbal product was confirmed to be safe (<xref rid="bib0053" ref-type="bibr">Hu&#x000a0;et&#x000a0;al., 2020</xref>). As part of self-care measures, a recommendation was made by the Ministry of AYUSH, Government of India on the use of Ayurveda immune boosters against COVID-19 (<xref rid="bib0072" ref-type="bibr">Li&#x000a0;et&#x000a0;al., 2020</xref>; <xref rid="bib0115" ref-type="bibr">Timoshyna&#x000a0;et&#x000a0;al., 2020</xref>; <xref rid="bib0118" ref-type="bibr">Vellingiri&#x000a0;et&#x000a0;al., 2020</xref>). Honey has also gained some attention due to its antiviral properties with reports on its ability to prevent viral replication (<xref rid="bib0028" ref-type="bibr">da&#x000a0;Cruz et&#x000a0;al., 2019</xref>; <xref rid="bib0026" ref-type="bibr">ClinicaTrials.gov,&#x000a0;2020</xref>). With safety in focus, it is pertinent that most of these repurposed herbal formulations mentioned above with no available safety data, are properly evaluated for use in COVID-19 patients, especially those with co-morbidities. It is also very important that the mechanisms of action of these herbal formulations are known to avoid contraindications or interactions with unintended molecular targets.</p></sec><sec id="sec0010"><label>4.3</label><title><italic>In silico</italic> screening of plant secondary phytochemicals against SARS-CoV-2</title><p id="para0023">In the search for effective therapeutics against COVID-19 from plant products, focus should be on plant molecules that are able to interact and bind with the SARS-CoV-2 virus proteins capable of promoting viral entry, replication and infection. Researchers have suggested that any therapeutic of interest should be able to show a high affinity to binding and inhibiting the SARS-CoV-2 spike protein, main protease enzyme (Mpro) and RdRp which are associated with host attachment and viral replication, resulting in infection in the individual. This has been demonstrated through <italic>in silico</italic> studies which is a quick way to identifying potential drugs (<xref rid="tbl0001" ref-type="table">Table&#x000a0;1</xref>
) (e.g <xref rid="bib0064" ref-type="bibr">Kar&#x000a0;et&#x000a0;al., 2020</xref>; <xref rid="bib0099" ref-type="bibr">Puttaswamy&#x000a0;et&#x000a0;al., 2020</xref>). The SARS-CoV-2 spike protein is known to attach itself to the human receptor ACE2 through the receptor binding domain (RBD), and this enables viral entry in host cells causing a breakdown in the system of the host <xref rid="bib0146" ref-type="bibr">Tai et&#x000a0;al., (2020)</xref>. In a molecular docking study conducted by <xref rid="bib0064" ref-type="bibr">Kar&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref> at the active binding pocket of the RBD of SARS-CoV-2 spike protein, phytocompounds such as adhatodine and anisotine, from <italic>Justicia adhatoda</italic> L.; beta-amyrin and mangiferin from <italic>Swertia chirata</italic> C.B.Clarke; beta-carotene and eugenol from <italic>Ocimum sanctum</italic> L. were found to exhibit an inhibitory effect against the spike protein with anisotine showing the most promising inhibitory potential in terms of binding energy score of 7.8 kcal/mol. A comprehensive interaction profiling of the anisotine-RBD SARSCoV- 2 spike protein complex showed that anisotine interacted with the RDB residues Lys417, Tyr453, Tyr495, Phe497 and Tyr505 of SARS-CoV-2 spike protein. Same inhibitory effect was observed with anisotine against the SARS-CoV-2 Mpro at the active binding pocket where there was an interaction against its residues Gly143, His41, Gln189 and Met165. Considering the findings from this study it can be deduced that anisotine is a potential drug target against the SARS-CoV-2 virus. Hence extensive studies should be carried out on this phytocompound for the possible development of therapeutic against COVID-19. In another molecular docking study, <xref rid="bib0099" ref-type="bibr">Puttaswamy&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref> evaluated 4,704 ligands against four target proteins: Spike, RdRp, Mpro and the Human TMPRSS2 priming the SARS-CoV-2 spike protein. Authors observed a unique pattern of structurally similar interaction of some phytochemicals with the target proteins. Among the phytochemicals evaluated, triterpenoids showed more than 50% strong interaction with the spike protein-RDB. Also, 32% of molecules that showed interesting interaction with the active site of human TMPRSS2 were flavonoids. Some of the plant molecules were seen to interact with more than one of the target proteins. For example, agathisflavone was seen to interact with RdRp and TMPRSS2, amentoflavone interacted with Mpro and spike protein, while isoginkgetin interacted with RdRp and Mpro. Through an <italic>in silico</italic> screening of the Traditional Chinese Medicine Systems Pharmacology Database (TCMSPD), compounds such as kaempferol, lignan, moupinamide, N-cisferuloyltyramine, quercetin, sugiol, tanshinone IIa, betulinic acid, dihydrotanshinone, coumaroyltyramine, cryptotanshinone, desmethoxyreserpine and dihomo-&#x003b3;-linolenic acid were identified as potential leads for the development of COVID-19 treatment (<xref rid="bib0004" ref-type="bibr">Alamanou,&#x000a0;2020</xref>).<table-wrap position="float" id="tbl0001"><label>Table 1</label><caption><p>Molecular docking studies of some plant molecules as potential therapeutic targets against SARS-CoV-2.</p></caption><alt-text id="alt0001">Table 1</alt-text><table frame="hsides" rules="groups"><thead><tr><th valign="top">Protein target</th><th valign="top">Plant molecule</th><th valign="top">Natural source</th><th valign="top">Plant family</th><th valign="top">Binding energy score</th><th valign="top">References</th></tr></thead><tbody><tr><td valign="top">Spike protein</td><td valign="top">Bismahanine</td><td valign="top">Murraya koenigii (L.) Spreng</td><td valign="top">Rutaceae</td><td valign="top">&#x02212;9.1</td><td valign="top"><xref rid="bib0099" ref-type="bibr">Puttaswamy&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Coagulin N</td><td valign="top">NA</td><td valign="top">NA</td><td valign="top">&#x02212;9.1</td><td valign="top"><xref rid="bib0099" ref-type="bibr">Puttaswamy&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Arecatannin A3</td><td valign="top">NA</td><td valign="top">NA</td><td valign="top">&#x02212; 8.9</td><td valign="top"><xref rid="bib0099" ref-type="bibr">Puttaswamy&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Coagulin K</td><td valign="top">NA</td><td valign="top">NA</td><td valign="top">&#x02212; 8.9</td><td valign="top"><xref rid="bib0099" ref-type="bibr">Puttaswamy&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Tannic acid</td><td valign="top">NA</td><td valign="top">NA</td><td valign="top">&#x02212; 8.9</td><td valign="top"><xref rid="bib0099" ref-type="bibr">Puttaswamy&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Kamalachalcone C</td><td valign="top"><italic>Mallotus philippensis</italic> (Lam.) M&#x000fc;ll. Arg.</td><td valign="top">Euphorbiaceae</td><td valign="top">&#x02212; 8.8</td><td valign="top"><xref rid="bib0099" ref-type="bibr">Puttaswamy&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Pseudojervine</td><td valign="top"><italic>Veratrum album</italic> L.</td><td valign="top">Melanthiaceae</td><td valign="top">&#x02212; 8.7</td><td valign="top"><xref rid="bib0099" ref-type="bibr">Puttaswamy&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Flavin adenine dinucleotide</td><td valign="top">NA</td><td valign="top"/><td valign="top">&#x02212; 8.6</td><td valign="top"><xref rid="bib0099" ref-type="bibr">Puttaswamy&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Graecunin E</td><td valign="top"><italic>Trigonella foenum-graecum</italic> L.</td><td valign="top">Fabaceae</td><td valign="top">&#x02212; 8.6</td><td valign="top"><xref rid="bib0099" ref-type="bibr">Puttaswamy&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Taraxerol</td><td valign="top"><italic>Clerodendrum trichotomum</italic> Thunb.</td><td valign="top">Lamiaceae</td><td valign="top">&#x02212;7.5</td><td valign="top"><xref rid="bib0064" ref-type="bibr">Kar&#x000a0;et&#x000a0;al. (2020</xref>a)</td></tr><tr><td valign="top"/><td valign="top">Friedelin</td><td valign="top"><italic>Clerodendrum trichotomum</italic> Thunb.</td><td valign="top"/><td valign="top">&#x02212;7.3</td><td valign="top"><xref rid="bib0064" ref-type="bibr">Kar&#x000a0;et&#x000a0;al. (2020</xref>a)</td></tr><tr><td valign="top"/><td valign="top">Stigmasterol</td><td valign="top"><italic>Clerodendrum trichotomum</italic> Thunb.</td><td valign="top"/><td valign="top">77.2</td><td valign="top"><xref rid="bib0064" ref-type="bibr">Kar&#x000a0;et&#x000a0;al. (2020</xref>a)</td></tr><tr><td valign="top"/><td valign="top">Anisotine</td><td valign="top"><italic>Justicia adhatoda</italic> L.</td><td valign="top">Acanthaceae</td><td valign="top">&#x02212;7.8</td><td valign="top"><xref rid="bib0064" ref-type="bibr">Kar&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Adhatodine</td><td valign="top"><italic>Justicia adhatoda</italic> L.</td><td valign="top"/><td valign="top">&#x02212;7.0</td><td valign="top"><xref rid="bib0064" ref-type="bibr">Kar&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Beta-carotene</td><td valign="top"><italic>Ocimum sanctum</italic> L.</td><td valign="top">Lamiaceae</td><td valign="top">&#x02212;7.2</td><td valign="top"><xref rid="bib0064" ref-type="bibr">Kar&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Eugenol</td><td valign="top"><italic>Ocimum sanctum</italic> L</td><td valign="top"/><td valign="top">&#x02212;7.3</td><td valign="top"><xref rid="bib0064" ref-type="bibr">Kar&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Mangiferin</td><td valign="top"><italic>Swertia chirata</italic> (Wall.) C. B. Clarke</td><td valign="top">Gentianaceae</td><td valign="top">&#x02212;7.5</td><td valign="top"><xref rid="bib0064" ref-type="bibr">Kar&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Beta-amyrin</td><td valign="top"><italic>Swertia chirata</italic> (Wall.) C. B. Clarke</td><td valign="top"/><td valign="top">&#x02212;7.1</td><td valign="top"><xref rid="bib0064" ref-type="bibr">Kar&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Glycyrrhizic acid</td><td valign="top"><italic>Glycyrrhiza glabra</italic> L.</td><td valign="top">Fabaceae</td><td valign="top">&#x02212; 9.5</td><td valign="top"><xref rid="bib0099" ref-type="bibr">Puttaswamy&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">cis-Miyabenol C</td><td valign="top"><italic>Foeniculum vulgare</italic> Mill. (fennel).</td><td valign="top">Apiacae</td><td valign="top">&#x02212; 9.4</td><td valign="top"><xref rid="bib0099" ref-type="bibr">Puttaswamy&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Proanthocyanidin A2</td><td valign="top">NA</td><td valign="top">NA</td><td valign="top">&#x02212; 9.2</td><td valign="top"><xref rid="bib0099" ref-type="bibr">Puttaswamy&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Granatin B</td><td valign="top"><italic>Punica granatum</italic> L.</td><td valign="top">Punicaceae</td><td valign="top">&#x02212; 9.1</td><td valign="top"><xref rid="bib0099" ref-type="bibr">Puttaswamy&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Hippophaenin B</td><td valign="top">NA</td><td valign="top">NA</td><td valign="top">&#x02212; 9.1</td><td valign="top"><xref rid="bib0099" ref-type="bibr">Puttaswamy&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">3-Caffeoyl-5-Feruloylquinic Acid</td><td valign="top">NA</td><td valign="top">NA</td><td valign="top">&#x02212;9.0</td><td valign="top"><xref rid="bib0099" ref-type="bibr">Puttaswamy&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top">TMPRSS2</td><td valign="top">3,3&#x02032;-Biplumbagin</td><td valign="top">NA</td><td valign="top">NA</td><td valign="top">&#x02212;8.9</td><td valign="top"><xref rid="bib0099" ref-type="bibr">Puttaswamy&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Agathisflavone</td><td valign="top">NA</td><td valign="top">NA</td><td valign="top">&#x02212;8.9</td><td valign="top"><xref rid="bib0099" ref-type="bibr">Puttaswamy&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Aromoline</td><td valign="top">NA</td><td valign="top">NA</td><td valign="top">&#x02212;8.9</td><td valign="top"><xref rid="bib0099" ref-type="bibr">Puttaswamy&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Chrysophanein</td><td valign="top">NA</td><td valign="top">NA</td><td valign="top">&#x02212;8.9</td><td valign="top"><xref rid="bib0099" ref-type="bibr">Puttaswamy&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top">RdRp</td><td valign="top">Eriodictyol-7-O-rutinoside</td><td valign="top"><italic>Citrus limon</italic> (L.) BURM.f.</td><td valign="top">Rutaceae</td><td valign="top">&#x02212;9.9</td><td valign="top"><xref rid="bib0099" ref-type="bibr">Puttaswamy&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Narirutin</td><td valign="top">NA</td><td valign="top">NA</td><td valign="top">&#x02212;9.7</td><td valign="top"><xref rid="bib0099" ref-type="bibr">Puttaswamy&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Hippomannin A</td><td valign="top">NA</td><td valign="top">NA</td><td valign="top">&#x02212;9.6</td><td valign="top"><xref rid="bib0099" ref-type="bibr">Puttaswamy&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Isoginkgetin</td><td valign="top">Ginkgo biloba L.</td><td valign="top">Ginkgoaceae</td><td valign="top">&#x02212;9.5</td><td valign="top"><xref rid="bib0099" ref-type="bibr">Puttaswamy&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Kaempferol 3-O-(6&#x02032;&#x02019;-galloyl)-beta-D-glucopyranoside</td><td valign="top">NA</td><td valign="top">NA</td><td valign="top">&#x02212;9.5</td><td valign="top"><xref rid="bib0099" ref-type="bibr">Puttaswamy&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Myricetin 3-rutinoside</td><td valign="top"><italic>Chrysobalanus icaco</italic> L.</td><td valign="top">Chrysobalanaceae</td><td valign="top">&#x02212;9.5</td><td valign="top"><xref rid="bib0099" ref-type="bibr">Puttaswamy&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Rotundioside B</td><td valign="top"><italic>Bupleurum rotundifolium</italic> L.</td><td valign="top">Apiaceae</td><td valign="top">&#x02212;9.5</td><td valign="top"><xref rid="bib0099" ref-type="bibr">Puttaswamy&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Tellimagradin I</td><td valign="top">NA</td><td valign="top">NA</td><td valign="top">&#x02212;9.5</td><td valign="top"><xref rid="bib0099" ref-type="bibr">Puttaswamy&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Agathisflavone</td><td valign="top">NA</td><td valign="top">NA</td><td valign="top">&#x02212;9.4</td><td valign="top"><xref rid="bib0099" ref-type="bibr">Puttaswamy&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Emblicanin A</td><td valign="top">NA</td><td valign="top"/><td valign="top">&#x02212;9.4</td><td valign="top"><xref rid="bib0099" ref-type="bibr">Puttaswamy&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Taiwanhomoflavone A</td><td valign="top"><italic>Cephalotaxus wilsoniana</italic> Hayata</td><td valign="top">Taxaceae</td><td valign="top">&#x02212;9.8</td><td valign="top"><xref rid="bib0060" ref-type="bibr">Joshi&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Beta-carotene</td><td valign="top"><italic>Ocimum sanctum</italic> L.</td><td valign="top"/><td valign="top">&#x02212;7.1</td><td valign="top"><xref rid="bib0064" ref-type="bibr">Kar&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Lactucopirin 15-oxolate</td><td valign="top"><italic>Lactuca virosa</italic> L.</td><td valign="top">Asteraceae</td><td valign="top">&#x02212;7.6</td><td valign="top"><xref rid="bib0060" ref-type="bibr">Joshi&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Taraxerol</td><td valign="top"><italic>Clerodendrum trichotomum</italic> Thunb.</td><td valign="top"/><td valign="top">&#x02212;7.4</td><td valign="top"><xref rid="bib0064" ref-type="bibr">Kar&#x000a0;et&#x000a0;al. (2020</xref>a)</td></tr><tr><td valign="top">Mpro</td><td valign="top">Anisotine</td><td valign="top"><italic>Justicia adhatoda</italic> L.</td><td valign="top">Acanthaceae</td><td valign="top">&#x02212;8.4</td><td valign="top"><xref rid="bib0064" ref-type="bibr">Kar&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Adhatodine</td><td valign="top"><italic>Justicia adhatoda</italic> L.</td><td valign="top"/><td valign="top">&#x02212;7.9</td><td valign="top"><xref rid="bib0064" ref-type="bibr">Kar&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Vasicoline</td><td valign="top"><italic>Justicia adhatoda</italic> L.</td><td valign="top"/><td valign="top">&#x02212;7.4</td><td valign="top"><xref rid="bib0064" ref-type="bibr">Kar&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Vasicolinone</td><td valign="top"><italic>Justicia adhatoda</italic> L.</td><td valign="top"/><td valign="top">&#x02212;7.3</td><td valign="top"><xref rid="bib0064" ref-type="bibr">Kar&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Beta-carotene</td><td valign="top"><italic>Ocimum sanctum</italic> L.</td><td valign="top"/><td valign="top">&#x02212;7.8</td><td valign="top"><xref rid="bib0064" ref-type="bibr">Kar&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Eugenol</td><td valign="top"><italic>Ocimum sanctum</italic> L.</td><td valign="top"/><td valign="top">&#x02212;7.6</td><td valign="top"><xref rid="bib0064" ref-type="bibr">Kar&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Caryophyllene</td><td valign="top"><italic>Ocimum sanctum</italic> L.</td><td valign="top"/><td valign="top">&#x02212;7.1</td><td valign="top"><xref rid="bib0064" ref-type="bibr">Kar&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Amarogentin</td><td valign="top"><italic>Swertia chirata</italic> (Wall.) C. B. Clarke</td><td valign="top"/><td valign="top">&#x02212;8.0</td><td valign="top"><xref rid="bib0064" ref-type="bibr">Kar&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Mangiferin</td><td valign="top"><italic>Swertia chirata</italic> (Wall.) C. B. Clarke</td><td valign="top"/><td valign="top">&#x02212;7.8</td><td valign="top"><xref rid="bib0064" ref-type="bibr">Kar&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top">Mpro</td><td valign="top">Taiwanhomoflavone A</td><td valign="top"><italic>Cephalotaxus wilsoniana</italic> Hayata</td><td valign="top">Taxaceae</td><td valign="top">&#x02212;9.6</td><td valign="top"><xref rid="bib0060" ref-type="bibr">Joshi&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Lactucopirin 15-oxolate</td><td valign="top"><italic>Lactuca virosa</italic> L.</td><td valign="top">Asteraceae</td><td valign="top">&#x02212;8.2</td><td valign="top"><xref rid="bib0060" ref-type="bibr">Joshi&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Glycyrrhizin</td><td valign="top"><italic>Glycyrrhiza glabra</italic> L.</td><td valign="top">Fabaceae</td><td valign="top">&#x02212;8.1</td><td valign="top"><xref rid="bib0147" ref-type="bibr">Narkhede et&#x000a0;al.(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Tryptanthrine</td><td valign="top"><italic>Strobilanthes cusia</italic> (Nees) O.Kuntze</td><td valign="top">Acanthaceae</td><td valign="top">&#x02212;8.2</td><td valign="top"><xref rid="bib0147" ref-type="bibr">Narkhede et&#x000a0;al.(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">&#x003b2;-sitosterol</td><td valign="top"><italic>Strobilanthes cusia</italic> (Nees) O.Kuntze</td><td valign="top"/><td valign="top">&#x02212;7.2</td><td valign="top"><xref rid="bib0147" ref-type="bibr">Narkhede et&#x000a0;al.(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Indirubin</td><td valign="top"><italic>Strobilanthes cusia</italic> (Nees) O.Kuntze</td><td valign="top"/><td valign="top">&#x02212;7.6</td><td valign="top"><xref rid="bib0147" ref-type="bibr">Narkhede et&#x000a0;al.(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Indican</td><td valign="top">NA</td><td valign="top">NA</td><td valign="top">&#x02212;7.5</td><td valign="top"><xref rid="bib0147" ref-type="bibr">Narkhede et&#x000a0;al.(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Indigo</td><td valign="top"><italic>Isatis indigotica</italic> L.</td><td valign="top">Brassicaceae</td><td valign="top">&#x02212;7.5</td><td valign="top"><xref rid="bib0147" ref-type="bibr">Narkhede et&#x000a0;al.(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Hesperetin</td><td valign="top"><italic>Citrus reticulata</italic> Blanco</td><td valign="top">Rutaceae</td><td valign="top">&#x02212;7.9</td><td valign="top"><xref rid="bib0147" ref-type="bibr">Narkhede et&#x000a0;al.(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Crysophanic acid</td><td valign="top"><italic>Rheum palmatum</italic> L.</td><td valign="top">Polygonaceae</td><td valign="top">&#x02212;7.3</td><td valign="top"><xref rid="bib0147" ref-type="bibr">Narkhede et&#x000a0;al.(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Rhein</td><td valign="top"><italic>Aloe barbadensis</italic> Mill.</td><td valign="top">Asphodelaceae</td><td valign="top">&#x02212;8.9</td><td valign="top"><xref rid="bib0147" ref-type="bibr">Narkhede et&#x000a0;al.(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Berberine</td><td valign="top"><italic>Berberis aristata</italic> DC.</td><td valign="top">Berberidaceae</td><td valign="top">&#x02212;8.1</td><td valign="top"><xref rid="bib0147" ref-type="bibr">Narkhede et&#x000a0;al.(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">&#x003b2;-caryophyllene</td><td valign="top"><italic>Ocimum</italic> spp.</td><td valign="top">Lamiaceae</td><td valign="top">&#x02212;7.2</td><td valign="top"><xref rid="bib0147" ref-type="bibr">Narkhede et&#x000a0;al.(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Taraxerol</td><td valign="top"><italic>Clerodendrum trichotomum</italic> Thunb.</td><td valign="top">Lamiaceae</td><td valign="top">&#x02212;8.4</td><td valign="top"><xref rid="bib0064" ref-type="bibr">Kar&#x000a0;et&#x000a0;al. (2020</xref>a)</td></tr><tr><td valign="top"/><td valign="top">Friedelin</td><td valign="top"><italic>Clerodendrum trichotomum</italic> Thunb.</td><td valign="top"/><td valign="top">&#x02212;7.9</td><td valign="top"><xref rid="bib0064" ref-type="bibr">Kar&#x000a0;et&#x000a0;al. (2020</xref>a)</td></tr><tr><td valign="top"/><td valign="top">Stigmasterol</td><td valign="top"><italic>Clerodendrum trichotomum</italic> Thunb.</td><td valign="top"/><td valign="top">&#x02212;7.7</td><td valign="top"><xref rid="bib0064" ref-type="bibr">Kar&#x000a0;et&#x000a0;al. (2020</xref>a)</td></tr><tr><td valign="top"/><td valign="top">Friedelin</td><td valign="top"><italic>Clerodendrum trichotomum</italic> Thunb.</td><td valign="top"/><td valign="top">&#x02212;7.1</td><td valign="top"><xref rid="bib0064" ref-type="bibr">Kar&#x000a0;et&#x000a0;al. (2020</xref>a)</td></tr><tr><td valign="top"/><td valign="top">Stigmasterol</td><td valign="top"><italic>Clerodendrum trichotomum</italic> Thunb.</td><td valign="top"/><td valign="top">&#x02212;7.0</td><td valign="top"><xref rid="bib0064" ref-type="bibr">Kar&#x000a0;et&#x000a0;al. (2020</xref>a)</td></tr><tr><td valign="top"/><td valign="top">Isoginkgetin</td><td valign="top"><italic>Ginkgo biloba</italic> L.</td><td valign="top"/><td valign="top">&#x02212;9.5</td><td valign="top"><xref rid="bib0099" ref-type="bibr">Puttaswamy&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Hypericin</td><td valign="top"><italic>Hypericum perforatum</italic> L.</td><td valign="top">Clusiaceae</td><td valign="top">&#x02212;10.4</td><td valign="top"><xref rid="bib0099" ref-type="bibr">Puttaswamy&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Amentoflavone</td><td valign="top">Ginkgo biloba L.</td><td valign="top"/><td valign="top">&#x02212;9.7</td><td valign="top"><xref rid="bib0099" ref-type="bibr">Puttaswamy&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Terflavin B</td><td valign="top"><italic>Terminalia chebula</italic> Retz., <italic>Terminalia catappa</italic> L.</td><td valign="top">Combretaceae</td><td valign="top">&#x02212;9.7</td><td valign="top"><xref rid="bib0099" ref-type="bibr">Puttaswamy&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Mudanpioside J</td><td valign="top"><italic>Paeonia delavayi</italic> Franch</td><td valign="top">Paeoniaceae</td><td valign="top">&#x02212;9.6</td><td valign="top"><xref rid="bib0099" ref-type="bibr">Puttaswamy&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Quercetin 3,5-digalactoside</td><td valign="top">NA</td><td valign="top">NA</td><td valign="top">&#x02212;9.6</td><td valign="top"><xref rid="bib0099" ref-type="bibr">Puttaswamy&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Vescalagin</td><td valign="top"><italic>Castanea sativa</italic> Mill</td><td valign="top">Fagaceae</td><td valign="top">&#x02212;9.6</td><td valign="top"><xref rid="bib0099" ref-type="bibr">Puttaswamy&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top">Mpro</td><td valign="top">Ginkgetin</td><td valign="top"><italic>Ginkgo biloba</italic> L.</td><td valign="top"/><td valign="top">&#x02212;9.5</td><td valign="top"><xref rid="bib0099" ref-type="bibr">Puttaswamy&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Cyanidin 3,5-diglucoside</td><td valign="top">NA</td><td valign="top">NA</td><td valign="top">&#x02212;9.4</td><td valign="top"><xref rid="bib0099" ref-type="bibr">Puttaswamy&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Delphinidin-3-O-(6-p-coumaroyl) glucoside</td><td valign="top">NA</td><td valign="top">NA</td><td valign="top">&#x02212;9.4</td><td valign="top"><xref rid="bib0099" ref-type="bibr">Puttaswamy&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top">ACE2</td><td valign="top">Taiwanhomoflavone A</td><td valign="top"><italic>Cephalotaxus wilsoniana</italic> Hayata</td><td valign="top">Taxaceae</td><td valign="top">&#x02212;7.6</td><td valign="top"><xref rid="bib0060" ref-type="bibr">Joshi&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Epicatechin-(4b,8)-epicatechin-<break/>(4b,6)-catechin</td><td valign="top">NA</td><td valign="top">NA</td><td valign="top">&#x02212;8.2</td><td valign="top"/></tr><tr><td valign="top"/><td valign="top">Epicatechin-4-epigallocatechin</td><td valign="top">NA</td><td valign="top">NA</td><td valign="top">&#x02212;7.2</td><td valign="top"><xref rid="bib0060" ref-type="bibr">Joshi&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Lactucopicrin 15-oxalate</td><td valign="top"><italic>Lactuca virosa</italic> L.</td><td valign="top">Asteraceae</td><td valign="top">&#x02212;8.3</td><td valign="top"><xref rid="bib0060" ref-type="bibr">Joshi&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Lactucopicrin</td><td valign="top"><italic>Lactuca virosa</italic> L.</td><td valign="top"/><td valign="top">&#x02212;8.3</td><td valign="top"/></tr><tr><td valign="top"/><td valign="top">Vitetrifolin D</td><td valign="top">NA</td><td valign="top">NA</td><td valign="top">&#x02212;7.3</td><td valign="top"><xref rid="bib0060" ref-type="bibr">Joshi&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Myricitrin</td><td valign="top"><italic>Myristica fragrans</italic> Houtt.</td><td valign="top">Myristicaceae</td><td valign="top">&#x02212;7.1</td><td valign="top"><xref rid="bib0060" ref-type="bibr">Joshi&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Apigenin</td><td valign="top">NA</td><td valign="top">NA</td><td valign="top">&#x02212;7.1</td><td valign="top"><xref rid="bib0010" ref-type="bibr">Antonio&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Kaempferol</td><td valign="top">NA</td><td valign="top">NA</td><td valign="top">&#x02212;7.2</td><td valign="top"><xref rid="bib0010" ref-type="bibr">Antonio&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Cassameridin</td><td valign="top"><italic>Litsea kawakamii</italic> Hayata</td><td valign="top">Lauraceae</td><td valign="top">&#x02212;8.1</td><td valign="top"><xref rid="bib0060" ref-type="bibr">Joshi&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Afzelin</td><td valign="top"><italic>Nymphaea odorata</italic> Aiton</td><td valign="top">Nymphaeaceae</td><td valign="top">&#x02212;7.1</td><td valign="top"><xref rid="bib0060" ref-type="bibr">Joshi&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Isoquercitrin</td><td valign="top">NA</td><td valign="top">NA</td><td valign="top">&#x02212;7.8</td><td valign="top"><xref rid="bib0010" ref-type="bibr">Antonio&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Silybin</td><td valign="top">NA</td><td valign="top">NA</td><td valign="top">&#x02212;8.0</td><td valign="top"><xref rid="bib0010" ref-type="bibr">Antonio&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Tetrahydrocurcumin</td><td valign="top">NA</td><td valign="top">NA</td><td valign="top">&#x02212;8.0</td><td valign="top"><xref rid="bib0010" ref-type="bibr">Antonio&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Aloin</td><td valign="top">NA</td><td valign="top">NA</td><td valign="top">&#x02212;8.4</td><td valign="top"><xref rid="bib0010" ref-type="bibr">Antonio&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Isoaloresin</td><td valign="top">NA</td><td valign="top">NA</td><td valign="top">&#x02212;7.8</td><td valign="top"><xref rid="bib0010" ref-type="bibr">Antonio&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Quercetin</td><td valign="top">NA</td><td valign="top">NA</td><td valign="top">&#x02212;8.7</td><td valign="top"><xref rid="bib0010" ref-type="bibr">Antonio&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Withaferin A</td><td valign="top">NA</td><td valign="top">NA</td><td valign="top">&#x02212;9.6</td><td valign="top"><xref rid="bib0010" ref-type="bibr">Antonio&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Hinokinin</td><td valign="top">NA</td><td valign="top">NA</td><td valign="top">&#x02212;7.1</td><td valign="top"><xref rid="bib0010" ref-type="bibr">Antonio&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Philligenin</td><td valign="top">NA</td><td valign="top">NA</td><td valign="top">&#x02212;7.8</td><td valign="top"><xref rid="bib0010" ref-type="bibr">Antonio&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Hupehemonside</td><td valign="top">NA</td><td valign="top">NA</td><td valign="top">&#x02212;7.1</td><td valign="top"><xref rid="bib0010" ref-type="bibr">Antonio&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Imperialine-3-b-D-glucoside</td><td valign="top">NA</td><td valign="top">NA</td><td valign="top">&#x02212;7.1</td><td valign="top"><xref rid="bib0010" ref-type="bibr">Antonio&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top">TMPRSS2</td><td valign="top">Silybin</td><td valign="top">NA</td><td valign="top">NA</td><td valign="top">&#x02212;11.9</td><td valign="top"><xref rid="bib0010" ref-type="bibr">Antonio&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Tetrahydrocurcumin</td><td valign="top">NA</td><td valign="top">NA</td><td valign="top">&#x02212;8.8</td><td valign="top"><xref rid="bib0010" ref-type="bibr">Antonio&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Corydine</td><td valign="top">NA</td><td valign="top">NA</td><td valign="top">&#x02212;7.9</td><td valign="top"><xref rid="bib0010" ref-type="bibr">Antonio&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Aloin</td><td valign="top">NA</td><td valign="top">NA</td><td valign="top">&#x02212;9.2</td><td valign="top"><xref rid="bib0010" ref-type="bibr">Antonio&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Baicalin</td><td valign="top">NA</td><td valign="top">NA</td><td valign="top">&#x02212;8.5</td><td valign="top"><xref rid="bib0010" ref-type="bibr">Antonio&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top">TMPRSS2</td><td valign="top">Geniposide</td><td valign="top">NA</td><td valign="top">NA</td><td valign="top">&#x02212;14.7</td><td valign="top"><xref rid="bib0010" ref-type="bibr">Antonio&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Dictyosphaeric acid A</td><td valign="top">NA</td><td valign="top">NA</td><td valign="top">&#x02212;14.0</td><td valign="top"><xref rid="bib0010" ref-type="bibr">Antonio&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Durumolide K</td><td valign="top">NA</td><td valign="top">NA</td><td valign="top">&#x02212;13.9</td><td valign="top"><xref rid="bib0100" ref-type="bibr">Rahman&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Microcarpin</td><td valign="top">NA</td><td valign="top">NA</td><td valign="top">&#x02212;13.3</td><td valign="top"><xref rid="bib0010" ref-type="bibr">Antonio&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr><tr><td valign="top"/><td valign="top">Isogemichalcone B</td><td valign="top">NA</td><td valign="top">NA</td><td valign="top">&#x02212;13.1</td><td valign="top"><xref rid="bib0010" ref-type="bibr">Antonio&#x000a0;et&#x000a0;al.&#x000a0;(2020)</xref></td></tr></tbody></table><table-wrap-foot><fn><p>Only plant molecules with binding anergy score between -7 and -15 are reported.</p></fn></table-wrap-foot></table-wrap></p></sec></sec><sec id="sec0011"><label>5</label><title>Safety concerns in the use of unproven natural products against COVID-19</title><p id="para0024">The use of herbal remedies as complementary or alternative medicines has been widely embraced in different parts of the world such as Africa, Australia, UK and other countries in Europe, North America and Asia (<xref rid="bib0018" ref-type="bibr">Calapai,&#x000a0;2008</xref>; <xref rid="bib0017" ref-type="bibr">Braun&#x000a0;et&#x000a0;al., 2010</xref>; <xref rid="bib0009" ref-type="bibr">Anquez-Traxler,&#x000a0;2011</xref>; <xref rid="bib0092" ref-type="bibr">Nirmal&#x000a0;et&#x000a0;al., 2013</xref>). In Africa, an estimate of 80% of the population use herbal remedies (<xref rid="bib0076" ref-type="bibr">Mahomoodally,&#x000a0;2013</xref>; <xref rid="bib0128" ref-type="bibr">WHO, 2019b</xref>). Herbal remedies have a global annual market of about US$60 billion (<xref rid="bib0128" ref-type="bibr">WHO,&#x000a0;2019b</xref>). The international trade in medicinal plants is expected to reach US$5 trillion by 2050 (<xref rid="bib0092" ref-type="bibr">Niraml&#x000a0;et&#x000a0;al., 2013</xref>). Thus, natural products have contributed immensely in the health care system globally. However, natural products may have adverse effects and must be used with caution. It is essential that the general public is aware of the risk associated with the use of unproven or uncertified products.</p><p id="para0025">Since the beginning of the COVID-19 pandemic, people have resorted to self-medication. The internet has been flooded with numerous products acclaimed to fight the virus. This led the United States Food and Drug Administration (FDA) to issue warnings to more than 68 firms producing and marketing these products (<xref rid="bib0040" ref-type="bibr">FDA,&#x000a0;2020c</xref>). Some of these products are: cannabidiol, restorative botanicals, hemp products, colloidal silver, vitamins, minerals, grapefruit seed extract amongst many others (<xref rid="tbl0002" ref-type="table">Table&#x000a0;2</xref>
). The warnings were issued as urgent measures to protect consumers from the negative effects that might result, as these products have not been proven, approved or authorised for use against COVID-19 (<xref rid="bib0040" ref-type="bibr">FDA,&#x000a0;2020c</xref>). For example, colloidal silver can cause serious side effects such as permanent bluish-grey discoloration on the skin (argyria) and contra-indications with antibiotics and thyroxine (<xref rid="bib0088" ref-type="bibr">NCCIH,&#x000a0;2017</xref>). A previous warning on the use of colloidal silver was issued by the FDA in 1999 indicating that the product is not safe or effective for treating any disease or condition (<xref rid="bib0036" ref-type="bibr">FDA,&#x000a0;1999</xref>). Kratom from <italic>Mitragyna speciosa</italic> plant is another acclaimed treatment. It is used traditionally to treat diarrhoea and fatigue and as a possible treatment for pain and management of opioid withdrawal symptoms (<xref rid="bib0089" ref-type="bibr">NCCIH,&#x000a0;2018</xref>). The extract is sold as a treatment for muscle pain or to suppress appetite (<xref rid="bib0082" ref-type="bibr">Mayo&#x000a0;Clinic,&#x000a0;2020</xref>). Two compounds,7-hydroxymitragynine and mitragynine, isolated from the leaves interacts with opioid receptors in the brain, producing sedation, pleasure, and decreased pain when administered in high doses (<xref rid="bib0089" ref-type="bibr">NCCIH,&#x000a0;2018</xref>). However, no scientific evidences of its health benefits exist (<xref rid="bib0089" ref-type="bibr">NCCIH,&#x000a0;2018</xref>). Side effects of kratom include increased aggression, hallucinations and delusion, nausea, constipation, irritability, anxiety, itching, difficulty in breathing, loss of appetite and weight, tremor, psychosis, seizures, liver damage and cases of fatalities (<xref rid="bib0089" ref-type="bibr">NCCIH,&#x000a0;2018</xref>; <xref rid="bib0082" ref-type="bibr">Mayo&#x000a0;Clinic,&#x000a0;2020</xref>). Ginseng detoxication pills which probably originated from the genus <italic>Panax,</italic> is another example of an acclaimed product in the management of COVID-19 (<xref rid="bib0040" ref-type="bibr">FDA,&#x000a0;2020c</xref>). The genus <italic>Panax</italic> in Greek means &#x0201c;all healing.&#x0201d; It is so called because it is believed to cure any kind of human disease (<xref rid="bib0066" ref-type="bibr">Kim,&#x000a0;2018</xref>). Ginseng is one of the most popular herbal remedies in the global market and there are several pharmacological reports on its ginsenoside compounds (<xref rid="bib0066" ref-type="bibr">Kim,&#x000a0;2018</xref>). However, the product also causes mastalgia and vaginal bleeding even when used at the recommended doses (<xref rid="bib0013" ref-type="bibr">Baldwin&#x000a0;et&#x000a0;al,&#x000a0;1986</xref>; <xref rid="bib0030" ref-type="bibr">Dunnick&#x000a0;and Nyska,&#x000a0;2013</xref>). Other side effects include lack of concentration, headaches, transient nervousness, excitation, epistaxis and allergies (<xref rid="bib0031" ref-type="bibr">Ekor,&#x000a0;2014</xref>). A case of Stevens&#x02013;Johnson syndrome was reported after the administration of ginseng to a patient for three days (<xref rid="bib0029" ref-type="bibr">Dega&#x000a0;et&#x000a0;al., 1996</xref>). The plant products may also have carcinogenic effects in the liver and thyroid and can induce tumorigenesis in the nasal cavity (<xref rid="bib0031" ref-type="bibr">Ekor,&#x000a0;2014</xref>).<table-wrap position="float" id="tbl0002"><label>Table 2</label><caption><p>A list of acclaimed new drug products related to the fight against Coronavirus Disease 2019 (COVID-19) with no scientific proof.</p></caption><alt-text id="alt0002">Table 2</alt-text><table frame="hsides" rules="groups"><thead><tr><th valign="top">Product</th><th valign="top">Unproven/Unapproved claims</th><th valign="top">Product originally intended</th><th valign="top">Issued date of warning</th><th valign="top">References</th></tr></thead><tbody><tr><td valign="top">Corecyte<sup>TM</sup> Healthy lung wellness injection and other CoreCyte products</td><td valign="top">Treat and/or prevent COVID-19 via intravenous administration; Improve and support lung health and protect against coronavirus.</td><td valign="top">&#x02013;</td><td valign="top">17 Aug 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top">Salt inhaler products</td><td valign="top">Boost the immunity of your lungs and respiratory tracts with breathing salt therapy to effectively fight coronavirus.</td><td valign="top">&#x02013;</td><td valign="top">11 Aug 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top">Chaga products</td><td valign="top">It may help fight against coronavirus.</td><td valign="top">&#x02013;</td><td valign="top">6 Aug 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top">BERSIH antiseptic alcohol 70% hand sanitizer and hand sanitizer gel</td><td valign="top">Contains 70% alcohol</td><td valign="top">&#x02013;</td><td valign="top">4 Aug 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top">Clearcare nogerm advanced hand sanitizer and lavar gel hand sanitizer</td><td valign="top">Products contain 70% and 75% ethanol</td><td valign="top">&#x02013;</td><td valign="top">23 July 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top">MMS tablets, nasal and mouth spray</td><td valign="top">If you have any flu-like symptoms or confirmed to have COVID-19, take 125 mL of one tablet dissolved in 2 L of water every two hours for eight days; One tablet dissolved in 1.5 L of water to be used in nasal or mouth dispensers into the nose and deep into the throat with three squirts per application against COVID-19.</td><td valign="top">&#x02013;</td><td valign="top">3 Aug 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top">E-Munity</td><td valign="top">The antiviral tincture boosts immune system and strengthen the body against COVID-19 and similar diseases.</td><td valign="top">&#x02013;</td><td valign="top">10 July 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top">Traditional Chinese Medicines (TCM)</td><td valign="top">TCM Lianhua Qingwen plays an important role in fighting against COVID-19 and its capsule has been proven effective for the treatment of COVID-19; Research provides scientific evidence for Lianhua Qingwen; Combining Western medicine and TCM appear to be the best approach to treating COVID-19.</td><td valign="top">&#x02013;</td><td valign="top">6 July 2020, 26 June 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top">COVID supplement protection pack, Thymosin-Alpha, and Methylene blue capsules</td><td valign="top">Improve immunity of the tissues most susceptible to COVID viral attack; Improve immune response once the virus has entered the body; Improve immune response after one experiences respiratory symptoms or fatigue; Improve immune response for those at high risk of moderate-to-severe COVID disease; Methylene blue works by producing a hydrogen peroxide burst within the blood to kill the coronavirus on contact.</td><td valign="top"><list list-type="simple" id="celist0002"><list-item id="celistitem0006"><p id="para0037">&#x02013;</p></list-item></list></td><td valign="top">30 June 2020, 19 June 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top">Iodine products</td><td valign="top">Taking iodine in the form of Lugol's iodine (the Coronavirus Terminator) internally kills COVID-19 or any other virus; Adding Lugol's iodine to &#x02018;Ciggy Juice&#x02019; ramps up the application of antiviral iodine to sensitive lung tissue.</td><td valign="top">Dietary supplement</td><td valign="top">10 June 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref>, <xref rid="bib0091" ref-type="bibr">NIH&#x000a0;2020</xref></td></tr><tr><td valign="top">Essential oil</td><td valign="top">Potent antiviral properties and a powerful antibiotic, particularly for RNA viruses, like the coronavirus responsible for acute respiratory syndromes.</td><td valign="top">Aromatherapy</td><td valign="top">8 June 2020, 26 May 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top">Silver Biotics, Silver Lozenges with Vitamin C</td><td valign="top">Take three or four swigs of liquid silver product a day as prophylactic against COVID -19.</td><td valign="top">To enhance immune system</td><td valign="top">1 June 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top">Silver gel ultimate skin and body care</td><td valign="top">Dab the silver gel around your nostrils.</td><td valign="top">First aid for skin</td><td valign="top">1 June 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top">Non-alcohol-based hand sanitizer - Purifi&#x02122;</td><td valign="top">The product is certified against coronavirus.</td><td valign="top">&#x02013;</td><td valign="top">28 May 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top">StayWell copper</td><td valign="top">Prevent, treat, mitigate, or cure COVID-19.</td><td valign="top">Antimicrobial germ killer</td><td valign="top">28 May 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top">Colloidal silver</td><td valign="top">Boost immune system; Colloidal silver has been a very effective way to kill virus; It's a potent remedy for any infection; Drink the silver and even nebulize it to get it directly in the lungs and at the site of the virus; Atomized fumes through ultrasonic humidifier can be inhaled deep into the lungs which may inhibit the virus from replicating too quickly; Colloidal silver 1100 PPM Immune support protect your immune system.</td><td valign="top">&#x02013;</td><td valign="top">14 Aug 2020, 26 May 2020, 11 May 2020, 1 April 2020, 6 March 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top">Nano silver 10 PPM (silver solution)</td><td valign="top">The Nano silver 10 PPM is your totally non-toxic key to halting COVID-19 attachment, penetration, and replication, with no reason to panic about COVID-19.</td><td valign="top">&#x02013;</td><td valign="top">15 May 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top">Vitamins</td><td valign="top">New study reveals vitamin D may be the key to COVID-19; Severity of coronavirus patient outcomes is directly tied to the patient's vitamin D status.</td><td valign="top">Immune support</td><td valign="top">26 May 2020, 20 May 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top"/><td valign="top">Vitamin D3-K2.</td><td valign="top">Immune support</td><td valign="top">11 May 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top"/><td valign="top">Your Coronavirus Secret Weapon &#x02013; Vitamin C.</td><td valign="top">&#x02013;</td><td valign="top">13 July 2020, 26 May 2020, 20 May 2020, 6 April 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top">Herb oils and minerals</td><td valign="top">-</td><td valign="top">General wellbeing</td><td valign="top">26 May 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top">COVID-19 cough syrup and COVIDXIX syrup</td><td valign="top">Prevent, treat, mitigate, or cure COVID-19.</td><td valign="top">&#x02013;</td><td valign="top">8 May 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top">Grapefruit seed extract</td><td valign="top">Gives a little extra daily protection.</td><td valign="top">General health benefits</td><td valign="top">26 May 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top">Colostrum</td><td valign="top">Colostrum is nature's way of protection against any immune threat.</td><td valign="top">Immune boaster, growth maintenance</td><td valign="top">26 May 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top">Cod liver oil products</td><td valign="top">Can help clear off cellular debris after any viral infection.</td><td valign="top">Source of vitamin A and D for general health benefits</td><td valign="top">26 May 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top">Cannabidiol (CBD) oils and other CBD products</td><td valign="top">CBD may suppress the productions of cytokines in the setting of infection; CBD oil and related products help combat COVID-19.</td><td valign="top">Anxiety, insomnia, epilepsy and other health benefits<break/></td><td valign="top">19 Aug 2020, 26 May 2020, 21 May 2020,<break/>16 April 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref>, <xref rid="bib0045" ref-type="bibr">Grinspoon&#x000a0;2020</xref></td></tr><tr><td valign="top">nCoV19 spike protein vaccine (NCB)</td><td valign="top">Two shots get you a titer that binds the spike protein and the receptor binding domain and make you immune to nCoV-2019.</td><td valign="top">&#x02013;</td><td valign="top">21 May 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top">Kratom</td><td valign="top">Contains compounds that can strengthen the immune system and keep the coronavirus at bay; May be type of master key against COVID-19.</td><td valign="top">&#x02013;</td><td valign="top">15 May 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top">CBD Hemp extract and supplements</td><td valign="top">Helps build a higher functioning immune system that can aid with symptoms and help a person stay healthy, to fight off illness and can help with COVID-19.</td><td valign="top">&#x02013;</td><td valign="top">15 May 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top">White Eagle native herbs</td><td valign="top">Yahweh: This formula works for almost every disease such as coronavirus.</td><td valign="top">&#x02013;</td><td valign="top">14 May 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top"/><td valign="top">Kolon Kleen: Works against coronavirus.</td><td valign="top">&#x02013;</td><td valign="top">14 May 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top"/><td valign="top">Maska Miakoda: Works with Yaweh formula for coronavirus.</td><td valign="top">&#x02013;</td><td valign="top">14 May 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top"/><td valign="top">Shar Mar formula</td><td valign="top">&#x02013;</td><td valign="top">14 May 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top"/><td valign="top">Socota and Henna herbal tea: Recommended for all respiratory viruses especially the coronaviruses.</td><td valign="top">&#x02013;</td><td valign="top">14 May 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top">Dietary supplements</td><td valign="top">NAC (N-acetylcysteine): Recommended for coronavirus.</td><td valign="top">General wellbeing</td><td valign="top">14 May 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top"/><td valign="top">Adaptogens: Reduce cortisol levels and improve immune response.</td><td valign="top">&#x02013;</td><td valign="top">14 May 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top"/><td valign="top">Zinc: Reduce the severity and duration of colds, flu, infections, wounds, and many other diseases.</td><td valign="top"/><td valign="top">14 May 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top"/><td valign="top">Magnesium: Assist with immune response and reduce susceptibility to viral infections.</td><td valign="top">General wellbeing</td><td valign="top">14 May 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top">Immune shot</td><td valign="top">Contains vitamin D3 that may help to fight COVID-19 by reducing the incidence, severity, and risk of death from current COVID -19.</td><td valign="top">&#x02013;</td><td valign="top">11 May 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top">Plum dragon herbs (Chinese herbs for cold-damp) Shanghan Lun phase of COVID-19</td><td valign="top">Boast immune system in the fight against COVID -19.</td><td valign="top">&#x02013;</td><td valign="top">8 May 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top">Durisan hand sanitizer</td><td valign="top">The water-based and alcohol-free kills 99% of human coronavirus.</td><td valign="top">&#x02013;</td><td valign="top">7 May 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top">Medicinal mushrooms</td><td valign="top">Mushrooms to be taken alongside each other in tincture form for both prevention and treatment and should be doubled if symptoms of COVID-19 begin.</td><td valign="top">General wellbeing</td><td valign="top">7 May 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top">Elderberry Syrup</td><td valign="top">&#x02013;</td><td valign="top">&#x02013;</td><td valign="top">7 May 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top">Liquorice root</td><td valign="top">Liquorice root act as a potential treatment for COVID-19.</td><td valign="top">&#x02013;</td><td valign="top">7 May 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top">Stephen Buhner COVID herbal blends, COVID-19 core formula</td><td valign="top">&#x02013;</td><td valign="top">&#x02013;</td><td valign="top">7 May 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top">Glutagenic virus protection kit</td><td valign="top">Use for prevention and as treatment against COVID-19</td><td valign="top">&#x02013;</td><td valign="top">6 May 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top">Liposomal sublingual gel supplement</td><td valign="top">The mixture gives a rapid and thorough reversal of COVID-19.</td><td valign="top">&#x02013;</td><td valign="top">6 May 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top">Liposomal vitamin C with silver excelsior immunity boost bundle</td><td valign="top">Help keep the immune system at top performance.</td><td valign="top">&#x02013;</td><td valign="top">4 May 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top">Transdermal patch (Santiste Labs LLC)</td><td valign="top">Offers possible resistance to the novel coronavirus; Boost your immune system and provide antiviral support all day.</td><td valign="top">&#x02013;</td><td valign="top">27 April 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top">Hopewell products (Warrior essential oil, Cinnamon bark, lung support, respiratory relief)</td><td valign="top">&#x02013;</td><td valign="top">&#x02013;</td><td valign="top">27 April 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top">Prefense non-alcoholic hand and skin sanitizer</td><td valign="top">Prefense hand and skin sanitizer offers an alternative to alcohol-based gels; The only product on the market today that kills germs on contact and offers continuous protection for up to 24 hours or 10 hand washings with only one application.</td><td valign="top">&#x02013;</td><td valign="top">23 April 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top">CopperTouch</td><td valign="top">Kills coronaviruses.</td><td valign="top">&#x02013;</td><td valign="top">21 April 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top">Earth Angel oils</td><td valign="top">Rub on top of the feet, wrists, and chest to fight viruses.</td><td valign="top">General wellbeing</td><td valign="top">14 April 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top">ViralDefense tincture</td><td valign="top">&#x02013;</td><td valign="top">&#x02013;</td><td valign="top">13 April 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top">Alpha 11 and Alpha 21</td><td valign="top">The use of Arogya's ayurvedic products like Alpha 21 and Alpha 11 prevent you from being infected with coronavirus.</td><td valign="top">&#x02013;</td><td valign="top">13 April 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top">Herbs of Kedem</td><td valign="top">Contain compounds that may inhibit the attachment of the new coronavirus to cells in the body.</td><td valign="top">General wellbeing</td><td valign="top">10 April 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top">Super silver toothpaste, super blue toothpaste, super silver wound gel and superblue silver immune gargle</td><td valign="top">Boost your immune system against virus.</td><td valign="top">&#x02013;</td><td valign="top">9 April 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top">Respiratory aid kit</td><td valign="top">The kit gives support to the immune system and the lungs and helps get through the respiratory illnesses more quickly and more easily.</td><td valign="top">&#x02013;</td><td valign="top">9 April 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top">Miracle mineral solution (MMS) (chlorine dioxide)</td><td valign="top">Confirmed cases of COVID-19 patients recovered after treatment with MMS.</td><td valign="top">&#x02013;</td><td valign="top">8 April 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top">Fortify humic beverage concentrate</td><td valign="top">Clinically proven antiviral that could help fight COVID-19; Can fight latent infections, because once the virus reactivates, it prevents the newly created viruses from entering your cells and reproducing, reducing your viral load over time.</td><td valign="top">&#x02013;</td><td valign="top">8 April 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top">Electric fulvic beverage concentrate</td><td valign="top">Extremely effective as antiviral.</td><td valign="top">&#x02013;</td><td valign="top">8 April 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top">China Corona Nosode</td><td valign="top">Boost immune system.</td><td valign="top">&#x02013;</td><td valign="top">7 April 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top">CoronaDefender herbal sachet</td><td valign="top">Formulated for modifying your body surface so that the novel coronavirus stands less chance to survive on your body.</td><td valign="top">&#x02013;</td><td valign="top">6 April 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top">Chinese herbal tea</td><td valign="top">Prevent COVID-19.</td><td valign="top">General wellbeing</td><td valign="top">6 April 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top">Chinese herbal solutions</td><td valign="top">Use for prevention and treatment of COVID -19.</td><td valign="top">&#x02013;</td><td valign="top">6 April 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top">Herbal Agastachis pill</td><td valign="top">&#x02013;</td><td valign="top">&#x02013;</td><td valign="top">6 April 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top">CoronaDefender Herbal tea</td><td valign="top">Formulated for internal use to better prepare yourself for fighting with the novel coronavirus when necessary.</td><td valign="top">&#x02013;</td><td valign="top">6 April 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top">Ginseng detoxication pill</td><td valign="top">Use it if infected with the novel coronavirus.</td><td valign="top">&#x02013;</td><td valign="top">6 April 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top">Honeysuckle and forsythia formula</td><td valign="top">Use it if infected with coronavirus.</td><td valign="top">&#x02013;</td><td valign="top">6 April 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top"><italic>Cannabis indica</italic></td><td valign="top">It speeds up recovery from coronavirus.</td><td valign="top">&#x02013;</td><td valign="top">6 April 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top">Saline therapy</td><td valign="top">It strengthens the lungs to fight against the novel coronavirus.</td><td valign="top">General wellbeing</td><td valign="top">30 March 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top">Corona-Cure antiseptic nasal defense</td><td valign="top">Kills COVID-19; Protect the vulnerable nasal passages from COVID-19 infection.</td><td valign="top">&#x02013;</td><td valign="top">26 March 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top">Quinessence antivirus synergy</td><td valign="top">It can't hurt to use the essential oils to avoid infection until a cure has been developed.</td><td valign="top">&#x02013;</td><td valign="top">6 March 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top">Vivify holistic clinic formula #1 and #3</td><td valign="top">Works against coronavirus.</td><td valign="top">&#x02013;</td><td valign="top">6 March 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top">Vivify holistic clinic &#x02013; Boneset (Loose leaf tea)</td><td valign="top">Effective against coronavirus.</td><td valign="top">&#x02013;</td><td valign="top">6 March 2020</td><td valign="top"><xref rid="bib0040" ref-type="bibr">FDA&#x000a0;2020c</xref></td></tr><tr><td valign="top">Baptized COVID organics</td><td valign="top">Relief symptoms of COVID-19.</td><td valign="top">&#x02013;</td><td valign="top">4 May 2020</td><td valign="top"><xref rid="bib0086" ref-type="bibr">Mugabi&#x000a0;2020</xref>, <xref rid="bib0134" ref-type="bibr">WHO,&#x000a0;2020f</xref></td></tr></tbody></table></table-wrap></p><p id="para0026">While acknowledging the fact that traditional medicines have enormous health benefits that may be exploited as possible therapeutics for COVID-19, the WHO recently warned against the use of unproven traditional herbs in the treatment of COVID-19 (<xref rid="bib0086" ref-type="bibr">Mugabi,&#x000a0;2020</xref>; <xref rid="bib0134" ref-type="bibr">WHO,&#x000a0;2020f</xref>). This came after a herbal drink named Baptized COVID Organics was introduced in Madagascar and acclaimed as being helpful in the treatment of COVID-19. Some African countries such as Guinea, Equatorial Guinea, Guinea-Bissau, Liberia and Tanzania purchased large quantities of this herbal drink (<xref rid="bib0086" ref-type="bibr">Mugabi,&#x000a0;2020</xref>). The drink is derived from an anti-malaria plant <italic>Artemisi</italic>a and mixed with other herbs. Although, the drink is acclaimed as helpful in relieving symptoms of COVID-19, there is currently no scientific proof or evidence. There is the fear of possible toxicity which may lead to adverse effects and no published safety evidence for this drink exists. A concern is that people who consume this drink may become susceptible to malaria as they may develop resistance to the drug artemisinin (<xref rid="bib0086" ref-type="bibr">Mugabi,&#x000a0;2020</xref>). Several herbal formulations have received approval from the Chinese Government and three patented herbal drugs are currently being used to treat COVID-19, with no strong scientific evidence of efficacies and safety (<xref rid="bib0008" ref-type="bibr">Ang&#x000a0;et&#x000a0;al., 2020</xref>; <xref rid="bib0027" ref-type="bibr">Cunningham&#x000a0;et&#x000a0;al., 2020</xref>; <xref rid="bib0138" ref-type="bibr">Yang,&#x000a0;2020</xref>). Finding an effective treatment for an ailment is important but safety is a major priority that must never be ignored. It cannot be disputed that all drugs, be it conventional, complementary or alternative, carry risks for the users (<xref rid="bib0061" ref-type="bibr">Juhn&#x000a0;et&#x000a0;al., 2007</xref>; <xref rid="bib0043" ref-type="bibr">Ghenadenik&#x000a0;et&#x000a0;al., 2012</xref>; <xref rid="bib0138" ref-type="bibr">Yang,&#x000a0;2020</xref>). However, with detailed clinical studies, safe dose ranges are attained, and possible adverse effects or contra-indications are known. Such important information assists in the prescription of such therapeutics to patients. Hence, it is of utmost importance that rigorous clinical studies with safety as a major focus are carried out on herbal remedies.</p><p id="para0027">There is much misleading information available on the internet on the use of garlic (<italic>Allium sativum</italic> L.) against COVID-19, which has led to the increased demand of garlic (<xref rid="bib0083" ref-type="bibr">McClain,&#x000a0;2020</xref>; <xref rid="bib0136" ref-type="bibr">Wiesemeyer,&#x000a0;2020</xref>). Although garlic has some medicinal properties, there is no evidence of its efficacy against COVID-19 (<xref rid="bib0135" ref-type="bibr">WHO,&#x000a0;2020g</xref>). Adverse effects which include light headedness, nausea, alteration of platelet function and coagulation, burning sensation in the gastrointestinal tract, diaphoresis, hypotension and allergy have been associated to the use of garlic (<xref rid="bib0101" ref-type="bibr">Rose&#x000a0;et&#x000a0;al., 1990</xref>; <xref rid="bib0016" ref-type="bibr">Borrelli&#x000a0;et&#x000a0;al., 2007</xref>; <xref rid="bib0123" ref-type="bibr">WebMD,&#x000a0;2020a</xref>).</p><p id="para0028">Another example of widely spread, misleading information is the use of ginger (<italic>Zingiber officinale</italic> Rosc.) to cure COVID-19. Ginger is often included in diets to treat nausea, vomiting, diabetes, migraine, menstrual cramps and osteoarthritis (<xref rid="bib0080" ref-type="bibr">Mashhadi&#x000a0;et&#x000a0;al., 2013</xref>; <xref rid="bib0124" ref-type="bibr">WebMD,&#x000a0;2020b</xref>). The plant possesses anticancer, anti-inflammatory, antidiabetic and antioxidant properties (<xref rid="bib0080" ref-type="bibr">Mashhadi&#x000a0;et&#x000a0;al., 2013</xref>). However, its cure against COVID-19 has not been established. The WHO warned in a message conveyed by the executive director of the WHO Health Emergencies Program, Michael Ryan on 3<sup>rd</sup> April 2020 that, though, ginger can have some health benefits, no evidence on its ability to cure COVID-19 exist (<xref rid="bib0137" ref-type="bibr">Wintle,&#x000a0;2020</xref>). Some side effects of ginger include heartburn, mouth irritation and diarrhoea. Although there are no reports of its contra-indication, there are concerns that ginger may interact with anticoagulants <xref rid="bib0051" ref-type="bibr">NCCIH&#x000a0;(2016)</xref>. Hence, it is not wise to use unproven natural products with the notion that they are completely free of side effects.</p><p id="para0029">One of the most used herbs in Chinese and Korean traditional medicine is the Semen Armeniacae Amarum, known as apricot seed (<italic>Prunus armeniaca</italic> L.). It has a long history in controlling acute lower respiratory infections (<xref rid="bib0058" ref-type="bibr">Jin&#x000a0;et&#x000a0;al., 2009</xref>). This is one of the common herbs included in the Chinese herbal formulations against COVID-19 (<xref rid="bib0008" ref-type="bibr">Ang&#x000a0;et&#x000a0;al., 2020</xref>). <italic>In vivo</italic> studies have shown its toxicity in rats, leading to fatalities (<xref rid="bib0113" ref-type="bibr">Suchard&#x000a0;et&#x000a0;al., 1998</xref>; <xref rid="bib0067" ref-type="bibr">Kim&#x000a0;et&#x000a0;al,&#x000a0;2012</xref>; <xref rid="bib0096" ref-type="bibr">Park&#x000a0;et&#x000a0;al., 2013</xref>). This toxicity has been linked to the presence of amygdalin and hydrogen cyanide which is more concentrated in the endocarp and can cause life-threatening respiratory disorders (<xref rid="bib0096" ref-type="bibr">Park&#x000a0;et&#x000a0;al., 2013</xref>). As a result, it is advised that the endocarp is removed when using it in herbal formulations (<xref rid="bib0096" ref-type="bibr">Park&#x000a0;et&#x000a0;al., 2013</xref>). Hence, a strong quality control needs to be set for this herb even after clinical studies on its potency against COVID-19 is established.</p></sec><sec id="sec0012"><label>6</label><title>Collaboration between research scientists, government and medicinal practitioners as a possible way forward</title><p id="para0030">The inclusion of traditional medicinal practitioners in the management of health crises is an important option that should not be overlooked. In many African countries, especially in the rural areas, and among the poor, traditional medicinal practitioners are often the closest resource when it comes to health issues with an estimated 80% of the African population using herbal remedies (<xref rid="bib0128" ref-type="bibr">WHO, 2019b</xref>). Most of these traditional healers have learned a wealth of knowledge from their ancestors with regards to plant medicinal use. It is regarded as a trade which helps to sustain their livelihoods (<xref rid="bib0065" ref-type="bibr">Karunamoorthi&#x000a0;et&#x000a0;al., 2013</xref>; <xref rid="bib0047" ref-type="bibr">Hamilton,&#x000a0;2014</xref>). These traditional healers may be aware of the negative effects that might result but do not have the capacity to follow the drug development process. Hence, a criticism of traditional healing is that, traditional healers lack a body of evidence to authenticate their practice through scientific knowledge (<xref rid="bib0085" ref-type="bibr">Mokgobi,&#x000a0;2014</xref>). Having the knowledge that a natural product can cure, manage or treat an infection is not enough. With the influx of herbal remedies and increase in self-medication especially in this COVID-19 era, safe use of drugs is an issue of great public health importance. The need for extensive toxicity assessment on herbal products for safe use and protection of public health cannot be overemphasized. However, there are many challenges when it comes to the regulation of herbal medicines in different parts of the world. Because of this, there is a need for a global standard and strong regulatory policies on herbal medicines (<xref rid="bib0031" ref-type="bibr">Ekor,&#x000a0;2014</xref>; <xref rid="bib0128" ref-type="bibr">WHO,&#x000a0;2019b</xref>).</p><p id="para0031">It is risky to use a drug when important parameters such as how it is absorbed, distributed, metabolized and excreted, the mechanisms of action of that drug, the safe dosage range, side effects or adverse effects that may result due to possible toxicity, and its interaction with other drugs and treatments are not known. Five major processes are involved in drug development. These include discovery and development, preclinical research, clinical research, FDA review and FDA post-market safety monitoring (<xref rid="bib0041" ref-type="bibr">FDA-CDER,&#x000a0;2016</xref>; <xref rid="bib0037" ref-type="bibr">FDA,&#x000a0;2018</xref>). The WHO has set some basic criteria that need to be followed in herbal formulations. These processes include efficacy, safety, quality control, marketing and regulatory guidelines (<xref rid="bib0002" ref-type="bibr">Akerele,&#x000a0;1993</xref>; <xref rid="bib0125" ref-type="bibr">WHO&#x000a0;Technical Report,&#x000a0;2018</xref>). Drug development processes may be rigorous but seems to be the only way to develop an effective and safe therapeutic (<xref rid="bib0138" ref-type="bibr">Yang,&#x000a0;2020</xref>). The safety assessment of effective therapeutics is critical for drug use. <italic>In silico</italic> methods for the assessment of drug safety has recently become a useful tool (<xref rid="bib0011" ref-type="bibr">Arvidson&#x000a0;et&#x000a0;al., 2008</xref>; <xref rid="bib0100" ref-type="bibr">Rahman&#x000a0;et&#x000a0;al., 2020</xref>). Such methods are relevant in identifying safe doses, drug interaction, among others, thereby giving a quick understanding of such a drug and a quick lead for further investigation. Though dose-response relationship is usually the main focus when it comes to safety assessment, some researchers have argued that this is not enough as other parameters need to be taken into consideration, before it can be concluded that a drug is safe. According to <xref rid="bib0071" ref-type="bibr">Li&#x000a0;(2004)</xref>, Five key parameters to be considered are; (1) Possible toxicity due to drug&#x02013;target interactions, including interactions with unintended molecular targets, or with molecular targets in unintended organs; (2) Chemical scaffolding and side-chains with safety concerns; (3) Toxicity in animals <italic>in vivo</italic> and <italic>in vitro</italic>; (4) Safety concerns due to toxification or detoxification, organ distribution, clearance and pharmacokinetic drug&#x02013;drug interactions and (5) Physiological, environmental and genetic factors that may enhance a patient's susceptibility. Most of these drug development stages need to be carried out by research scientists and clinicians. Therefore, collaborative efforts are needed. For instance, traditional medicine researchers in Togo are working in collaboration with scientists to find ways for traditional medicine to be integrated into the treatment of COVID-19 (<xref rid="bib0086" ref-type="bibr">Mugabi,&#x000a0;2020</xref>). Governments, especially in developing countries, have pivotal roles to play in these collaborations, such as capacity building for traditional healers and scientists alike. With the available wealth of knowledge on natural products with antiviral properties, possible safe and effective preventive agents or therapeutics against COVID-19 may be discovered through such global collaborative efforts and selfless dedication to practice.</p></sec><sec id="sec0013"><label>7</label><title>Recommendation and conclusion</title><p id="para0032">The COVID-19 pandemic has resulted in the influx of high volumes of unproven and unapproved products in the market globally and increased self-medication. A number of vaccines have recently been approved for use to curb the spread of the virus. However, availability and acceptance by some critics is a big challenge. Conventional drugs such as remdesivir, chloroquine/hydroxychloroquine and dexamethasone are the major proposed drugs that are currently under trials for the management of this disease. Repurposing of therapeutics including those of natural products already available in the market, have been advocated by researchers with some countries already approving such for treatment or management of COVID-19. Natural products are helpful in the treatment of infections, but the consumption of unproven and unapproved products is a great health risk. It is of utmost importance that proposed or repurposed natural products against the novel SARS-CoV-2 virus are well evaluated for efficacy, mechanisms of action and safety before use. Collaborative efforts between researchers, governments and traditional medicinal practitioners in the search and development of possible safe and effective therapeutics from natural products, that may be helpful in the treatment or management of COVID-19 is a good option to explore.</p></sec><sec sec-type="COI-statement"><title>Declaration of Competing Interest</title><p id="para0034">The authors of this review declare no conflict of interest whatsoever.</p></sec></body><back><ref-list id="cebibl1"><title>References</title><ref id="bib0001"><element-citation publication-type="journal" id="sbref0001"><person-group person-group-type="author"><name><surname>Abdalla</surname><given-names>M.A.</given-names></name><name><surname>McGaw</surname><given-names>L.J.</given-names></name></person-group><article-title>Bioprospecting of South African plants as a unique resource for bioactive endophytic microbes</article-title><source>Front. Pharmacol.</source><volume>9</volume><year>2018</year><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">29387012</pub-id></element-citation></ref><ref id="bib0145"><element-citation publication-type="journal" id="sbref0145"><person-group person-group-type="author"><name><surname>Ahmad</surname><given-names>J.</given-names></name><name><surname>Ikram</surname><given-names>S.</given-names></name><name><surname>Ahmad</surname><given-names>F.</given-names></name><name><surname>Rehman</surname><given-names>I.U.</given-names></name><name><surname>Mushtaq</surname><given-names>M.</given-names></name></person-group><article-title>SARS-CoV-2 RNA dependent RNA polymerase (RdRp) - A drug repurposing study</article-title><source>Heliyon</source><volume>6</volume><year>2020</year><fpage>4502</fpage></element-citation></ref><ref id="bib0002"><element-citation publication-type="journal" id="sbref0002"><person-group person-group-type="author"><name><surname>Akerele</surname><given-names>O.</given-names></name></person-group><article-title>Nature's medicinal bounty: don't throw it away</article-title><source>World Health Forum</source><volume>14</volume><year>1993</year><fpage>390</fpage><lpage>395</lpage><pub-id pub-id-type="pmid">8185790</pub-id></element-citation></ref><ref id="bib0003"><element-citation publication-type="journal" id="sbref0003"><person-group person-group-type="author"><name><surname>Akindele</surname><given-names>A.J.</given-names></name><name><surname>Agunbiade</surname><given-names>F.O.</given-names></name><name><surname>Sofidiya</surname><given-names>M.O.</given-names></name><name><surname>Awodele</surname><given-names>O.</given-names></name><name><surname>Sowemimo</surname><given-names>A.</given-names></name><name><surname>Ade-Ademilua</surname><given-names>O.</given-names></name><name><surname>Akinleye</surname><given-names>M.O.</given-names></name><name><surname>Ishola1</surname><given-names>I.O.</given-names></name><name><surname>Orabueze</surname><given-names>I.</given-names></name><name><surname>Salu</surname><given-names>O.B.</given-names></name><name><surname>Oreagba</surname><given-names>I.A.</given-names></name><name><surname>Asekun</surname><given-names>O.T.</given-names></name><name><surname>Odukoya</surname><given-names>O.</given-names></name></person-group><article-title>COVID-19 pandemic: a case for phytomedicines</article-title><source>Nat. Prod. Commun.</source><volume>15</volume><year>2020</year><fpage>1</fpage><lpage>9</lpage></element-citation></ref><ref id="bib0004"><element-citation publication-type="book" id="sbref0004"><person-group person-group-type="author"><name><surname>Alamanou</surname><given-names>M.T.</given-names></name></person-group><chapter-title>Anti-Coronavirus Natural Products and <italic>In silico</italic> Screening</chapter-title><year>2020</year><ext-link ext-link-type="uri" xlink:href="https://towardsdatascience.com/anti-coronavirus-natural-products-and-in-silico-screening-54d9f03b7daf" id="interref0004">https://towardsdatascience.com/anti-coronavirus-natural-products-and-in-silico-screening-54d9f03b7daf</ext-link></element-citation></ref><ref id="bib0005"><element-citation publication-type="journal" id="sbref0005"><person-group person-group-type="author"><name><surname>Allison</surname><given-names>A.C.</given-names></name><name><surname>Cacabelos</surname><given-names>R.</given-names></name><name><surname>Lombardi</surname><given-names>V.R.M.</given-names></name><name><surname>Alvarez</surname><given-names>X.A.</given-names></name><name><surname>Vigo</surname><given-names>C.</given-names></name></person-group><article-title>Celastrol, a potent antioxidant and anti-inflammatory drug, as a possible treatment for Alzheimer's disease</article-title><source>Prog. Neuropsychopharmacol. Biol. Psychiatry</source><volume>25</volume><year>2001</year><fpage>1341</fpage><lpage>1357</lpage><pub-id pub-id-type="pmid">11513350</pub-id></element-citation></ref><ref id="bib0006"><element-citation publication-type="journal" id="sbref0006"><person-group person-group-type="author"><name><surname>Alvin</surname><given-names>A.</given-names></name><name><surname>Miller</surname><given-names>C.I.</given-names></name><name><surname>Neilan</surname><given-names>B.A.</given-names></name></person-group><article-title>Exploring the potential of endophytes from medicinal plants as sources of antimycobacterial compounds</article-title><source>Microbiol. Res.</source><volume>169</volume><year>2014</year><fpage>483</fpage><lpage>495</lpage><pub-id pub-id-type="pmid">24582778</pub-id></element-citation></ref><ref id="bib0007"><element-citation publication-type="journal" id="sbref0007"><person-group person-group-type="author"><name><surname>Andersen</surname><given-names>K.G.</given-names></name><name><surname>Rambaut</surname><given-names>A.</given-names></name><name><surname>Lipkin</surname><given-names>W.I.</given-names></name><name><surname>Holmes</surname><given-names>E.C.</given-names></name><name><surname>Garry</surname><given-names>R.F.</given-names></name></person-group><article-title>The proximal origin of SARS-CoV-2</article-title><source>Nat. Med.</source><volume>26</volume><year>2020</year><fpage>450</fpage><lpage>455</lpage><pub-id pub-id-type="pmid">32284615</pub-id></element-citation></ref><ref id="bib0008"><element-citation publication-type="journal" id="sbref0008"><person-group person-group-type="author"><name><surname>Ang</surname><given-names>L.</given-names></name><name><surname>Lee</surname><given-names>H.W.</given-names></name><name><surname>Choi</surname><given-names>J.Y.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Lee</surname><given-names>M.S.</given-names></name></person-group><article-title>Herbal medicine and pattern identification for treating COVID-19: A rapid review of guidelines</article-title><source>Integr. Med. Res.</source><volume>9</volume><year>2020</year><object-id pub-id-type="publisher-id">100407</object-id></element-citation></ref><ref id="bib0009"><element-citation publication-type="journal" id="sbref0009"><person-group person-group-type="author"><name><surname>Anquez-Traxler</surname><given-names>C.</given-names></name></person-group><article-title>The legal and regulatory framework of herbal medicinal products in the European Union: a focus on the traditional herbal medicines category</article-title><source>Drug Inf. J.</source><volume>45</volume><year>2011</year><fpage>15</fpage><lpage>23</lpage></element-citation></ref><ref id="bib0010"><element-citation publication-type="journal" id="sbref0010"><person-group person-group-type="author"><name><surname>Antonio</surname><given-names>A.D.S.</given-names></name><name><surname>Wiedemann</surname><given-names>L.S.M.</given-names></name><name><surname>Veiga-Junior</surname><given-names>V.F.</given-names></name></person-group><article-title>Natural products' role against COVID-19</article-title><source>RSC Adv.</source><volume>10</volume><year>2020</year><fpage>23379</fpage><lpage>23393</lpage></element-citation></ref><ref id="bib0011"><element-citation publication-type="journal" id="sbref0011"><person-group person-group-type="author"><name><surname>Arvidson</surname><given-names>K.B.</given-names></name><name><surname>Valerio</surname><given-names>L.G.</given-names></name><name><surname>Diaz</surname><given-names>M.</given-names></name><name><surname>Chanderbhan</surname><given-names>R.F.</given-names></name></person-group><article-title><italic>In Silico</italic> toxicological screening of natural products</article-title><source>Toxicol. Mech. Methods</source><volume>18</volume><year>2008</year><fpage>2</fpage><lpage>3</lpage></element-citation></ref><ref id="bib0012"><element-citation publication-type="book" id="sbref0012"><person-group person-group-type="author"><name><surname>Auwaerter</surname><given-names>P.G.</given-names></name></person-group><chapter-title>Coronavirus Treatment: What's in Development</chapter-title><year>2020</year><publisher-name>John Hopkins Medicine</publisher-name><ext-link ext-link-type="uri" xlink:href="https://www.hopkinsmedicine.org/health/conditions-and-diseases/coronavirus/coronavirus-treatment-whats-in-development" id="interref0005">https://www.hopkinsmedicine.org/health/conditions-and-diseases/coronavirus/coronavirus-treatment-whats-in-development</ext-link></element-citation></ref><ref id="bib0013"><element-citation publication-type="journal" id="sbref0013"><person-group person-group-type="author"><name><surname>Baldwin</surname><given-names>C.A.</given-names></name><name><surname>Anderson</surname><given-names>L.A.</given-names></name><name><surname>Phillipson</surname><given-names>J.D.</given-names></name></person-group><article-title>What pharmacists should know about Ginseng?</article-title><source>Pharm. J.</source><volume>237</volume><year>1986</year><fpage>583</fpage><lpage>586</lpage></element-citation></ref><ref id="bib0014"><element-citation publication-type="journal" id="sbref0014"><person-group person-group-type="author"><name><surname>Beigel</surname><given-names>J.H.</given-names></name><name><surname>Tomashek</surname><given-names>K.M.</given-names></name><name><surname>Dodd</surname><given-names>L.E.</given-names></name><name><surname>Mehta</surname><given-names>A.K.</given-names></name><name><surname>Zingman</surname><given-names>B.S.</given-names></name><name><surname>Kalil</surname><given-names>A.C.</given-names></name><name><surname>Hohmann</surname><given-names>E.</given-names></name><name><surname>Chu</surname><given-names>H.Y.</given-names></name><name><surname>Luetkemeyer</surname><given-names>A.</given-names></name><name><surname>Kline</surname><given-names>S.</given-names></name><name><surname>de Castilla</surname><given-names>D.L.</given-names></name><name><surname>Finberg</surname><given-names>R.W.</given-names></name><name><surname>Dierberg</surname><given-names>K.</given-names></name><name><surname>Tapson</surname><given-names>V.</given-names></name><name><surname>Hsieh</surname><given-names>L.</given-names></name><name><surname>Patterson</surname><given-names>T.F.</given-names></name><name><surname>Paredes</surname><given-names>R.</given-names></name><name><surname>Sweeney</surname><given-names>D.A.</given-names></name><name><surname>Short</surname><given-names>W.R.</given-names></name><name><surname>Touloumi</surname><given-names>G.</given-names></name><name><surname>Lye</surname><given-names>D.C.</given-names></name><name><surname>Ohmagari</surname><given-names>N.</given-names></name><name><surname>Oh</surname><given-names>M.</given-names></name><name><surname>Ruiz&#x02011;Palacios</surname><given-names>G.M.</given-names></name><name><surname>Benfield</surname><given-names>T.</given-names></name><name><surname>F&#x000e4;tkenheuer</surname><given-names>G.</given-names></name><name><surname>Kortepeter</surname><given-names>M.G.</given-names></name><name><surname>Atmar</surname><given-names>R.L.</given-names></name><name><surname>Creech</surname><given-names>C.B.</given-names></name><name><surname>Lundgren</surname><given-names>J.</given-names></name><name><surname>Babiker</surname><given-names>A.G.</given-names></name><name><surname>Pett</surname><given-names>S.</given-names></name><name><surname>Neaton</surname><given-names>J.D.</given-names></name><name><surname>Burgess</surname><given-names>T.H.</given-names></name><name><surname>Bonnett</surname><given-names>T.</given-names></name><name><surname>Green</surname><given-names>M.</given-names></name><name><surname>Makowski</surname><given-names>M.</given-names></name><name><surname>Osinusi</surname><given-names>A.</given-names></name><name><surname>Nayak</surname><given-names>S.</given-names></name><name><surname>Lane</surname><given-names>H.C.</given-names></name></person-group><article-title>Remdesivir for the treatment of Covid-19 &#x02013; preliminary report</article-title><source>N. Engl. J. Med.</source><volume>383</volume><year>2020</year><fpage>1813</fpage><lpage>1826</lpage><pub-id pub-id-type="pmid">32445440</pub-id></element-citation></ref><ref id="bib0015"><element-citation publication-type="journal" id="sbref0015"><person-group person-group-type="author"><name><surname>Benarba</surname><given-names>B.</given-names></name><name><surname>Pandiella</surname><given-names>A.</given-names></name></person-group><article-title>Medicinal plants as sources of active molecules against COVID-19</article-title><source>Front. Pharmacol.</source><volume>11</volume><year>2020</year><fpage>1189</fpage><pub-id pub-id-type="pmid">32848790</pub-id></element-citation></ref><ref id="bib0016"><element-citation publication-type="journal" id="sbref0016"><person-group person-group-type="author"><name><surname>Borrelli</surname><given-names>F.</given-names></name><name><surname>Capasso</surname><given-names>R.</given-names></name><name><surname>Izzo</surname><given-names>A.</given-names></name></person-group><article-title>Garlic (<italic>Allium sativum</italic> L.): Adverse effects and drug interactions in humans</article-title><source>Mol. Nutr. Food Res.</source><volume>51</volume><year>2007</year><fpage>1386</fpage><lpage>1397</lpage><pub-id pub-id-type="pmid">17918162</pub-id></element-citation></ref><ref id="bib0017"><element-citation publication-type="journal" id="sbref0017"><person-group person-group-type="author"><name><surname>Braun</surname><given-names>L.A.</given-names></name><name><surname>Tiralongo</surname><given-names>E.</given-names></name><name><surname>Wilkinson</surname><given-names>J.M.</given-names></name><name><surname>Poole</surname><given-names>S.</given-names></name><name><surname>Spitzer</surname><given-names>O.</given-names></name><name><surname>Bailey</surname><given-names>M.</given-names></name><name><surname>Dooley</surname><given-names>M.</given-names></name></person-group><article-title>Adverse reactions to complementary medicines: the Australian pharmacy experience</article-title><source>Int. J. Pharm. Pract.</source><volume>18</volume><year>2010</year><fpage>242</fpage><lpage>244</lpage><pub-id pub-id-type="pmid">20636677</pub-id></element-citation></ref><ref id="bib0018"><element-citation publication-type="journal" id="sbref0018"><person-group person-group-type="author"><name><surname>Calapai</surname><given-names>G.</given-names></name></person-group><article-title>European legislation on herbal medicines: a look into the future</article-title><source>Drug Saf.</source><volume>31</volume><year>2008</year><fpage>428</fpage><lpage>431</lpage><pub-id pub-id-type="pmid">18422385</pub-id></element-citation></ref><ref id="bib0019"><element-citation publication-type="book" id="sbref0019"><person-group person-group-type="author"><collab>CDC</collab></person-group><chapter-title>Middle East Respiratory Syndrome (MERS)</chapter-title><year>2020</year><publisher-name>Centers for Disease Control and Prevention</publisher-name><ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/coronavirus/mers/about/symptoms.html" id="interref0006">https://www.cdc.gov/coronavirus/mers/about/symptoms.html</ext-link></element-citation></ref><ref id="bib0020"><element-citation publication-type="book" id="sbref0020"><person-group person-group-type="author"><collab>CDC</collab></person-group><chapter-title>What you Should Know About COVID-19 to Protect Yourself and Others</chapter-title><year>2020</year><ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/coronavirus/2019-ncov/downloads/2019-ncov-factsheet.pdf" id="interref0007">https://www.cdc.gov/coronavirus/2019-ncov/downloads/2019-ncov-factsheet.pdf</ext-link></element-citation></ref><ref id="bib0021"><element-citation publication-type="book" id="sbref0021"><person-group person-group-type="author"><collab>CDC</collab></person-group><chapter-title>People of Any Age With Underlying Medical Conditions</chapter-title><year>2020</year><publisher-name>Centeres for Diseases Control and Prevention</publisher-name><ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html" id="interref0008">https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html</ext-link></element-citation></ref><ref id="bib0022"><element-citation publication-type="book" id="sbref0022"><person-group person-group-type="author"><name><surname>CDC</surname></name></person-group><chapter-title>Coronavirus Disease 2019 (COVID-19) Symptoms of coronavirus</chapter-title><year>2020</year><ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html" id="interref0009">https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html</ext-link></element-citation></ref><ref id="bib0023"><element-citation publication-type="book" id="sbref0023"><person-group person-group-type="author"><collab>Chemocare</collab></person-group><chapter-title>Dexamethasone</chapter-title><year>2020</year><ext-link ext-link-type="uri" xlink:href="http://chemocare.com/chemotherapy/drug-info/dexamethasone.aspx" id="interref0010">http://chemocare.com/chemotherapy/drug-info/dexamethasone.aspx</ext-link></element-citation></ref><ref id="bib0024"><element-citation publication-type="journal" id="sbref0024"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Shen</surname><given-names>T.</given-names></name><name><surname>Zhong</surname><given-names>L.</given-names></name><name><surname>Liu</surname><given-names>Z.</given-names></name><name><surname>Dong</surname><given-names>X.</given-names></name><name><surname>Huang</surname><given-names>T.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Xiao</surname><given-names>H.</given-names></name></person-group><article-title>Research progress of Chloroquine and Hydroxychloroquine on the COVID-19 and their potential risks in clinic use</article-title><source>Front. Pharmacol.</source><volume>11</volume><year>2020</year><fpage>1167</fpage><pub-id pub-id-type="pmid">32848774</pub-id></element-citation></ref><ref id="bib0025"><element-citation publication-type="journal" id="sbref0025"><person-group person-group-type="author"><name><surname>Clark</surname><given-names>A.</given-names></name><name><surname>Jit</surname><given-names>M.</given-names></name><name><surname>Warren-Gash</surname><given-names>C.</given-names></name><name><surname>Guthrie</surname><given-names>B.</given-names></name><name><surname>Wang</surname><given-names>H.H.X.</given-names></name><name><surname>Mercer</surname><given-names>S.W.</given-names></name><name><surname>Sanderson</surname><given-names>C.</given-names></name><name><surname>McKee</surname><given-names>M.</given-names></name><name><surname>Troeger</surname><given-names>C.</given-names></name><name><surname>Ong</surname><given-names>K.L.</given-names></name><name><surname>Checchi</surname><given-names>F.</given-names></name><name><surname>Perel</surname><given-names>P.</given-names></name><name><surname>Joseph</surname><given-names>S.</given-names></name><name><surname>Gibbs</surname><given-names>H.P.</given-names></name><name><surname>Banerjee</surname><given-names>A.</given-names></name><name><surname>Eggo</surname><given-names>R.M.</given-names></name></person-group><article-title>Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study</article-title><source>Lancet Glob. Health</source><volume>8</volume><year>2020</year><fpage>1003</fpage><lpage>1017</lpage></element-citation></ref><ref id="bib0026"><element-citation publication-type="book" id="sbref0026"><person-group person-group-type="author"><collab>ClinicaTrials.gov</collab></person-group><chapter-title>Efficacy of Natural Honey Treatment in Patients With Novel Coronavirus</chapter-title><year>2020</year><ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT04323345" id="interref0011">https://clinicaltrials.gov/ct2/show/NCT04323345</ext-link></element-citation></ref><ref id="bib0027"><element-citation publication-type="journal" id="sbref0027"><person-group person-group-type="author"><name><surname>Cunningham</surname><given-names>A.C.</given-names></name><name><surname>Goh</surname><given-names>H.P.</given-names></name><name><surname>Koh</surname><given-names>D.</given-names></name></person-group><article-title>Treatment of COVID-19: old tricks for new challenges</article-title><source>Crit. Care</source><volume>24</volume><year>2020</year><fpage>91</fpage><pub-id pub-id-type="pmid">32178711</pub-id></element-citation></ref><ref id="bib0028"><element-citation publication-type="book" id="sbref0028"><person-group person-group-type="author"><name><surname>da Cruz</surname><given-names>B.C.F.</given-names></name><name><surname>Ronqui</surname><given-names>L.</given-names></name><name><surname>Scharnoski</surname><given-names>P.</given-names></name><name><surname>Scharnoski</surname><given-names>P.</given-names></name><name><surname>Peruzzolo</surname><given-names>M.</given-names></name><name><surname>Santos</surname><given-names>P.D.R.</given-names></name><name><surname>Halak</surname><given-names>A.</given-names></name><name><surname>Wielewski</surname><given-names>P.</given-names></name><name><surname>Magro</surname><given-names>J.M.</given-names></name><name><surname>de Araujo</surname><given-names>K.F.</given-names></name></person-group><chapter-title>Health Benefits of Honey</chapter-title><year>2019</year><ext-link ext-link-type="uri" xlink:href="https://www.intechopen.com/online-first/health-benefits-of-honey" id="interref0012">https://www.intechopen.com/online-first/health-benefits-of-honey</ext-link></element-citation></ref><ref id="bib0029"><element-citation publication-type="journal" id="sbref0029"><person-group person-group-type="author"><name><surname>Dega</surname><given-names>H.</given-names></name><name><surname>Laporte</surname><given-names>J.L.</given-names></name><name><surname>Franc&#x000e8;s</surname><given-names>C.</given-names></name><name><surname>Herson</surname><given-names>S.</given-names></name><name><surname>Chosidow</surname><given-names>O.</given-names></name></person-group><article-title>Ginseng as a cause for Stevens&#x02013;Johnson syndrome?</article-title><source>Lancet</source><volume>347</volume><year>1996</year><fpage>1344</fpage></element-citation></ref><ref id="bib0030"><element-citation publication-type="journal" id="sbref0030"><person-group person-group-type="author"><name><surname>Dunnick</surname><given-names>J.K.</given-names></name><name><surname>Nyska</surname><given-names>A.</given-names></name></person-group><article-title>The toxicity and pathology of selected dietary herbal medicines</article-title><source>Toxicol. Pathol.</source><volume>41</volume><year>2013</year><fpage>374</fpage><lpage>386</lpage><pub-id pub-id-type="pmid">23262639</pub-id></element-citation></ref><ref id="bib0031"><element-citation publication-type="journal" id="sbref0031"><person-group person-group-type="author"><name><surname>Ekor</surname><given-names>M.</given-names></name></person-group><article-title>The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety</article-title><source>Front. Pharmacol.</source><volume>4</volume><year>2014</year><fpage>177</fpage><pub-id pub-id-type="pmid">24454289</pub-id></element-citation></ref><ref id="bib0032"><element-citation publication-type="journal" id="sbref0032"><person-group person-group-type="author"><name><surname>Eyvazzadeh</surname><given-names>A.</given-names></name></person-group><article-title>Treatment for coronavirus disease (COVID-19)</article-title><source>Healthline</source><year>2020</year><ext-link ext-link-type="uri" xlink:href="https://www.healthline.com/health/coronavirus-treatment" id="interref0013">https://www.healthline.com/health/coronavirus-treatment</ext-link></element-citation></ref><ref id="bib0033"><element-citation publication-type="journal" id="sbref0033"><person-group person-group-type="author"><name><surname>Fan</surname><given-names>H.H.</given-names></name><name><surname>Wang</surname><given-names>L.Q.</given-names></name><name><surname>Liu</surname><given-names>W.L.</given-names></name><name><surname>An</surname><given-names>X.P.</given-names></name><name><surname>Liu</surname><given-names>Z.D.</given-names></name><name><surname>He</surname><given-names>X.Q.</given-names></name><name><surname>Song</surname><given-names>L.H.</given-names></name><name><surname>Tong</surname><given-names>Y.G.</given-names></name></person-group><article-title>Repurposing of clinically approved drugs for treatment of corona-virus disease 2019 in a 2019-novel coronavirus-related coronavirus model</article-title><source>Chin. Med. J.</source><volume>133</volume><year>2020</year><fpage>1051</fpage><lpage>1056</lpage><pub-id pub-id-type="pmid">32149769</pub-id></element-citation></ref><ref id="bib0034"><element-citation publication-type="journal" id="sbref0034"><person-group person-group-type="author"><name><surname>Fardet</surname><given-names>L.</given-names></name><name><surname>Genereau</surname><given-names>T.</given-names></name><name><surname>Cabane</surname><given-names>J.</given-names></name><name><surname>Kettaneh</surname><given-names>A.</given-names></name></person-group><article-title>Severe strongyloidiasis in corticosteroid-treated patients</article-title><source>Clin. Microbiol. Infect.</source><volume>12</volume><year>2006</year><fpage>945</fpage><lpage>947</lpage><pub-id pub-id-type="pmid">16961629</pub-id></element-citation></ref><ref id="bib0035"><element-citation publication-type="book" id="sbref0035"><person-group person-group-type="author"><name><surname>Farooq</surname><given-names>D.</given-names></name></person-group><chapter-title>Effectiveness of Hydroxychloroquine in COVID-19 Patients (Covid)</chapter-title><year>2020</year><publisher-name>United States National Library of Medicine</publisher-name><comment>ClinicalTrials.gov</comment><ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT04328272?type=Intr&#x00026;cond=covid19&#x00026;draw=2&#x00026;rank2" id="interref0014">https://clinicaltrials.gov/ct2/show/NCT04328272?type=Intr&#x00026;cond=covid19&#x00026;draw=2&#x00026;rank2</ext-link></element-citation></ref><ref id="bib0036"><element-citation publication-type="journal" id="sbref0036"><person-group person-group-type="author"><collab>FDA</collab></person-group><article-title>United States Food and Drug Administration Rules and regulations: over-the-counter drug products containing colloidal silver ingredients or silver salts. Final rule</article-title><source>Fed. Regist.</source><volume>64</volume><year>1999</year><fpage>44653</fpage><lpage>44658</lpage><pub-id pub-id-type="pmid">10558603</pub-id></element-citation></ref><ref id="bib0037"><element-citation publication-type="book" id="sbref0037"><person-group person-group-type="author"><collab>FDA</collab></person-group><chapter-title>The Drug Development Process</chapter-title><year>2018</year><publisher-name>United States Food and Drug Administration</publisher-name><ext-link ext-link-type="uri" xlink:href="https://www.fda.gov/patients/learn-about-drug-and-device-approvals/drug-development-process" id="interref0015">https://www.fda.gov/patients/learn-about-drug-and-device-approvals/drug-development-process</ext-link></element-citation></ref><ref id="bib0038"><element-citation publication-type="book" id="sbref0038"><person-group person-group-type="author"><collab>FDA</collab></person-group><chapter-title>Coronavirus (COVID-19) Update: FDA Issues Emergency use Authorization for Potential COVID-19 Treatment</chapter-title><year>2020</year><ext-link ext-link-type="uri" xlink:href="https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-issues-emergency-use-authorization-potential-covid-19-treatment" id="interref0016">https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-issues-emergency-use-authorization-potential-covid-19-treatment</ext-link></element-citation></ref><ref id="bib0039"><element-citation publication-type="book" id="sbref0039"><person-group person-group-type="author"><collab>FDA</collab></person-group><chapter-title>FDA Cautions Against use of Hydroxychloroquine or Chloroquine for COVID-19 Outside of the Hospital Setting or a Clinical Trial Due to Risk of Heart Rhythm Problems</chapter-title><year>2020</year><ext-link ext-link-type="uri" xlink:href="https://www.fda.gov/drugs/drug-safety-and-availability/fda-cautions-against-use-hydroxychloroquine-or-chloroquine-covid-19-outside-hospital-setting-or" id="interref0017">https://www.fda.gov/drugs/drug-safety-and-availability/fda-cautions-against-use-hydroxychloroquine-or-chloroquine-covid-19-outside-hospital-setting-or</ext-link></element-citation></ref><ref id="bib0040"><element-citation publication-type="book" id="sbref0040"><person-group person-group-type="author"><collab>FDA</collab></person-group><chapter-title>Fraudulent Coronavirus Disease 2019 (COVID-19) Products</chapter-title><year>2020</year><ext-link ext-link-type="uri" xlink:href="https://www.fda.gov/consumers/health-fraud-scams/fraudulent-coronavirus-disease-2019-covid-19-products" id="interref0018">https://www.fda.gov/consumers/health-fraud-scams/fraudulent-coronavirus-disease-2019-covid-19-products</ext-link></element-citation></ref><ref id="bib0041"><element-citation publication-type="book" id="sbref0041"><person-group person-group-type="author"><collab>FDA-CDER</collab></person-group><chapter-title>Botanical Drug Development Guidance for Industry. U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research</chapter-title><year>2016</year><comment>https://www.fda.gov/files/drugs/published/Botanical-Drug-Development&#x02013;Guidance-for-Industry.pdf</comment></element-citation></ref><ref id="bib0042"><element-citation publication-type="book" id="sbref0042"><person-group person-group-type="author"><name><surname>Gazeta</surname><given-names>N.</given-names></name></person-group><chapter-title>A Virology Expert Answers Key Questions on COVID-19</chapter-title><year>2020</year><publisher-name>World Economic Forum</publisher-name><ext-link ext-link-type="uri" xlink:href="https://www.weforum.org/agenda/2020/03/covid-19-explained-virology-expert/" id="interref0019">https://www.weforum.org/agenda/2020/03/covid-19-explained-virology-expert/</ext-link></element-citation></ref><ref id="bib0043"><element-citation publication-type="journal" id="sbref0043"><person-group person-group-type="author"><name><surname>Ghenadenik</surname><given-names>A.</given-names></name><name><surname>Rochais</surname><given-names>&#x000c9;.</given-names></name><name><surname>Atkinson</surname><given-names>S.</given-names></name><name><surname>Bussi&#x000e8;res</surname><given-names>J.F.</given-names></name></person-group><article-title>Potential risks associated with medication administration, as identified by simple tools and observations</article-title><source>Can. J. Hosp. Pharm.</source><volume>65</volume><issue>4</issue><year>2012</year></element-citation></ref><ref id="bib0044"><element-citation publication-type="journal" id="sbref0044"><person-group person-group-type="author"><name><surname>Grein</surname><given-names>J.</given-names></name><name><surname>Ohmagari</surname><given-names>N.</given-names></name><name><surname>Shin</surname><given-names>D.</given-names></name><name><surname>Diaz</surname><given-names>G.</given-names></name><name><surname>Asperges</surname><given-names>E.</given-names></name><name><surname>Castagna</surname><given-names>A</given-names></name><name><surname>Feldt</surname><given-names>T.</given-names></name><name><surname>Green</surname><given-names>G.</given-names></name><name><surname>Green</surname><given-names>M.L.</given-names></name><name><surname>Lescure</surname><given-names>F.X.</given-names></name><name><surname>Nicastri</surname><given-names>E.</given-names></name><name><surname>Oda</surname><given-names>R.</given-names></name><name><surname>Yo</surname><given-names>K.</given-names></name><name><surname>Quiros-Roldan</surname><given-names>E.</given-names></name><name><surname>Studemeister</surname><given-names>A.</given-names></name><name><surname>Redinski</surname><given-names>J.</given-names></name><name><surname>Ahmed</surname><given-names>S.</given-names></name><name><surname>Bernett</surname><given-names>J.</given-names></name><name><surname>Chelliah</surname><given-names>D.</given-names></name><name><surname>Chen</surname><given-names>D.</given-names></name><name><surname>Chihara</surname><given-names>S.</given-names></name><name><surname>Cohen</surname><given-names>S.H.</given-names></name><name><surname>Cunningham</surname><given-names>J.</given-names></name><name><surname>Monforte</surname><given-names>A.D</given-names></name><name><surname>Ismail</surname><given-names>S.</given-names></name><name><surname>Kato</surname><given-names>H.</given-names></name><name><surname>Lapadula</surname><given-names>G.</given-names></name><name><surname>L'Her</surname><given-names>E.</given-names></name><name><surname>Maeno</surname><given-names>T.</given-names></name><name><surname>Majumder</surname><given-names>S.</given-names></name><name><surname>Massari</surname><given-names>M.</given-names></name><name><surname>Mora-Rillo</surname><given-names>M.</given-names></name><name><surname>Mutoh</surname><given-names>Y.</given-names></name><name><surname>Nguyen</surname><given-names>D.</given-names></name><name><surname>Verweij</surname><given-names>E.</given-names></name><name><surname>Zoufaly</surname><given-names>A.</given-names></name><name><surname>Osinusi</surname><given-names>A.O.</given-names></name><name><surname>DeZure</surname><given-names>A.</given-names></name><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Zhong</surname><given-names>L.</given-names></name><name><surname>Chokkalingam</surname><given-names>A.</given-names></name><name><surname>Elboudwarej</surname><given-names>E.</given-names></name><name><surname>Telep</surname><given-names>L.</given-names></name><name><surname>Timbs</surname><given-names>L.</given-names></name><name><surname>Henne</surname><given-names>I.</given-names></name><name><surname>Sellers</surname><given-names>S.</given-names></name><name><surname>Cao</surname><given-names>H.</given-names></name><name><surname>Tan</surname><given-names>S.K.</given-names></name><name><surname>Winterbourne</surname><given-names>L.</given-names></name><name><surname>Desai</surname><given-names>P.</given-names></name><name><surname>Mera</surname><given-names>R.</given-names></name><name><surname>Gaggar</surname><given-names>A.</given-names></name><name><surname>Myers</surname><given-names>R.P.</given-names></name><name><surname>Brainard</surname><given-names>D.M.</given-names></name><name><surname>Childs</surname><given-names>R.</given-names></name><name><surname>Flanigan</surname><given-names>T.</given-names></name></person-group><article-title>Compassionate use of Remdesivir for patients with severe Covid-19</article-title><source>N. Engl. J. Med.</source><volume>382</volume><year>2020</year><fpage>2327</fpage><lpage>2336</lpage><pub-id pub-id-type="pmid">32275812</pub-id></element-citation></ref><ref id="bib0045"><element-citation publication-type="book" id="sbref0045"><person-group person-group-type="author"><name><surname>Grinspoon</surname><given-names>P.</given-names></name></person-group><chapter-title>Cannabidiol (CBD) &#x02013; What we Know and What we Don't</chapter-title><year>2020</year><publisher-name>Harvard Health Publishing</publisher-name><ext-link ext-link-type="uri" xlink:href="https://www.health.harvard.edu/blog/cannabidiol-cbd-what-we-know-and-what-we-dont-2018082414476" id="interref0020">https://www.health.harvard.edu/blog/cannabidiol-cbd-what-we-know-and-what-we-dont-2018082414476</ext-link></element-citation></ref><ref id="bib0046"><element-citation publication-type="book" id="sbref0046"><person-group person-group-type="author"><name><surname>Hallmann</surname><given-names>J.</given-names></name><name><surname>Schulz</surname><given-names>B.</given-names></name><name><surname>Berg</surname><given-names>G.</given-names></name></person-group><chapter-title>Isolation procedures for endophytic microorganisms</chapter-title><source>Microbial Root Endophytes</source><year>2006</year><publisher-name>Springer</publisher-name><publisher-loc>Berlin, Heidelberg, New York</publisher-loc><fpage>299</fpage><lpage>314</lpage></element-citation></ref><ref id="bib0047"><element-citation publication-type="journal" id="sbref0047"><person-group person-group-type="author"><name><surname>Hamilton</surname><given-names>A.C.</given-names></name></person-group><article-title>Medicinal plants, conservation and livelihoods</article-title><source>Biodivers. Conserv.</source><volume>13</volume><year>2014</year><fpage>1477</fpage><lpage>1517</lpage></element-citation></ref><ref id="bib0048"><element-citation publication-type="book" id="sbref0048"><person-group person-group-type="author"><name><surname>Hassanin</surname><given-names>A.</given-names></name></person-group><chapter-title>Coronavirus Origins: Genome Analysis Suggests two Viruses May Have Combined</chapter-title><year>2020</year><publisher-name>World Economic Forum</publisher-name><ext-link ext-link-type="uri" xlink:href="https://www.weforum.org/agenda/2020/03/coronavirus-origins-genome-analysis-covid19-data-science-bats-pangolins/" id="interref0021">https://www.weforum.org/agenda/2020/03/coronavirus-origins-genome-analysis-covid19-data-science-bats-pangolins/</ext-link></element-citation></ref><ref id="bib0049"><element-citation publication-type="book" id="sbref0049"><person-group person-group-type="author"><collab>Health24</collab></person-group><chapter-title>Infectious Diseases</chapter-title><year>2020</year><ext-link ext-link-type="uri" xlink:href="https://www.health24.com/Medical/Infectious-diseases/Coronavirus/a-brief-history-of-the-coronavirus-family-including-one-pandemic-we-might-have-missed-20200325" id="interref0022">https://www.health24.com/Medical/Infectious-diseases/Coronavirus/a-brief-history-of-the-coronavirus-family-including-one-pandemic-we-might-have-missed-20200325</ext-link></element-citation></ref><ref id="bib0050"><element-citation publication-type="book" id="sbref0050"><person-group person-group-type="author"><name><surname>Herper</surname><given-names>M.</given-names></name></person-group><chapter-title>Hydroxychloroquine Does not Prevent Covid-19 Infection if Exposed, Study Says</chapter-title><year>2020</year><ext-link ext-link-type="uri" xlink:href="https://www.statnews.com/2020/06/03/hydroxychloroquine-does-not-prevent-covid-19-infection-in-people-who-have-been-exposed-study-says/" id="interref0023">https://www.statnews.com/2020/06/03/hydroxychloroquine-does-not-prevent-covid-19-infection-in-people-who-have-been-exposed-study-says/</ext-link></element-citation></ref><ref id="bib0144"><element-citation publication-type="journal" id="sbref0144"><person-group person-group-type="author"><name><surname>Hodos</surname><given-names>R.A.</given-names></name><name><surname>Kidd</surname><given-names>B.A.</given-names></name><name><surname>Khader</surname><given-names>S.</given-names></name><name><surname>Readhead</surname><given-names>B.P.</given-names></name><name><surname>Dudley</surname><given-names>J.T.</given-names></name></person-group><article-title>Computational approaches to drug repurposing and pharmacology, Wiley Interdiscip</article-title><source>Rev. Syst. Biol. Med.</source><volume>8</volume><year>2016</year><fpage>186</fpage><lpage>210</lpage></element-citation></ref><ref id="bib0052"><element-citation publication-type="journal" id="sbref0052"><person-group person-group-type="author"><name><surname>Hoffmann</surname><given-names>M.</given-names></name><name><surname>Kleine-Weber</surname><given-names>H.</given-names></name><name><surname>Schroeder</surname><given-names>S.</given-names></name><name><surname>Kr&#x000fc;ger</surname><given-names>N.</given-names></name><name><surname>Herrler</surname><given-names>T.</given-names></name><name><surname>Erichsen</surname><given-names>S.</given-names></name><name><surname>Nitsche</surname><given-names>A.</given-names></name></person-group><article-title>SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor</article-title><source>Cell</source><volume>181</volume><year>2020</year><fpage>271</fpage><lpage>280</lpage><pub-id pub-id-type="pmid">32142651</pub-id></element-citation></ref><ref id="bib0053"><element-citation publication-type="journal" id="sbref0053"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>K.</given-names></name><name><surname>Guan</surname><given-names>W.J.</given-names></name><name><surname>Bi</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>B.</given-names></name><name><surname>Liu</surname><given-names>Q.</given-names></name><name><surname>Song</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Duan</surname><given-names>Z.</given-names></name><name><surname>Zheng</surname><given-names>Q.</given-names></name><name><surname>Yang</surname><given-names>Z.</given-names></name><name><surname>Liang</surname><given-names>J.</given-names></name><name><surname>Han</surname><given-names>M.</given-names></name><name><surname>Ruan</surname><given-names>L.</given-names></name><name><surname>Wu</surname><given-names>C.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Jia</surname><given-names>Z.</given-names></name><name><surname>Zhong</surname><given-names>N.</given-names></name></person-group><article-title>Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with Coronavirus disease 2019: a multicenter, prospective,randomized controlled trial</article-title><source>Phytomedicine</source><volume>2020</volume><year>2020</year><object-id pub-id-type="publisher-id">153242</object-id></element-citation></ref><ref id="bib0054"><element-citation publication-type="journal" id="sbref0054"><person-group person-group-type="author"><name><surname>Islam</surname><given-names>M.T.</given-names></name><name><surname>Sarkar</surname><given-names>C.</given-names></name><name><surname>El-Kersh</surname><given-names>D.M.</given-names></name><name><surname>Jamaddar</surname><given-names>S.</given-names></name><name><surname>Uddin</surname><given-names>S.J.</given-names></name><name><surname>Shilpi</surname><given-names>J.A.</given-names></name><name><surname>Mubarak</surname><given-names>M.S.</given-names></name></person-group><article-title>Natural products and their derivatives against coronavirus: a review of the non-clinical and pre-clinical data</article-title><source>Phytother. Res.</source><volume>2020</volume><year>2020</year><fpage>1</fpage><lpage>22</lpage></element-citation></ref><ref id="bib0055"><element-citation publication-type="journal" id="sbref0055"><person-group person-group-type="author"><name><surname>Iwata-Yoshikawa</surname><given-names>N.</given-names></name><name><surname>Okamura</surname><given-names>T.</given-names></name><name><surname>Shimizu</surname><given-names>Y.</given-names></name><name><surname>Hasegawa</surname><given-names>H.</given-names></name><name><surname>Takeda</surname><given-names>M.</given-names></name><name><surname>Nagata</surname><given-names>N.</given-names></name></person-group><article-title>TMPRSS2 contributes to virus spread and immunopathology in the airways of murine models after coronavirus infection</article-title><source>J. Virol.</source><volume>93</volume><year>2019</year><fpage>1815</fpage><lpage>1818</lpage></element-citation></ref><ref id="bib0056"><element-citation publication-type="book" id="sbref0056"><comment>Chapter 12</comment><person-group person-group-type="author"><name><surname>Jaiswal</surname><given-names>N.K.</given-names></name><name><surname>Saxena</surname><given-names>S.K.</given-names></name></person-group><chapter-title>Classical Coronaviruses</chapter-title><comment>S.K.</comment><person-group person-group-type="editor"><name><surname>Saxena</surname><given-names>S.K.</given-names></name></person-group><source>Coronavirus Disease 2019 (COVID-19), Medical Virology: from Pathogenesis to Disease Control</source><year>2020</year><publisher-name>Springer Nature</publisher-name><fpage>141</fpage><lpage>213</lpage></element-citation></ref><ref id="bib0057"><element-citation publication-type="journal" id="sbref0057"><person-group person-group-type="author"><name><surname>Jean</surname><given-names>S.S.</given-names></name><name><surname>Lee</surname><given-names>P.I.</given-names></name><name><surname>Hsueh</surname><given-names>P.R.</given-names></name></person-group><article-title>Treatment options for COVID-19: the reality and challenges</article-title><source>J. Microbiol. Immunol. Infect.</source><volume>53</volume><year>2020</year><fpage>436</fpage><lpage>443</lpage><pub-id pub-id-type="pmid">32307245</pub-id></element-citation></ref><ref id="bib0058"><element-citation publication-type="journal" id="sbref0058"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>B.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Tian</surname><given-names>X.</given-names></name><name><surname>Cai</surname><given-names>Y.</given-names></name><name><surname>Gao</surname><given-names>P.</given-names></name></person-group><article-title>Mutagenicity of Chinese traditional medicine Semen Armeniacae amarum by two modified Ames tests</article-title><source>BMC Complement. Altern. Med.</source><volume>9</volume><year>2009</year><fpage>43</fpage><pub-id pub-id-type="pmid">19912670</pub-id></element-citation></ref><ref id="bib0059"><element-citation publication-type="book" id="sbref0059"><person-group person-group-type="author"><name><surname>Joseph</surname><given-names>A.</given-names></name></person-group><chapter-title>New England Journal retract Covid-19 Studies, Including one that Raised Safety Concerns About Malaria Drugs</chapter-title><comment>Lancet</comment><year>2020</year><ext-link ext-link-type="uri" xlink:href="https://www.statnews.com/2020/06/04/lancet-retracts-major-covid-19-paper-that-raised-safety-concerns-about-malaria-drugs/" id="interref0025">https://www.statnews.com/2020/06/04/lancet-retracts-major-covid-19-paper-that-raised-safety-concerns-about-malaria-drugs/</ext-link></element-citation></ref><ref id="bib0060"><element-citation publication-type="journal" id="sbref0060"><person-group person-group-type="author"><name><surname>Joshi</surname><given-names>R.S.</given-names></name><name><surname>Jagdale</surname><given-names>S.S.</given-names></name><name><surname>Bansode</surname><given-names>S.B.</given-names></name><name><surname>Shankar</surname><given-names>S.S.</given-names></name><name><surname>Tellis</surname><given-names>M.B.</given-names></name><name><surname>Pandya</surname><given-names>V.K.</given-names></name><name><surname>Chugh</surname><given-names>A.</given-names></name><name><surname>Giri</surname><given-names>A.P.</given-names></name><name><surname>Kulkarni</surname><given-names>M.J.</given-names></name></person-group><article-title>Discovery of potential multi-target-directed ligands by targeting host-specific SARS-CoV-2 structurally conserved main protease</article-title><source>J. Biomol. Struct. Dyn</source><year>2020</year><pub-id pub-id-type="doi">10.1080/07391102.2020.1760137</pub-id><comment>1-4.</comment></element-citation></ref><ref id="bib0061"><element-citation publication-type="journal" id="sbref0061"><person-group person-group-type="author"><name><surname>Juhn</surname><given-names>P.</given-names></name><name><surname>Phillips</surname><given-names>A.</given-names></name><name><surname>Buto</surname><given-names>K.</given-names></name></person-group><article-title>Balancing modern medical benefits and risks</article-title><source>Health Aff.</source><volume>26</volume><year>2007</year><fpage>647</fpage><lpage>652</lpage></element-citation></ref><ref id="bib0062"><element-citation publication-type="journal" id="sbref0062"><person-group person-group-type="author"><name><surname>Kahn</surname><given-names>J.S.</given-names></name><name><surname>McIntosh</surname><given-names>K.</given-names></name></person-group><article-title>History and recent advances in coronavirus discovery</article-title><source>Pediatr. Infect. Dis. J.</source><volume>24</volume><year>2005</year><fpage>S223</fpage><lpage>S227</lpage><pub-id pub-id-type="pmid">16378050</pub-id></element-citation></ref><ref id="bib0063"><element-citation publication-type="journal" id="sbref0063"><person-group person-group-type="author"><name><surname>Kan</surname><given-names>B</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Jing</surname><given-names>H</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Jiang</surname><given-names>X</given-names></name><name><surname>Yan</surname><given-names>M</given-names></name><name><surname>Liang</surname><given-names>W</given-names></name><name><surname>Zheng</surname><given-names>H</given-names></name><name><surname>Wan</surname><given-names>K.</given-names></name><name><surname>Liu</surname><given-names>O.</given-names></name><name><surname>Cui</surname><given-names>B.</given-names></name><name><surname>Xu</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>E.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Ye</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>G.</given-names></name><name><surname>Li</surname><given-names>M.</given-names></name><name><surname>Cui</surname><given-names>Z.</given-names></name><name><surname>Qi</surname><given-names>X.</given-names></name><name><surname>Chen</surname><given-names>K.</given-names></name><name><surname>Du</surname><given-names>L.</given-names></name><name><surname>Gao</surname><given-names>K.</given-names></name><name><surname>Zhao</surname><given-names>Y.T</given-names></name><name><surname>Zou</surname><given-names>X.Z.</given-names></name><name><surname>Feng</surname><given-names>Y.J.</given-names></name><name><surname>Gao</surname><given-names>Y.F.</given-names></name><name><surname>Hai</surname><given-names>R.</given-names></name><name><surname>Yu</surname><given-names>D.</given-names></name><name><surname>Guan</surname><given-names>Y.</given-names></name><name><surname>Xu</surname><given-names>J.</given-names></name></person-group><article-title>Molecular evolution analysis and geographic investigation of severe acute respiratory syndrome coronavirus- like virus in palm civets at an animal market and on farms</article-title><source>J. Virol.</source><volume>79</volume><year>2005</year><fpage>11892</fpage><lpage>11900</lpage><pub-id pub-id-type="pmid">16140765</pub-id></element-citation></ref><ref id="bib0064"><element-citation publication-type="journal" id="sbref0064"><person-group person-group-type="author"><name><surname>Kar</surname><given-names>P.</given-names></name><name><surname>Kumar</surname><given-names>V.</given-names></name><name><surname>Vellingiri</surname><given-names>B.</given-names></name><name><surname>Sen</surname><given-names>A.</given-names></name><name><surname>Jaishee</surname><given-names>N.</given-names></name><name><surname>Anandraj</surname><given-names>A.</given-names></name><name><surname>Malhotra</surname><given-names>H.</given-names></name><name><surname>Bhattacharyya</surname><given-names>S.</given-names></name><name><surname>Mukhopadhyay</surname><given-names>S.</given-names></name><name><surname>Kinoshita</surname><given-names>M.</given-names></name><name><surname>Govindasamy</surname><given-names>V.</given-names></name><name><surname>Roy</surname><given-names>A.</given-names></name><name><surname>Naidoo</surname><given-names>D.</given-names></name><name><surname>Subramaniam</surname><given-names>M.D.</given-names></name></person-group><article-title>Anisotine and amarogentin as promising inhibitory candidates against SARSCoV- 2 proteins: a computational investigation</article-title><source>J. Biomol. Struct. Dyn.</source><volume>2020</volume><year>2020</year><fpage>1</fpage><lpage>12</lpage></element-citation></ref><ref id="bib0065"><element-citation publication-type="journal" id="sbref0065"><person-group person-group-type="author"><name><surname>Karunamoorthi</surname><given-names>K.</given-names></name><name><surname>Jegajeevanram</surname><given-names>K.</given-names></name><name><surname>Vijayalakshmi</surname><given-names>J.</given-names></name><name><surname>Mengistie</surname><given-names>E.</given-names></name></person-group><article-title>Traditional medicinal plants: a source of phytotherapeutic modality in Resource-Constrained Health care settings</article-title><source>Evid. Based Complement. Altern. Med.</source><volume>18</volume><year>2013</year><fpage>67</fpage><lpage>74</lpage></element-citation></ref><ref id="bib0066"><element-citation publication-type="journal" id="sbref0066"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>J.H.</given-names></name></person-group><article-title>Pharmacological and medical applications of Panax ginseng and ginsenosides: a review for use in cardiovascular diseases</article-title><source>J. Ginseng Res.</source><volume>42</volume><year>2018</year><fpage>264</fpage><lpage>269</lpage><pub-id pub-id-type="pmid">29983607</pub-id></element-citation></ref><ref id="bib0067"><element-citation publication-type="journal" id="sbref0067"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>S.R.</given-names></name><name><surname>Lee</surname><given-names>J.W.</given-names></name><name><surname>Lim</surname><given-names>S.Y.</given-names></name><name><surname>Jung</surname><given-names>Y.S.</given-names></name><name><surname>Choi</surname><given-names>H.Y.</given-names></name><name><surname>Kim</surname><given-names>J.D.</given-names></name></person-group><article-title>Rat single oral dose toxicity test of Armeniacae Semen (including endocarp)</article-title><source>Korean J. Intern. Med.</source><volume>33</volume><year>2012</year><fpage>145</fpage><lpage>159</lpage></element-citation></ref><ref id="bib0068"><element-citation publication-type="book" id="sbref0068"><person-group person-group-type="author"><name><surname>Koe</surname><given-names>T.</given-names></name></person-group><chapter-title>Covid-19 Natural Product Trial: New Curcumin, Artemisinin Supplement to be Tested on Patients. Nutra Ingredients-asia.com</chapter-title><year>2020</year><ext-link ext-link-type="uri" xlink:href="https://www.nutraingredients-asia.com/Article/2020/04/23/COVID-19-natural-product-trial-New-curcumin-artemisinin-supplement-to-be-tested-on-patients" id="interref0026">https://www.nutraingredients-asia.com/Article/2020/04/23/COVID-19-natural-product-trial-New-curcumin-artemisinin-supplement-to-be-tested-on-patients</ext-link></element-citation></ref><ref id="bib0069"><element-citation publication-type="journal" id="sbref0069"><person-group person-group-type="author"><name><surname>Kutney</surname><given-names>J.P.</given-names></name><name><surname>Hewitt</surname><given-names>G.M.</given-names></name><name><surname>Kurihara</surname><given-names>T.</given-names></name><name><surname>Salisbury</surname><given-names>P.J.</given-names></name><name><surname>Sindelar</surname><given-names>R.D.</given-names></name><name><surname>Stuart</surname><given-names>K.L.</given-names></name><name><surname>Townsley</surname><given-names>P.M.</given-names></name><name><surname>Chalmers</surname><given-names>W.T.</given-names></name><name><surname>Jacoli</surname><given-names>G.G.</given-names></name></person-group><article-title>Cyto-toxic diterpenes triptolide, tripdiolide, and cyto-toxic triterpenes from tissue cultures of Tripterygium wilfodii</article-title><source>Can. J. Chem.</source><volume>59</volume><year>1981</year><fpage>2677</fpage><lpage>2683</lpage></element-citation></ref><ref id="bib0070"><element-citation publication-type="journal" id="sbref0070"><person-group person-group-type="author"><name><surname>Lau</surname><given-names>S.K.P.</given-names></name><name><surname>Luk</surname><given-names>H.K.H.</given-names></name><name><surname>Wong</surname><given-names>A.C.P.</given-names></name><name><surname>Li</surname><given-names>K.S.M.</given-names></name><name><surname>Zhu</surname><given-names>L.</given-names></name><name><surname>He</surname><given-names>Z.</given-names></name><name><surname>Fung</surname><given-names>J.</given-names></name><name><surname>Chan</surname><given-names>T.T.Y.</given-names></name><name><surname>Fung</surname><given-names>K.S.C</given-names></name><name><surname>Woo</surname><given-names>P.C.Y.</given-names></name></person-group><article-title>Possible bat origin of severe acute respiratory syndrome coronavirus 2</article-title><source>Emerg. Infect. Dis.</source><volume>26</volume><year>2020</year><fpage>1542</fpage><lpage>1547</lpage><pub-id pub-id-type="pmid">32315281</pub-id></element-citation></ref><ref id="bib0071"><element-citation publication-type="journal" id="sbref0071"><person-group person-group-type="author"><name><surname>Li</surname><given-names>A.P.</given-names></name></person-group><article-title>A comprehensive approach for drug safety assessment</article-title><source>Chem. Biol. Interact.</source><volume>150</volume><year>2004</year><fpage>27</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">15522259</pub-id></element-citation></ref><ref id="bib0072"><element-citation publication-type="journal" id="sbref0072"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Guo</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Zhong</surname><given-names>D.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Clarke</surname><given-names>M.</given-names></name><name><surname>Jin</surname><given-names>R.</given-names></name></person-group><article-title>Traditional Chinese herbal medicine for treating novel coronavirus (COVID-19) pneumonia: Protocol for a systematic review and meta-analysis</article-title><source>Syst. Rev.</source><volume>9</volume><year>2020</year><fpage>75</fpage><pub-id pub-id-type="pmid">32268923</pub-id></element-citation></ref><ref id="bib0073"><element-citation publication-type="journal" id="sbref0073"><person-group person-group-type="author"><name><surname>Lowe</surname><given-names>D.</given-names></name></person-group><article-title>Chloroquine, past and present</article-title><source>Sci. Transl. Med</source><year>2020</year><ext-link ext-link-type="uri" xlink:href="https://blogs.sciencemag.org/pipeline/archives/2020/03/20/chloroquine-past-and-present" id="interref0027">https://blogs.sciencemag.org/pipeline/archives/2020/03/20/chloroquine-past-and-present</ext-link></element-citation></ref><ref id="bib0074"><element-citation publication-type="journal" id="sbref0074"><person-group person-group-type="author"><name><surname>Lung</surname><given-names>J.</given-names></name><name><surname>Lin</surname><given-names>Y.S.</given-names></name><name><surname>Yang</surname><given-names>Y.H.</given-names></name><name><surname>Chou</surname><given-names>Y.L.</given-names></name><name><surname>Shu</surname><given-names>L.H.</given-names></name><name><surname>Cheng</surname><given-names>Y.C.</given-names></name><name><surname>Liu</surname><given-names>H.T</given-names></name><name><surname>Wu</surname><given-names>Y.</given-names></name></person-group><article-title>The potential chemical structure of anti-SARS-CoV-2 RNA-dependent RNA polymerase</article-title><source>J. Med. Virol.</source><volume>92</volume><year>2020</year><fpage>693</fpage><lpage>697</lpage><pub-id pub-id-type="pmid">32167173</pub-id></element-citation></ref><ref id="bib0075"><element-citation publication-type="journal" id="sbref0075"><person-group person-group-type="author"><name><surname>Lv</surname><given-names>R.B.</given-names></name><name><surname>Wang</surname><given-names>W.J.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name></person-group><article-title>COVID-19 suspected cases treated with Lianhua Qingwen decoction: A clinical observation of 63 cases</article-title><source>J. Chin. Med.</source><volume>2</volume><year>2020</year><fpage>1</fpage><lpage>5</lpage></element-citation></ref><ref id="bib0076"><element-citation publication-type="journal" id="sbref0076"><person-group person-group-type="author"><name><surname>Mahomoodally</surname><given-names>M.F.</given-names></name></person-group><article-title>Traditional medicines in Africa: an appraisal of ten potent African medicinal plants</article-title><source>Evid.-Based Complement. Altern. Med.</source><volume>2013</volume><year>2013</year><fpage>14</fpage></element-citation></ref><ref id="bib0077"><element-citation publication-type="journal" id="sbref0077"><person-group person-group-type="author"><name><surname>Manganyi</surname><given-names>M.C.</given-names></name><name><surname>Ateba</surname><given-names>C.N.</given-names></name></person-group><article-title>Untapped potentials of endophytic fungi: a review of novel bioactive compounds with biological applications</article-title><source>Microorganisms</source><volume>8</volume><year>2020</year><fpage>1934</fpage></element-citation></ref><ref id="bib0078"><element-citation publication-type="journal" id="sbref0078"><person-group person-group-type="author"><name><surname>Mani</surname><given-names>J.S.</given-names></name><name><surname>Johnson</surname><given-names>J.B.</given-names></name><name><surname>Steel</surname><given-names>J.C.</given-names></name><name><surname>Broszczak</surname><given-names>D.A.</given-names></name><name><surname>Neilsen</surname><given-names>P.M.</given-names></name><name><surname>Walsh</surname><given-names>K.B.</given-names></name><name><surname>Naiker</surname><given-names>M.</given-names></name></person-group><article-title>Natural product-derived phytochemicals as potential agents against coronaviruses: a review</article-title><source>Virus Res.</source><volume>284</volume><year>2020</year><object-id pub-id-type="publisher-id">197989</object-id></element-citation></ref><ref id="bib0079"><element-citation publication-type="book" id="sbref0079"><person-group person-group-type="author"><name><surname>Mansour</surname><given-names>S.</given-names></name></person-group><chapter-title>The Role of Resistant Starch in COVID-19 Infection</chapter-title><year>2020</year><publisher-name>NIH United States National Library of Medicine</publisher-name><comment>ClinicalTrials.gov</comment><ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT04342689" id="interref0028">https://clinicaltrials.gov/ct2/show/NCT04342689</ext-link></element-citation></ref><ref id="bib0080"><element-citation publication-type="journal" id="sbref0080"><person-group person-group-type="author"><name><surname>Mashhadi</surname><given-names>N.S.</given-names></name><name><surname>Ghiasvand</surname><given-names>R.</given-names></name><name><surname>Askari</surname><given-names>G.</given-names></name><name><surname>Hariri</surname><given-names>M.</given-names></name><name><surname>Darvishi</surname><given-names>L.</given-names></name><name><surname>Mofid</surname><given-names>M.R.</given-names></name></person-group><article-title>Anti-oxidative and anti-inflammatory effects of ginger in health and physical activity: review of current evidence</article-title><source>Int. J. Prevent. Med.</source><volume>4</volume><issue>Suppl 1</issue><year>2013</year><fpage>S36</fpage><lpage>S42</lpage></element-citation></ref><ref id="bib0081"><element-citation publication-type="journal" id="sbref0081"><person-group person-group-type="author"><name><surname>Matthay</surname><given-names>M.A.</given-names></name><name><surname>Thompson</surname><given-names>B.T.</given-names></name></person-group><article-title>Dexamethasone in hospitalised patients with COVID-19: addressing uncertainties</article-title><source>Lancet Respir. Med.</source><year>2020</year><fpage>S2213</fpage><lpage>S2600</lpage></element-citation></ref><ref id="bib0082"><element-citation publication-type="book" id="sbref0082"><person-group person-group-type="author"><collab>Mayo Clinic</collab></person-group><chapter-title>Kratom: Unsafe and Ineffective</chapter-title><year>2020</year><ext-link ext-link-type="uri" xlink:href="https://www.mayoclinic.org/healthy-lifestyle/consumer-health/in-depth/kratom/art-20402171" id="interref0029">https://www.mayoclinic.org/healthy-lifestyle/consumer-health/in-depth/kratom/art-20402171</ext-link></element-citation></ref><ref id="bib0083"><element-citation publication-type="book" id="sbref0083"><person-group person-group-type="author"><name><surname>McClain</surname><given-names>S.D.</given-names></name></person-group><chapter-title>Shortages, High Prices Press Garlic Supply</chapter-title><year>2020</year><publisher-name>Capital Press</publisher-name><ext-link ext-link-type="uri" xlink:href="https://www.capitalpress.com/nation_world/agriculture/shortages-high-prices-press-garlic-supply/article_84b280d4-88e5-11ea-8606-7b44e2297dec.html" id="interref0030">https://www.capitalpress.com/nation_world/agriculture/shortages-high-prices-press-garlic-supply/article_84b280d4-88e5-11ea-8606-7b44e2297dec.html</ext-link></element-citation></ref><ref id="bib0084"><element-citation publication-type="book" id="sbref0084"><person-group person-group-type="author"><collab>Medscape</collab></person-group><chapter-title>NIAID Testing remdesivir plus MS drug for COVID-19</chapter-title><year>2020</year><publisher-name>Medscape Medical News</publisher-name><ext-link ext-link-type="uri" xlink:href="https://www.medscape.com/viewarticle/935606" id="interref0031">https://www.medscape.com/viewarticle/935606</ext-link></element-citation></ref><ref id="bib0085"><element-citation publication-type="journal" id="sbref0085"><person-group person-group-type="author"><name><surname>Mokgobi</surname><given-names>M.</given-names></name></person-group><article-title>Western-trained health care practitioners&#x02019; knowledge of and experiences with traditional healing</article-title><source>Afr. J. Phys. Health Educ. Recreat. Dance</source><volume>2014</volume><issue>Suppl 2</issue><year>2014</year><fpage>1</fpage><pub-id pub-id-type="pmid">26753180</pub-id></element-citation></ref><ref id="bib0086"><element-citation publication-type="book" id="sbref0086"><person-group person-group-type="author"><name><surname>Mugabi</surname><given-names>I.</given-names></name></person-group><chapter-title>COVID-19: WHO Cautions Against the Use of Traditional Herbs in Africa</chapter-title><year>2020</year><ext-link ext-link-type="uri" xlink:href="https://www.dw.com/en/covid-19-who-cautions-against-the-use-of-traditional-herbs-in-africa/a-53341901" id="interref0032">https://www.dw.com/en/covid-19-who-cautions-against-the-use-of-traditional-herbs-in-africa/a-53341901</ext-link></element-citation></ref><ref id="bib0087"><element-citation publication-type="journal" id="sbref0087"><person-group person-group-type="author"><name><surname>Nabavi</surname><given-names>S.F.</given-names></name><name><surname>Nabavi</surname><given-names>S.M.</given-names></name><name><surname>Habtemariam</surname><given-names>S.</given-names></name><name><surname>Berindan-Neagoe</surname><given-names>I.</given-names></name><name><surname>Cismaru</surname><given-names>A.</given-names></name><name><surname>Izadi</surname><given-names>M.</given-names></name></person-group><article-title>Should we try the anti-inflammatory natural product, celastrol, for COVID-19?</article-title><source>Phytother. Res.</source><volume>2020</volume><year>2020</year><fpage>1</fpage><lpage>2</lpage></element-citation></ref><ref id="bib0147"><element-citation publication-type="journal" id="sbref0147"><person-group person-group-type="author"><name><surname>Narkhede</surname><given-names>R.R.</given-names></name><name><surname>Pise</surname><given-names>A.V.</given-names></name><name><surname>Cheke</surname><given-names>R.S.</given-names></name><name><surname>Shinde</surname><given-names>S.D.</given-names></name></person-group><article-title>Recognition of natural products as potential inhibitors of COVID-19 main protease (Mpro): In-silico evidences, Nat. prod. bioprospect</article-title><source>Nat. prod. bioprospect.</source><volume>10</volume><year>2020</year><fpage>297</fpage><lpage>306</lpage><pub-id pub-id-type="pmid">32557405</pub-id></element-citation></ref><ref id="bib0051"><element-citation publication-type="book" id="sbref0051"><person-group person-group-type="author"><collab>NCCIH</collab></person-group><chapter-title>Ginger</chapter-title><year>2016</year><publisher-name>National Center for Complementary of Integrative Health</publisher-name><ext-link ext-link-type="uri" xlink:href="https://www.nccih.nih.gov/health/ginger" id="interref0024">https://www.nccih.nih.gov/health/ginger</ext-link></element-citation></ref><ref id="bib0088"><element-citation publication-type="book" id="sbref0088"><person-group person-group-type="author"><collab>NCCIH</collab></person-group><chapter-title>Colloidal Silver</chapter-title><year>2017</year><publisher-name>National Center for Complementary and Integrative Health</publisher-name><ext-link ext-link-type="uri" xlink:href="https://www.nccih.nih.gov/health/colloidal-silver" id="interref0033">https://www.nccih.nih.gov/health/colloidal-silver</ext-link></element-citation></ref><ref id="bib0089"><element-citation publication-type="book" id="sbref0089"><person-group person-group-type="author"><collab>NCCIH</collab></person-group><chapter-title>Kratom</chapter-title><year>2018</year><publisher-name>National Center for Complementary and Integrative Health</publisher-name><ext-link ext-link-type="uri" xlink:href="https://www.nccih.nih.gov/health/kratom" id="interref0034">https://www.nccih.nih.gov/health/kratom</ext-link></element-citation></ref><ref id="bib0090"><element-citation publication-type="book" id="sbref0090"><person-group person-group-type="author"><collab>NCI</collab></person-group><chapter-title>Dexamethasone</chapter-title><year>2019</year><publisher-name>National Cancer Institute, the National Institutes of Health</publisher-name><comment>https://www.cancer.gov/about-cancer/treatment/drugs/dexamethasone#:&#x0223c;:text=Use%20in%20Cancer,Leukemia</comment></element-citation></ref><ref id="bib0091"><element-citation publication-type="book" id="sbref0091"><person-group person-group-type="author"><collab>NIH</collab></person-group><chapter-title>Iodine Fact Sheet for Health Professionals</chapter-title><year>2020</year><publisher-name>National Institute of Health</publisher-name><ext-link ext-link-type="uri" xlink:href="https://ods.od.nih.gov/factsheets/Iodine-HealthProfessional/" id="interref0035">https://ods.od.nih.gov/factsheets/Iodine-HealthProfessional/</ext-link></element-citation></ref><ref id="bib0092"><element-citation publication-type="journal" id="sbref0092"><person-group person-group-type="author"><name><surname>Nirmal</surname><given-names>S.A.</given-names></name><name><surname>Pal</surname><given-names>S.C.</given-names></name><name><surname>Otimenyin</surname><given-names>S.O</given-names></name><name><surname>Aye</surname><given-names>T.</given-names></name><name><surname>Elachouri</surname><given-names>M.</given-names></name><name><surname>Kundu</surname><given-names>S.K.</given-names></name><name><surname>Thandavarayan</surname><given-names>R.A.</given-names></name><name><surname>Mandal</surname><given-names>S.C.</given-names></name></person-group><article-title>Contribution of herbal products in global market</article-title><source>Pharmacol. Rev.</source><volume>2013</volume><year>2013</year><fpage>95</fpage><lpage>104</lpage></element-citation></ref><ref id="bib0093"><element-citation publication-type="journal" id="sbref0093"><person-group person-group-type="author"><name><surname>Orhan</surname><given-names>I.E.</given-names></name><name><surname>Deniz</surname><given-names>F.S.S.</given-names></name></person-group><article-title>Natural products as potential leads against coronaviruses: could they be encouraging structural models against SARS-CoV-2?</article-title><source>Nat. Prod. Bioprospect.</source><volume>10</volume><year>2020</year><fpage>171</fpage><lpage>186</lpage><pub-id pub-id-type="pmid">32529545</pub-id></element-citation></ref><ref id="bib0094"><element-citation publication-type="journal" id="sbref0094"><person-group person-group-type="author"><name><surname>Paden</surname><given-names>C.R.</given-names></name><name><surname>Yusof</surname><given-names>M.F.B.M.</given-names></name><name><surname>Al Hammadi</surname><given-names>Z.M.</given-names></name><name><surname>Queen</surname><given-names>K.</given-names></name><name><surname>Tao</surname><given-names>Y.</given-names></name><name><surname>Eltahir</surname><given-names>Y.M.</given-names></name><name><surname>Elsayed</surname><given-names>E.A.</given-names></name><name><surname>Marzoug</surname><given-names>B.A.</given-names></name><name><surname>Bensalah</surname><given-names>O.K.A.</given-names></name><name><surname>Khalafalla</surname><given-names>A.I.</given-names></name><name><surname>Al Mulla</surname><given-names>M.</given-names></name><name><surname>Khudhair</surname><given-names>A.</given-names></name><name><surname>Elkheir</surname><given-names>K.A.</given-names></name><name><surname>Issa</surname><given-names>Z.B.</given-names></name><name><surname>Pradeep</surname><given-names>K.</given-names></name><name><surname>Elsaleh</surname><given-names>F.N.</given-names></name><name><surname>Imambaccus</surname><given-names>H.</given-names></name><name><surname>Sasse</surname><given-names>J.</given-names></name><name><surname>Weber</surname><given-names>S.</given-names></name><name><surname>Shi</surname><given-names>M.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Pham</surname><given-names>H.</given-names></name><name><surname>Kim</surname><given-names>L.</given-names></name><name><surname>Hall</surname><given-names>A.J.</given-names></name><name><surname>Gerber</surname><given-names>S.I.</given-names></name><name><surname>Al Hosani</surname><given-names>F.I.</given-names></name><name><surname>Tong</surname><given-names>S.</given-names></name><name><surname>Al Muhairi</surname><given-names>S.S.M.</given-names></name></person-group><article-title>Zoonotic origin and transmission of Middle East respiratory syndrome coronavirus in the UAE</article-title><source>Zoonoses Public Health</source><volume>65</volume><year>2018</year><fpage>322</fpage><lpage>333</lpage><pub-id pub-id-type="pmid">29239118</pub-id></element-citation></ref><ref id="bib0095"><element-citation publication-type="journal" id="sbref0095"><person-group person-group-type="author"><name><surname>Panyod</surname><given-names>S.</given-names></name><name><surname>Ho</surname><given-names>C.T.</given-names></name><name><surname>Sheen</surname><given-names>L.Y.</given-names></name></person-group><article-title>Dietary therapy and herbal medicine for COVID-19 prevention: a review and perspective</article-title><source>J. Tradit. Complement. Med.</source><volume>10</volume><year>2020</year><fpage>420</fpage><lpage>427</lpage><pub-id pub-id-type="pmid">32691006</pub-id></element-citation></ref><ref id="bib0096"><element-citation publication-type="journal" id="sbref0096"><person-group person-group-type="author"><name><surname>Park</surname><given-names>J.H.</given-names></name><name><surname>Seo</surname><given-names>B.I.</given-names></name><name><surname>Cho</surname><given-names>S.Y.</given-names></name><name><surname>Park</surname><given-names>K.R.</given-names></name><name><surname>Choi</surname><given-names>S.H.</given-names></name><name><surname>Han</surname><given-names>C.K.</given-names></name><name><surname>Song</surname><given-names>C.H.</given-names></name><name><surname>Park</surname><given-names>S.J.</given-names></name><name><surname>Ku</surname><given-names>S.K.</given-names></name></person-group><article-title>Single oral dose toxicity study of prebrewed Armeniacae Semen in Rats</article-title><source>Toxicol. Res.</source><volume>29</volume><year>2013</year><fpage>91</fpage><lpage>98</lpage><pub-id pub-id-type="pmid">24278634</pub-id></element-citation></ref><ref id="bib0097"><element-citation publication-type="journal" id="sbref0097"><person-group person-group-type="author"><name><surname>Puri</surname><given-names>S.C.</given-names></name><name><surname>Nazir</surname><given-names>S.</given-names></name><name><surname>Chawla</surname><given-names>R.</given-names></name><name><surname>Arora</surname><given-names>R.</given-names></name><name><surname>Riyaz-ul-Hasan</surname><given-names>S.</given-names></name><name><surname>Amna</surname><given-names>T.</given-names></name><name><surname>Ahmed</surname><given-names>B.</given-names></name><name><surname>Verma</surname><given-names>V.</given-names></name><name><surname>Singh</surname><given-names>S.</given-names></name><name><surname>Sagar</surname><given-names>R.</given-names></name><name><surname>Sharma</surname><given-names>S.</given-names></name><name><surname>Kumar</surname><given-names>R.</given-names></name><name><surname>Sharma</surname><given-names>R.K.</given-names></name><name><surname>Qaz</surname><given-names>G.N.</given-names></name></person-group><article-title>The endophytic fungus <italic>Trametes hirsutaas</italic> a novel alternative source of podophyllotoxin and related aryl tetralin lignans</article-title><source>J. Biotechnol.</source><volume>122</volume><year>2006</year><fpage>494</fpage><lpage>510</lpage><pub-id pub-id-type="pmid">16375985</pub-id></element-citation></ref><ref id="bib0098"><element-citation publication-type="journal" id="sbref0098"><person-group person-group-type="author"><name><surname>Puri</surname><given-names>S.C.</given-names></name><name><surname>Verma</surname><given-names>V.</given-names></name><name><surname>Amna</surname><given-names>T.</given-names></name><name><surname>Qazi</surname><given-names>G.N.</given-names></name><name><surname>Spiteller</surname><given-names>M.</given-names></name></person-group><article-title>An endophytic fungus from <italic>Nothapodytes foetida</italic> that produces Camptothecin</article-title><source>J. Nat. Prod.</source><volume>68</volume><year>2005</year><fpage>1717</fpage><lpage>1719</lpage><pub-id pub-id-type="pmid">16378360</pub-id></element-citation></ref><ref id="bib0099"><element-citation publication-type="journal" id="sbref0099"><person-group person-group-type="author"><name><surname>Puttaswamy</surname><given-names>H.</given-names></name><name><surname>Gowtham</surname><given-names>H.G.</given-names></name><name><surname>Ojha</surname><given-names>M.D.</given-names></name><name><surname>Yadav</surname><given-names>A.</given-names></name><name><surname>Choudhir</surname><given-names>G.</given-names></name><name><surname>Raguraman</surname><given-names>V.</given-names></name><name><surname>Kongkham</surname><given-names>B.</given-names></name><name><surname>Selvaraju</surname><given-names>K.</given-names></name><name><surname>Shareef</surname><given-names>S.</given-names></name><name><surname>Gehlot</surname><given-names>P.</given-names></name><name><surname>Ahamed</surname><given-names>F.</given-names></name><name><surname>Chauhan</surname><given-names>L.</given-names></name></person-group><article-title><italic>In silico</italic> studies evidenced the role of structurally diverse plant secondary metabolites in reducing SARS&#x02011;CoV&#x02011;2 pathogenesis</article-title><source>Sci. Rep.</source><volume>10</volume><year>2020</year><fpage>20584</fpage><pub-id pub-id-type="pmid">33239694</pub-id></element-citation></ref><ref id="bib0100"><element-citation publication-type="journal" id="sbref0100"><person-group person-group-type="author"><name><surname>Rahman</surname><given-names>N.</given-names></name><name><surname>Basharat</surname><given-names>Z.</given-names></name><name><surname>Yousuf</surname><given-names>M.</given-names></name><name><surname>Castaldo</surname><given-names>G.</given-names></name><name><surname>Rastrelli</surname><given-names>L.</given-names></name><name><surname>Khan</surname><given-names>H.</given-names></name></person-group><article-title>Virtual screening of natural products against Type II Transmembrane Serine Protease (TMPRSS2), the priming agent of Coronavirus 2 (SARS-CoV-2)</article-title><source>Molecules</source><volume>25</volume><year>2020</year><fpage>2271</fpage></element-citation></ref><ref id="bib0101"><element-citation publication-type="journal" id="sbref0101"><person-group person-group-type="author"><name><surname>Rose</surname><given-names>K.D.</given-names></name><name><surname>Croissant</surname><given-names>P.D.</given-names></name><name><surname>Parliament</surname><given-names>C.F.</given-names></name><name><surname>Levin</surname><given-names>M.B.</given-names></name></person-group><article-title>Spontaneous spinal epidural hematoma with associated platelet dysfunction from excessive garlic ingestion: a case report</article-title><source>Neurosurgery</source><volume>26</volume><year>1990</year><fpage>880</fpage><lpage>882</lpage><pub-id pub-id-type="pmid">2352608</pub-id></element-citation></ref><ref id="bib0102"><element-citation publication-type="journal" id="sbref0102"><person-group person-group-type="author"><name><surname>Ryan</surname><given-names>R.P.</given-names></name><name><surname>Germaine</surname><given-names>K.</given-names></name><name><surname>Franks</surname><given-names>A.</given-names></name><name><surname>Ryan</surname><given-names>D.J.</given-names></name><name><surname>Dowling</surname><given-names>D.N.</given-names></name></person-group><article-title>Bacterial endophytes: recent developments and applications</article-title><source>FEMS Microbiol. Lett.</source><volume>278</volume><year>2008</year><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">18034833</pub-id></element-citation></ref><ref id="bib0104"><element-citation publication-type="journal" id="sbref0104"><person-group person-group-type="author"><name><surname>Schr&#x000f6;der</surname><given-names>I.</given-names></name></person-group><article-title>COVID-19: A risk assessment perspective</article-title><source>ACS Chem. Health Saf.</source><volume>27</volume><year>2020</year><fpage>160</fpage><lpage>169</lpage></element-citation></ref><ref id="bib0105"><element-citation publication-type="journal" id="sbref0105"><person-group person-group-type="author"><name><surname>Self</surname><given-names>W.H.</given-names></name><name><surname>Semler</surname><given-names>M.W.</given-names></name><name><surname>Leither</surname><given-names>L.M</given-names></name><name><surname>Casey</surname><given-names>J.D.</given-names></name><name><surname>Angus</surname><given-names>D.C.</given-names></name><name><surname>Brower</surname><given-names>R.G.</given-names></name><name><surname>Chang</surname><given-names>S.Y.</given-names></name><name><surname>Collins</surname><given-names>S.P.</given-names></name><name><surname>Eppensteiner</surname><given-names>J.C.</given-names></name><name><surname>Filbin</surname><given-names>M.R.</given-names></name><name><surname>Files</surname><given-names>D.C</given-names></name><name><surname>Gibbs</surname><given-names>K.W.</given-names></name><name><surname>Ginde</surname><given-names>A.A.</given-names></name><name><surname>Gong</surname><given-names>M.N.</given-names></name><name><surname>Harrell</surname><given-names>F.E.</given-names></name><name><surname>Hayden</surname><given-names>D.L.</given-names></name><name><surname>Hough</surname><given-names>C.L.</given-names></name><name><surname>Johnson</surname><given-names>N.J.</given-names></name><name><surname>Khan</surname><given-names>A.</given-names></name><name><surname>Lindsell</surname><given-names>C.J.</given-names></name><name><surname>Matthay</surname><given-names>M.A.</given-names></name><name><surname>Moss</surname><given-names>M.</given-names></name><name><surname>Park</surname><given-names>P.K.</given-names></name><name><surname>Rice</surname><given-names>T.W.</given-names></name><name><surname>Robinson</surname><given-names>B.R.H.</given-names></name><name><surname>Schoenfeld</surname><given-names>D.A.</given-names></name><name><surname>Shapiro</surname><given-names>N.I.</given-names></name><name><surname>Steingrub</surname><given-names>J.S.</given-names></name><name><surname>Ulysse</surname><given-names>C.A.</given-names></name><name><surname>Weissman</surname><given-names>A.</given-names></name><name><surname>Yealy</surname><given-names>D.M.</given-names></name><name><surname>Thompson</surname><given-names>B.T.</given-names></name><name><surname>Brown</surname><given-names>S.M.</given-names></name></person-group><article-title>Effect of hydroxychloroquine on clinical status at 14 days in hospitalized patients with COVID-19: a randomized clinical trial</article-title><source>J. Am. Med. Assoc.</source><volume>324</volume><year>2020</year><fpage>2165</fpage><lpage>2176</lpage></element-citation></ref><ref id="bib0106"><element-citation publication-type="journal" id="sbref0106"><person-group person-group-type="author"><name><surname>Selim</surname><given-names>K.A.</given-names></name><name><surname>Elkhateeb</surname><given-names>W.A.</given-names></name><name><surname>Tawila</surname><given-names>A.M.</given-names></name><name><surname>El-Beih</surname><given-names>A.A.</given-names></name><name><surname>Abdel-Rahman</surname><given-names>T.M.</given-names></name><name><surname>El-Diwany</surname><given-names>A.I.</given-names></name><name><surname>Ahmed</surname><given-names>E.F.</given-names></name></person-group><article-title>Antiviral and antioxidant potential of fungal endophytes of Egyptian medicinal plants</article-title><source>Fermentation</source><volume>4</volume><year>2018</year><fpage>49</fpage></element-citation></ref><ref id="bib0107"><element-citation publication-type="journal" id="sbref0107"><person-group person-group-type="author"><name><surname>Shereen</surname><given-names>M.A.</given-names></name><name><surname>Khan</surname><given-names>S.</given-names></name><name><surname>Kazmi</surname><given-names>A.</given-names></name><name><surname>Bashir</surname><given-names>N.</given-names></name><name><surname>Siddique</surname><given-names>R.</given-names></name></person-group><article-title>COVID-19 infection: origin, transmission, and characteristics of human coronaviruses</article-title><source>J. Adv. Res.</source><volume>24</volume><year>2020</year><fpage>91</fpage><lpage>98</lpage><pub-id pub-id-type="pmid">32257431</pub-id></element-citation></ref><ref id="bib0108"><element-citation publication-type="journal" id="sbref0108"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>K.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Xie</surname><given-names>B.</given-names></name><name><surname>Yang</surname><given-names>S.S.</given-names></name><name><surname>Liu</surname><given-names>D.</given-names></name><name><surname>Dai</surname><given-names>G.</given-names></name><name><surname>Chen</surname><given-names>Q.</given-names></name></person-group><article-title>Celastrol alleviates chronic obstructive pulmonary disease by inhibiting cellular inflammation induced by cigarette smoke via the Ednrb/Kng1 Signaling Pathway</article-title><source>Front. Pharmacol.</source><volume>9</volume><year>2018</year><fpage>1276</fpage><pub-id pub-id-type="pmid">30498444</pub-id></element-citation></ref><ref id="bib0109"><element-citation publication-type="journal" id="sbref0109"><person-group person-group-type="author"><name><surname>Sohail</surname><given-names>M.N.</given-names></name><name><surname>Rasul</surname><given-names>F.</given-names></name><name><surname>Karim</surname><given-names>A.</given-names></name><name><surname>Kanwal</surname><given-names>U.</given-names></name><name><surname>Attitalla</surname><given-names>I.H.</given-names></name></person-group><article-title>Plants as a source of natural antiviral agents</article-title><source>Asian J. Anim. Vet. Adv.</source><volume>6</volume><year>2011</year><fpage>1125</fpage><lpage>1152</lpage></element-citation></ref><ref id="bib0110"><element-citation publication-type="journal" id="sbref0110"><person-group person-group-type="author"><name><surname>Stauffer</surname><given-names>W.M.</given-names></name><name><surname>Alpern</surname><given-names>J.D.</given-names></name><name><surname>Walker</surname><given-names>P.F.</given-names></name></person-group><article-title>COVID-19 and Dexamethasone a potential strategy to avoid steroid-related Strongyloides hyperinfection</article-title><source>J. Am. Med. Assoc.</source><volume>324</volume><year>2020</year><fpage>623</fpage><lpage>624</lpage></element-citation></ref><ref id="bib0111"><element-citation publication-type="journal" id="sbref0111"><person-group person-group-type="author"><name><surname>Stirgus</surname><given-names>E.</given-names></name></person-group><article-title>Universities across Georgia research ways to prevent, treat COVID-19. Coronavirus pandemic: research</article-title><source>Atlanta J.-Const.</source><year>2020</year><comment>https://www.ajc.com/news/state&#x02013;regional/the-fight-for-cure/gGkf3FXK5OeP5QVYClLcCJ/</comment></element-citation></ref><ref id="bib0112"><element-citation publication-type="journal" id="sbref0112"><person-group person-group-type="author"><name><surname>Strobel</surname><given-names>G.A.</given-names></name></person-group><article-title>Endophytes as sources of bioactive products</article-title><source>Microbes Infect.</source><volume>5</volume><year>2003</year><fpage>535</fpage><lpage>544</lpage><pub-id pub-id-type="pmid">12758283</pub-id></element-citation></ref><ref id="bib0113"><element-citation publication-type="journal" id="sbref0113"><person-group person-group-type="author"><name><surname>Suchard</surname><given-names>J.R.</given-names></name><name><surname>Wallace</surname><given-names>K.L.</given-names></name><name><surname>Gerkin</surname><given-names>R.D.</given-names></name></person-group><article-title>Acute cyanide toxicity caused by apricot kernel ingestion</article-title><source>Ann. Emerg. Med.</source><volume>32</volume><year>1998</year><fpage>742</fpage><lpage>744</lpage><pub-id pub-id-type="pmid">9832674</pub-id></element-citation></ref><ref id="bib0114"><element-citation publication-type="journal" id="sbref0114"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>J.</given-names></name><name><surname>Zhu</surname><given-names>A.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Zheng</surname><given-names>K.</given-names></name><name><surname>Zhuang</surname><given-names>Z.</given-names></name><name><surname>Chen</surname><given-names>Z.</given-names></name><name><surname>Shi</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>Z.</given-names></name><name><surname>Chen</surname><given-names>S.B.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Dai</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Huang</surname><given-names>S.</given-names></name><name><surname>Huang</surname><given-names>X.</given-names></name><name><surname>Luo</surname><given-names>L.</given-names></name><name><surname>Wen</surname><given-names>L.</given-names></name><name><surname>Zhuo</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>F.</given-names></name><name><surname>Feng</surname><given-names>L.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Zhong</surname><given-names>N.</given-names></name><name><surname>Yang</surname><given-names>Z.</given-names></name><name><surname>Huang</surname><given-names>J.</given-names></name><name><surname>Zhao</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>Y.M.</given-names></name></person-group><article-title>Isolation of infectious SARS-CoV-2 from urine of a COVID-19 patient</article-title><source>Emerg. Microbes Infect.</source><volume>9</volume><year>2020</year><fpage>991</fpage><lpage>993</lpage><pub-id pub-id-type="pmid">32342724</pub-id></element-citation></ref><ref id="bib0146"><element-citation publication-type="journal" id="sbref0146"><person-group person-group-type="author"><name><surname>Tai</surname><given-names>W.</given-names></name><name><surname>He</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Pu</surname><given-names>J.</given-names></name><name><surname>Voronin</surname><given-names>D.</given-names></name><name><surname>Jiang</surname><given-names>S.</given-names></name><name><surname>Zhou</surname><given-names>Y.</given-names></name><name><surname>Du</surname><given-names>L.</given-names></name></person-group><article-title>Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine</article-title><source>Cell. Mol. Immunol.</source><volume>17</volume><year>2020</year><fpage>613</fpage><lpage>620</lpage><pub-id pub-id-type="pmid">32203189</pub-id></element-citation></ref><ref id="bib0115"><element-citation publication-type="book" id="sbref0115"><person-group person-group-type="author"><name><surname>Timoshyna</surname><given-names>A.</given-names></name><name><surname>Xu</surname><given-names>L.</given-names></name><name><surname>Ke</surname><given-names>Z.</given-names></name></person-group><chapter-title>COVID-19&#x02014;the Role of Wild Plants in Health Treatment and Why Sustainability of Their Trade Matters. Traffic</chapter-title><year>2020</year><ext-link ext-link-type="uri" xlink:href="https://www.traffic.org/news/covid-19-the-role-of-wild-plants-in-health-treatment/" id="interref0036">https://www.traffic.org/news/covid-19-the-role-of-wild-plants-in-health-treatment/</ext-link></element-citation></ref><ref id="bib0117"><element-citation publication-type="journal" id="sbref0117"><person-group person-group-type="author"><name><surname>van Doremalen</surname><given-names>N.</given-names></name><name><surname>Bushmaker</surname><given-names>T.</given-names></name><name><surname>Morris</surname><given-names>D.H.</given-names></name><name><surname>Holbrook</surname><given-names>M.G.</given-names></name><name><surname>Gamble</surname><given-names>A.</given-names></name><name><surname>Williamson</surname><given-names>B.N.</given-names></name><name><surname>Tamin</surname><given-names>A.</given-names></name><name><surname>Harcourt</surname><given-names>J.L.</given-names></name><name><surname>Thornburg</surname><given-names>N.J.</given-names></name><name><surname>Gerber</surname><given-names>S.I.</given-names></name><name><surname>Lloyd-Smith</surname><given-names>J.O.</given-names></name><name><surname>De Wit</surname><given-names>E.</given-names></name><name><surname>Munster</surname><given-names>V.J.</given-names></name></person-group><article-title>Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1</article-title><source>N. Engl. J. Med.</source><volume>382</volume><year>2020</year><fpage>1564</fpage><lpage>1567</lpage><pub-id pub-id-type="pmid">32182409</pub-id></element-citation></ref><ref id="bib0118"><element-citation publication-type="journal" id="sbref0118"><person-group person-group-type="author"><name><surname>Vellingiri</surname><given-names>B.</given-names></name><name><surname>Jayaramayya</surname><given-names>K.</given-names></name><name><surname>Iyer</surname><given-names>M.</given-names></name><name><surname>Narayanasamy</surname><given-names>A.</given-names></name><name><surname>Govindasamy</surname><given-names>V.</given-names></name><name><surname>Giridharan</surname><given-names>B.</given-names></name><name><surname>Ganesan</surname><given-names>S.</given-names></name><name><surname>Venugopal</surname><given-names>A.</given-names></name><name><surname>Venkatesan</surname><given-names>D.</given-names></name><name><surname>Ganesana</surname><given-names>H.</given-names></name><name><surname>Rajagopalan</surname><given-names>K.</given-names></name><name><surname>Rahman</surname><given-names>P.K.S.M.</given-names></name><name><surname>Cho</surname><given-names>S.G.</given-names></name><name><surname>Kumar</surname><given-names>N.S.</given-names></name><name><surname>Subramaniamk</surname><given-names>M.D.</given-names></name></person-group><article-title>COVID-19: a promising cure for the global panic</article-title><source>Sci. Total Environ.</source><volume>725</volume><year>2020</year><object-id pub-id-type="publisher-id">138277</object-id></element-citation></ref><ref id="bib0119"><element-citation publication-type="journal" id="sbref0119"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>M.</given-names></name><name><surname>Cao</surname><given-names>R.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Yang</surname><given-names>X.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Xu</surname><given-names>M.</given-names></name><name><surname>Shi</surname><given-names>Z.</given-names></name><name><surname>Hu</surname><given-names>Z.</given-names></name><name><surname>Zhong</surname><given-names>W.</given-names></name><name><surname>Xiao</surname><given-names>G.</given-names></name></person-group><article-title>Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) <italic>in</italic> vitro</article-title><source>Cell Res.</source><volume>30</volume><year>2020</year><fpage>269</fpage><lpage>271</lpage><pub-id pub-id-type="pmid">32020029</pub-id></element-citation></ref><ref id="bib0120"><element-citation publication-type="journal" id="sbref0120"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Xu</surname><given-names>X.</given-names></name><name><surname>Gao</surname><given-names>R.</given-names></name><name><surname>Lu</surname><given-names>R.</given-names></name><name><surname>Han</surname><given-names>K.</given-names></name><name><surname>Wu</surname><given-names>G.</given-names></name><name><surname>Tan</surname><given-names>W.</given-names></name></person-group><article-title>Detection of SARS-CoV-2 in different types of clinical specimens</article-title><source>J. Am. Med. Assoc.</source><volume>323</volume><year>2020</year><fpage>1843</fpage><lpage>1844</lpage></element-citation></ref><ref id="bib0121"><element-citation publication-type="journal" id="sbref0121"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>D.</given-names></name><name><surname>Du</surname><given-names>G.</given-names></name><name><surname>Du</surname><given-names>R.</given-names></name><name><surname>Zhao</surname><given-names>J.</given-names></name><name><surname>Jin</surname><given-names>Y.</given-names></name><name><surname>Fu</surname><given-names>S.</given-names></name><name><surname>Gao</surname><given-names>L.</given-names></name><name><surname>Cheng</surname><given-names>Z.</given-names></name><name><surname>Lu</surname><given-names>O.</given-names></name><name><surname>Hu</surname><given-names>Y.</given-names></name><name><surname>Luo</surname><given-names>G.</given-names></name><name><surname>Wang</surname><given-names>K.</given-names></name><name><surname>Lu</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>Ruan</surname><given-names>S.</given-names></name><name><surname>Yang</surname><given-names>C.</given-names></name><name><surname>Mei</surname><given-names>C.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Ding</surname><given-names>D.</given-names></name><name><surname>Wu</surname><given-names>F.</given-names></name><name><surname>Tang</surname><given-names>X.</given-names></name><name><surname>Ye</surname><given-names>X.</given-names></name><name><surname>Ye</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>B.</given-names></name><name><surname>Yang</surname><given-names>J.</given-names></name><name><surname>Yin</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>A.</given-names></name><name><surname>Fan</surname><given-names>G.</given-names></name><name><surname>Zhou</surname><given-names>F.</given-names></name><name><surname>Liu</surname><given-names>Z.</given-names></name><name><surname>Gu</surname><given-names>X.</given-names></name><name><surname>Xu</surname><given-names>J.</given-names></name><name><surname>Shang</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Cao</surname><given-names>L.</given-names></name><name><surname>Guo</surname><given-names>T.</given-names></name><name><surname>Wan</surname><given-names>Y.</given-names></name><name><surname>Qin</surname><given-names>H.</given-names></name><name><surname>Jiang</surname><given-names>Y.</given-names></name><name><surname>Jaki</surname><given-names>T.</given-names></name><name><surname>Hayden</surname><given-names>F.G.</given-names></name><name><surname>Horby</surname><given-names>P.W.</given-names></name><name><surname>Cao</surname><given-names>B.</given-names></name><name><surname>Wang</surname><given-names>C.</given-names></name></person-group><article-title>Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial</article-title><source>Lancet</source><volume>395</volume><year>2020</year><fpage>1569</fpage><lpage>1578</lpage><pub-id pub-id-type="pmid">32423584</pub-id></element-citation></ref><ref id="bib0122"><element-citation publication-type="journal" id="sbref0122"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Yang</surname><given-names>L.</given-names></name></person-group><article-title>Turning the tide: Natural products and natural-product-inspired chemicals as potential counters to SARS-CoV-2 infection</article-title><source>Front. Pharmacol.</source><volume>11</volume><year>2020</year><fpage>1013</fpage><comment>|</comment><pub-id pub-id-type="pmid">32714193</pub-id></element-citation></ref><ref id="bib0123"><element-citation publication-type="book" id="sbref0123"><person-group person-group-type="author"><collab>WebMD</collab></person-group><chapter-title>Garlic</chapter-title><year>2020</year><comment>https://www.webmd.com/vitamins/ai/ingredientmono-300/garlic#:&#x0223c;:text=Garlic%20has%20been%20used%20safely,increase%20the%20risk%20of%20bleeding</comment></element-citation></ref><ref id="bib0124"><element-citation publication-type="book" id="sbref0124"><person-group person-group-type="author"><collab>WebMD</collab></person-group><chapter-title>Ginger: Possible Health Benefits and Side Effects</chapter-title><year>2020</year><ext-link ext-link-type="uri" xlink:href="https://www.webmd.com/vitamins-and-supplements/ginger-uses-and-risks#2" id="interref0037">https://www.webmd.com/vitamins-and-supplements/ginger-uses-and-risks#2</ext-link></element-citation></ref><ref id="bib0125"><element-citation publication-type="book" id="sbref0125"><person-group person-group-type="author"><collab>WHO Technical Report Series</collab></person-group><chapter-title>World Health Organisation Guidelines on Good Herbal Processing Practices for Herbal Medicines</chapter-title><year>2018</year><ext-link ext-link-type="uri" xlink:href="https://www.who.int/traditional-complementary-integrative-medicine/publications/trs1010_annex1.pdf?ua=1" id="interref0038">https://www.who.int/traditional-complementary-integrative-medicine/publications/trs1010_annex1.pdf?ua=1</ext-link></element-citation></ref><ref id="bib0127"><element-citation publication-type="book" id="sbref0127"><person-group person-group-type="author"><collab>WHO</collab></person-group><chapter-title>Middle East respiratory syndrome coronavirus (MERS-CoV)</chapter-title><year>2019</year><ext-link ext-link-type="uri" xlink:href="https://www.who.int/news-room/fact-sheets/detail/middle-east-respiratory-syndrome-coronavirus-(mers-cov" id="interref0040">https://www.who.int/news-room/fact-sheets/detail/middle-east-respiratory-syndrome-coronavirus-(mers-cov</ext-link></element-citation></ref><ref id="bib0128"><element-citation publication-type="book" id="sbref0128"><person-group person-group-type="author"><collab>WHO</collab></person-group><chapter-title>WHO Global Report on Traditional and Complementary Medicine 2019</chapter-title><year>2019</year><ext-link ext-link-type="uri" xlink:href="https://www.who.int/traditional-complementary-integrative-medicine/WhoGlobalReportOnTraditionalAndComplementaryMedicine2019.pdf?ua=1" id="interref0041">https://www.who.int/traditional-complementary-integrative-medicine/WhoGlobalReportOnTraditionalAndComplementaryMedicine2019.pdf?ua=1</ext-link></element-citation></ref><ref id="bib0129"><element-citation publication-type="book" id="sbref0129"><person-group person-group-type="author"><collab>WHO</collab></person-group><chapter-title>About COVID-19</chapter-title><year>2020</year><ext-link ext-link-type="uri" xlink:href="http://www.emro.who.int/health-topics/corona-virus/about-covid-19.html" id="interref0042">http://www.emro.who.int/health-topics/corona-virus/about-covid-19.html</ext-link></element-citation></ref><ref id="bib0130"><element-citation publication-type="book" id="sbref0130"><person-group person-group-type="author"><collab><italic>WHO</italic></collab></person-group><chapter-title>Coronavirus</chapter-title><year>2020</year><ext-link ext-link-type="uri" xlink:href="https://www.who.int/health-topics/coronavirus#tab=tab_1" id="interref0043">https://www.who.int/health-topics/coronavirus#tab=tab_1</ext-link></element-citation></ref><ref id="bib0131"><element-citation publication-type="book" id="sbref0131"><person-group person-group-type="author"><collab>WHO</collab></person-group><chapter-title>World Health Organisation Announces COVID-19 outbreak a pandemic</chapter-title><year>2020</year><ext-link ext-link-type="uri" xlink:href="http://www.euro.who.int/en/health-topics/health-emergencies/coronavirus-covid19/news/news/2020/3/who-announces-covid-19-outbreak-a-pandemic" id="interref0044">http://www.euro.who.int/en/health-topics/health-emergencies/coronavirus-covid19/news/news/2020/3/who-announces-covid-19-outbreak-a-pandemic</ext-link></element-citation></ref><ref id="bib0132"><element-citation publication-type="book" id="sbref0132"><person-group person-group-type="author"><collab><italic>WHO</italic></collab></person-group><chapter-title>WHO Coronavirus Disease (COVID-19) Dashboard</chapter-title><year>2020</year><ext-link ext-link-type="uri" xlink:href="https://covid19.who.int/?gclid=EAIaIQobChMIosyV2brX6wIVDevtCh0vpw45EAAYASAAEgLKaPD_BwE" id="interref0045">https://covid19.who.int/?gclid=EAIaIQobChMIosyV2brX6wIVDevtCh0vpw45EAAYASAAEgLKaPD_BwE</ext-link></element-citation></ref><ref id="bib0133"><element-citation publication-type="book" id="sbref0133"><person-group person-group-type="author"><collab>WHO</collab></person-group><chapter-title>WHO Welcomes Preliminary Results About Dexamethasone Use in Treating Critically Ill COVID-19 Patients</chapter-title><year>2020</year><ext-link ext-link-type="uri" xlink:href="https://www.who.int/news-room/detail/16-06-2020-who-welcomes-preliminary-results-about-dexamethasone-use-in-treating-critically-ill-covid-19-patients" id="interref0046">https://www.who.int/news-room/detail/16-06-2020-who-welcomes-preliminary-results-about-dexamethasone-use-in-treating-critically-ill-covid-19-patients</ext-link></element-citation></ref><ref id="bib0134"><element-citation publication-type="book" id="sbref0134"><person-group person-group-type="author"><collab>WHO</collab></person-group><chapter-title>WHO Supports Scientifically-Proven Traditional Medicine</chapter-title><year>2020</year><ext-link ext-link-type="uri" xlink:href="https://www.afro.who.int/news/who-supports-scientifically-proven-traditional-medicine" id="interref0047">https://www.afro.who.int/news/who-supports-scientifically-proven-traditional-medicine</ext-link></element-citation></ref><ref id="bib0135"><element-citation publication-type="book" id="sbref0135"><person-group person-group-type="author"><collab>WHO</collab></person-group><chapter-title>Coronavirus Disease (COVID-19) Advice for the Public: Myth Busters. Can Eating Garlic Help Prevent Infection With the New Coronavirus?</chapter-title><year>2020</year><ext-link ext-link-type="uri" xlink:href="https://www.who.int/images/default-source/health-topics/coronavirus/myth-busters/19.png" id="interref0048">https://www.who.int/images/default-source/health-topics/coronavirus/myth-busters/19.png</ext-link></element-citation></ref><ref id="bib0136"><element-citation publication-type="book" id="sbref0136"><person-group person-group-type="author"><name><surname>Wiesemeyer</surname><given-names>J.</given-names></name></person-group><chapter-title>USDA Officials, Forecasts are Murky Re: Factoring in phase 1 of U.S./China Accord</chapter-title><year>2020</year><ext-link ext-link-type="uri" xlink:href="https://www.profarmer.com/markets/policy/usda-officials-forecasts-are-murky-re-factoring-phase-1-us/china-accord" id="interref0049">https://www.profarmer.com/markets/policy/usda-officials-forecasts-are-murky-re-factoring-phase-1-us/china-accord</ext-link></element-citation></ref><ref id="bib0137"><element-citation publication-type="book" id="sbref0137"><person-group person-group-type="author"><name><surname>Wintle</surname><given-names>T.</given-names></name></person-group><chapter-title>Enjoy Ginger, but it's not a 'Cure' for COVID-19, Says WHO</chapter-title><year>2020</year><comment>https://newseu.cgtn.com/news/2020-04-03/Enjoy-ginger-but-it-s-not-a-cure-for-COVID-19-says-WHO&#x02013;Pn0Wuje3UA/index.html</comment></element-citation></ref><ref id="bib0138"><element-citation publication-type="journal" id="sbref0138"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Y.</given-names></name></person-group><article-title>Use of herbal drugs to treat COVID-19 should be with caution</article-title><source>Lancet N. Am. Ed.</source><volume>395</volume><year>2020</year><fpage>1689</fpage><lpage>1690</lpage></element-citation></ref><ref id="bib0139"><element-citation publication-type="journal" id="sbref0139"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Z.</given-names></name><name><surname>Wu</surname><given-names>K.</given-names></name><name><surname>Xu</surname><given-names>Y.</given-names></name><name><surname>Xia</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Ge</surname><given-names>M.</given-names></name><name><surname>Shao</surname><given-names>L.</given-names></name></person-group><article-title>Three novel chromanones with biological activities from the endophytic fungus Phomopsis CGMCC No. 5416</article-title><source>J. Antibiot. (Tokyo)</source><volume>73</volume><year>2020</year><fpage>194</fpage><lpage>199</lpage><pub-id pub-id-type="pmid">31873196</pub-id></element-citation></ref><ref id="bib0140"><element-citation publication-type="journal" id="sbref0140"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>G.</given-names></name><name><surname>Sun</surname><given-names>S.</given-names></name><name><surname>Zhu</surname><given-names>T.</given-names></name><name><surname>Lin</surname><given-names>Z.</given-names></name><name><surname>Gu</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>D.</given-names></name><name><surname>Gu</surname><given-names>Q.</given-names></name></person-group><article-title>Antiviral isoindolone derivatives from an endophytic fungus <italic>Emericella</italic> sp. associated with <italic>Aegiceras corniculatum</italic></article-title><source>Phytochemistry</source><volume>72</volume><issue>11&#x02013;12</issue><year>2011</year><fpage>1436</fpage><lpage>1442</lpage><pub-id pub-id-type="pmid">21601895</pub-id></element-citation></ref><ref id="bib0141"><element-citation publication-type="journal" id="sbref0141"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>R.</given-names></name><name><surname>Chen</surname><given-names>Z.</given-names></name><name><surname>Wu</surname><given-names>S.S.</given-names></name><name><surname>Xu</surname><given-names>J.</given-names></name><name><surname>Kong</surname><given-names>L.C.</given-names></name><name><surname>Wei</surname><given-names>P.</given-names></name></person-group><article-title>Celastrol enhances the anti-liver cancer activity of Sorafenib</article-title><source>Sci. Monit.</source><volume>25</volume><year>2019</year><fpage>4068</fpage><lpage>4075</lpage></element-citation></ref><ref id="bib0142"><element-citation publication-type="journal" id="sbref0142"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>T.</given-names></name><name><surname>Wu</surname><given-names>Q.</given-names></name><name><surname>Zhang</surname><given-names>Z.</given-names></name></person-group><article-title>Probable pangolin origin of SARS-CoV-2 associated with the COVID-19 outbreak</article-title><source>Curr. Biol.</source><volume>30</volume><year>2020</year><fpage>1346</fpage><lpage>1351</lpage><pub-id pub-id-type="pmid">32197085</pub-id></element-citation></ref><ref id="bib0143"><element-citation publication-type="journal" id="sbref0143"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>H.</given-names></name><name><surname>Michaelis</surname><given-names>M.L.</given-names></name><name><surname>Blagg</surname><given-names>B.S.J.</given-names></name></person-group><article-title>Hsp90 Modulation for the treatment of Alzheimer's disease</article-title><source>Adv. Pharmacol.</source><volume>2012</volume><year>2012</year><fpage>6</fpage></element-citation></ref></ref-list><ack id="ack0001"><title>Acknowledgements</title><p id="para0035">The authors are grateful to Dr Wendy Stirk (Research Center for Plant Growth and Development, University of KwaZulu-Natal, South Africa), May Okafor (University of KwaZulu-Natal, South Africa), Mrs Lee Warren (Research Center for Plant Growth and Development, University of KwaZulu-Natal, South Africa) and Dr. Osariyekemwen Uyi (Pennsylvania State University, United States of America) for their valuable technical support and copy-editing. AGO-U is grateful to the Research Centre for Plant Growth and Development under the University of KwaZulu-Natal for Postdoctoral research funding.</p></ack></back></article>